[
    {
        "_id": "medical_type1_0",
        "type": "factual",
        "question": "What is the most common type of skin cancer?",
        "answer": [
            "Basal cell carcinoma"
        ],
        "original_answer": [
            "Basal cell carcinoma (BCC) is the most common type of skin cancer."
        ],
        "evidence": "Basal cell carcinoma (BCC) is the most common type of skin cancer",
        "context": [
            [
                "60_Basal Cell Skin Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1",
        "type": "factual",
        "question": "From which cell type does basal cell carcinoma arise?",
        "answer": [
            "Basal cells"
        ],
        "original_answer": [
            "Basal cell carcinoma arises from basal cells in the lower part of the epidermis."
        ],
        "evidence": "BCC arises from basal cells in the lower part of the epidermis",
        "context": [
            [
                "60_Basal Cell Skin Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_2",
        "type": "factual",
        "question": "Which anatomical locations are most commonly affected by basal cell carcinoma?",
        "answer": [
            "Face, head, neck"
        ],
        "original_answer": [
            "BCC most commonly develops in sun-exposed areas such as the face, head, and neck."
        ],
        "evidence": "BCC most commonly develops in sun-exposed areas such as the face, head, and neck",
        "context": [
            [
                "60_Basal Cell Skin Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_3",
        "type": "factual",
        "question": "What is the primary risk factor for basal cell carcinoma?",
        "answer": [
            "UV radiation"
        ],
        "original_answer": [
            "UV radiation exposure is a primary risk factor for BCC."
        ],
        "evidence": "UV radiation exposure is a primary risk factor for BCC",
        "context": [
            [
                "60_Basal Cell Skin Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_7",
        "type": "factual",
        "question": "Is immune suppression a risk factor for BCC?",
        "answer": [
            "Immune suppression"
        ],
        "original_answer": [
            "Immune suppression is a risk factor for BCC."
        ],
        "evidence": "Radiation therapy and immune suppression are risk factors for BCC",
        "context": [
            [
                "60_Basal Cell Skin Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_10",
        "type": "factual",
        "question": "What is the most common treatment for basal cell carcinoma?",
        "answer": [
            "Surgery"
        ],
        "original_answer": [
            "Surgery is the most common treatment for BCC."
        ],
        "evidence": "Surgery is the most common treatment for BCC",
        "context": [
            [
                "60_Basal Cell Skin Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_14",
        "type": "factual",
        "question": "Which skin cancer subtype arises from basal cells?",
        "answer": [
            "Basal cell carcinoma"
        ],
        "original_answer": [
            "Basal cell carcinoma is the skin cancer subtype that arises from basal cells."
        ],
        "evidence": "Basal cell carcinoma (BCC) is the most common type of skin cancer",
        "context": [
            [
                "60_Basal Cell Skin Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_16",
        "type": "factual",
        "question": "Is sun exposure a risk factor for BCC?",
        "answer": [
            "Sun exposure"
        ],
        "original_answer": [
            "Sun exposure is a risk factor for BCC."
        ],
        "evidence": "BCC most commonly develops in sun-exposed areas such as the face, head, and neck",
        "context": [
            [
                "60_Basal Cell Skin Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_26",
        "type": "factual",
        "question": "What is a brown or glossy black bump with rolled border a symptom of?",
        "answer": [
            "BCC"
        ],
        "original_answer": [
            "A brown or glossy black bump with rolled border is a symptom of BCC."
        ],
        "evidence": "BCC presents as flat, pale or yellow areas, red patches, shiny bumps, open sores, or brown/black bumps with rolled borders",
        "context": [
            [
                "60_Basal Cell Skin Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_28",
        "type": "factual",
        "question": "Is autoimmune disease associated with increased BCC risk?",
        "answer": [
            "Autoimmune disease"
        ],
        "original_answer": [
            "Autoimmune disease is a risk factor for BCC."
        ],
        "evidence": "Autoimmune disease is listed as a risk factor for BCC in the ontology",
        "context": [
            [
                "60_Basal Cell Skin Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_31",
        "type": "factual",
        "question": "What is the most common type of skin cancer?",
        "answer": [
            "Basal cell carcinoma"
        ],
        "original_answer": [
            "Basal cell carcinoma (BCC) is the most common type of skin cancer."
        ],
        "evidence": "Basal cell carcinoma (BCC) is the most common type of skin cancer",
        "context": [
            [
                "60_Basal Cell Skin Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_32",
        "type": "factual",
        "question": "From which cells does basal cell carcinoma arise?",
        "answer": [
            "Basal cells"
        ],
        "original_answer": [
            "BCC arises from basal cells in the lower part of the epidermis."
        ],
        "evidence": "BCC arises from basal cells in the lower part of the epidermis",
        "context": [
            [
                "60_Basal Cell Skin Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_33",
        "type": "factual",
        "question": "Which anatomical locations are most commonly affected by BCC?",
        "answer": [
            "Face, head, neck"
        ],
        "original_answer": [
            "BCC most commonly develops in sun-exposed areas such as the face, head, and neck."
        ],
        "evidence": "BCC most commonly develops in sun-exposed areas such as the face, head, and neck",
        "context": [
            [
                "60_Basal Cell Skin Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_34",
        "type": "factual",
        "question": "What is the primary risk factor for developing basal cell carcinoma?",
        "answer": [
            "UV radiation"
        ],
        "original_answer": [
            "UV radiation exposure is a primary risk factor for BCC."
        ],
        "evidence": "UV radiation exposure is a primary risk factor for BCC",
        "context": [
            [
                "60_Basal Cell Skin Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_38",
        "type": "factual",
        "question": "Is immune suppression a risk factor for basal cell carcinoma?",
        "answer": [
            "Immune suppression"
        ],
        "original_answer": [
            "Immune suppression is a risk factor for BCC."
        ],
        "evidence": "Radiation therapy and immune suppression are risk factors for BCC",
        "context": [
            [
                "60_Basal Cell Skin Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_41",
        "type": "factual",
        "question": "What is the most common treatment for basal cell carcinoma?",
        "answer": [
            "Surgery"
        ],
        "original_answer": [
            "Surgery is the most common treatment for BCC."
        ],
        "evidence": "Surgery is the most common treatment for BCC",
        "context": [
            [
                "60_Basal Cell Skin Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_44",
        "type": "factual",
        "question": "What is recommended for follow-up after BCC treatment?",
        "answer": [
            "Skin exams"
        ],
        "original_answer": [
            "Follow-up includes full skin exams with a doctor at least once a year."
        ],
        "evidence": "Follow-up includes full skin exams with a doctor at least once a year",
        "context": [
            [
                "60_Basal Cell Skin Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_45",
        "type": "factual",
        "question": "Which cell type is affected in basal cell carcinoma?",
        "answer": [
            "Basal cells"
        ],
        "original_answer": [
            "Basal cells are the cell type affected in BCC."
        ],
        "evidence": "Basal cells",
        "context": [
            [
                "60_Basal Cell Skin Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_46",
        "type": "factual",
        "question": "Is sun exposure a risk factor for BCC?",
        "answer": [
            "Sun exposure"
        ],
        "original_answer": [
            "Sun exposure is a risk factor for BCC."
        ],
        "evidence": "Sun exposure",
        "context": [
            [
                "60_Basal Cell Skin Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_47",
        "type": "factual",
        "question": "Are tanning beds considered a risk factor for BCC?",
        "answer": [
            "Tanning beds"
        ],
        "original_answer": [
            "Tanning beds are a risk factor for BCC."
        ],
        "evidence": "Tanning beds",
        "context": [
            [
                "60_Basal Cell Skin Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_48",
        "type": "factual",
        "question": "Does having red or blond hair increase the risk of BCC?",
        "answer": [
            "Red hair, blond hair"
        ],
        "original_answer": [
            "Red hair and blond hair increase the risk of BCC."
        ],
        "evidence": "Fair skin, light hair, and light eye color increase the risk of BCC",
        "context": [
            [
                "60_Basal Cell Skin Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_49",
        "type": "factual",
        "question": "Is light eye color associated with increased risk of BCC?",
        "answer": [
            "Light eye color"
        ],
        "original_answer": [
            "Light eye color increases the risk of BCC."
        ],
        "evidence": "Fair skin, light hair, and light eye color increase the risk of BCC",
        "context": [
            [
                "60_Basal Cell Skin Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_52",
        "type": "factual",
        "question": "Is autoimmune disease a risk factor for BCC?",
        "answer": [
            "Autoimmune disease"
        ],
        "original_answer": [
            "Autoimmune disease is a risk factor for BCC."
        ],
        "evidence": "Autoimmune disease",
        "context": [
            [
                "60_Basal Cell Skin Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_54",
        "type": "factual",
        "question": "What does a shiny bump on the skin suggest in the context of BCC?",
        "answer": [
            "Shiny bump"
        ],
        "original_answer": [
            "A shiny bump is a symptom of BCC."
        ],
        "evidence": "Shiny bump",
        "context": [
            [
                "60_Basal Cell Skin Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_55",
        "type": "factual",
        "question": "What is the significance of a brown or glossy black bump with rolled border?",
        "answer": [
            "BCC"
        ],
        "original_answer": [
            "A brown or glossy black bump with rolled border is a symptom of BCC."
        ],
        "evidence": "Brown or glossy black bump with rolled border",
        "context": [
            [
                "60_Basal Cell Skin Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_56",
        "type": "factual",
        "question": "Which exams are essential for diagnosing BCC?",
        "answer": [
            "Physical exam, Skin exam"
        ],
        "original_answer": [
            "Physical exam and skin exam are essential for diagnosing BCC."
        ],
        "evidence": "Physical exam, Skin exam",
        "context": [
            [
                "60_Basal Cell Skin Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_57",
        "type": "factual",
        "question": "What role does biopsy play in BCC diagnosis?",
        "answer": [
            "Biopsy"
        ],
        "original_answer": [
            "Biopsy is a diagnostic method for BCC."
        ],
        "evidence": "Biopsy",
        "context": [
            [
                "60_Basal Cell Skin Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_59",
        "type": "factual",
        "question": "What treatments are available for BCC besides surgery?",
        "answer": [
            "Radiation therapy, systemic therapy"
        ],
        "original_answer": [
            "Radiation therapy and systemic therapy are treatments for BCC besides surgery."
        ],
        "evidence": "Radiation therapy or systemic therapy may be used in some cases of BCC",
        "context": [
            [
                "60_Basal Cell Skin Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_62",
        "type": "factual",
        "question": "What is the primary cancer type discussed in this context?",
        "answer": [
            "Primary CNS lymphoma"
        ],
        "original_answer": [
            "Primary CNS lymphoma is the primary cancer type."
        ],
        "evidence": "Primary CNS lymphoma is a rare and aggressive cancer that starts in lymphocytes within the central nervous system",
        "context": [
            [
                "53_Primary Central Nervous System Lymphoma_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_63",
        "type": "factual",
        "question": "Which cells does primary CNS lymphoma originate from?",
        "answer": [
            "Lymphocytes"
        ],
        "original_answer": [
            "Primary CNS lymphoma originates from lymphocytes."
        ],
        "evidence": "Primary CNS lymphoma is a rare and aggressive cancer that starts in lymphocytes within the central nervous system",
        "context": [
            [
                "53_Primary Central Nervous System Lymphoma_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_64",
        "type": "factual",
        "question": "What is the most common location affected by primary CNS lymphoma?",
        "answer": [
            "Brain"
        ],
        "original_answer": [
            "The brain is most commonly affected by primary CNS lymphoma."
        ],
        "evidence": "Primary CNS lymphoma most commonly affects the brain, but can also involve the spinal cord, cerebrospinal fluid, and eyes",
        "context": [
            [
                "53_Primary Central Nervous System Lymphoma_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_65",
        "type": "factual",
        "question": "Name a cancer subtype of primary CNS lymphoma that affects the eyes.",
        "answer": [
            "Vitreoretinal lymphoma"
        ],
        "original_answer": [
            "Vitreoretinal lymphoma is a subtype that affects the eyes."
        ],
        "evidence": "Vitreoretinal lymphoma is a cancer subtype of primary CNS lymphoma that affects the eyes, retina, and vitreous",
        "context": [
            [
                "53_Primary Central Nervous System Lymphoma_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_67",
        "type": "factual",
        "question": "What is a major risk factor for developing primary CNS lymphoma?",
        "answer": [
            "Impaired immune system"
        ],
        "original_answer": [
            "An impaired immune system is a major risk factor."
        ],
        "evidence": "Impaired immune system is a risk factor for primary CNS lymphoma",
        "context": [
            [
                "53_Primary Central Nervous System Lymphoma_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_68",
        "type": "factual",
        "question": "Which viral infection is considered a risk factor for primary CNS lymphoma?",
        "answer": [
            "HIV infection"
        ],
        "original_answer": [
            "HIV infection is a risk factor for primary CNS lymphoma."
        ],
        "evidence": "Immunodeficiency disorders, HIV infection, Epstein-Barr virus, autoimmune diseases, organ transplant, and older age are risk factors for primary CNS lymphoma",
        "context": [
            [
                "53_Primary Central Nervous System Lymphoma_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_71",
        "type": "factual",
        "question": "What is the standard biopsy procedure for diagnosing primary CNS lymphoma?",
        "answer": [
            "Stereotactic biopsy"
        ],
        "original_answer": [
            "Stereotactic biopsy is the standard diagnostic procedure."
        ],
        "evidence": "Stereotactic biopsy is the standard diagnostic procedure for primary CNS lymphoma",
        "context": [
            [
                "53_Primary Central Nervous System Lymphoma_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_73",
        "type": "factual",
        "question": "What is a typical initial clinical assessment for suspected primary CNS lymphoma?",
        "answer": [
            "Neurological exam"
        ],
        "original_answer": [
            "A neurological exam is a typical initial clinical assessment."
        ],
        "evidence": "Primary CNS lymphoma is diagnosed using neurological exam, imaging (MRI or CT), biopsy, blood tests, eye exam, and lumbar puncture",
        "context": [
            [
                "53_Primary Central Nervous System Lymphoma_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_75",
        "type": "factual",
        "question": "What specialized treatment is given if the eyes are involved in primary CNS lymphoma?",
        "answer": [
            "Intraocular chemotherapy"
        ],
        "original_answer": [
            "Intraocular chemotherapy or radiation may be used if the eyes are involved."
        ],
        "evidence": "Intraocular chemotherapy or radiation may be used if the eyes are involved",
        "context": [
            [
                "53_Primary Central Nervous System Lymphoma_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_76",
        "type": "factual",
        "question": "What is the main chemotherapy drug for primary CNS lymphoma?",
        "answer": [
            "High-dose methotrexate"
        ],
        "original_answer": [
            "High-dose methotrexate is the main chemotherapy drug."
        ],
        "evidence": "High-dose methotrexate is the main chemotherapy drug used for primary CNS lymphoma",
        "context": [
            [
                "53_Primary Central Nervous System Lymphoma_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_77",
        "type": "factual",
        "question": "Which immunotherapy drug is primarily used in the treatment of primary CNS lymphoma?",
        "answer": [
            "Rituximab"
        ],
        "original_answer": [
            "Rituximab is the main immunotherapy drug used."
        ],
        "evidence": "Rituximab is the main immunotherapy drug used for primary CNS lymphoma",
        "context": [
            [
                "53_Primary Central Nervous System Lymphoma_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_78",
        "type": "factual",
        "question": "What is the most commonly used radiation technique for primary CNS lymphoma?",
        "answer": [
            "Whole-brain radiation therapy"
        ],
        "original_answer": [
            "Whole-brain radiation therapy (WBRT) is the most commonly used technique."
        ],
        "evidence": "Whole-brain radiation therapy (WBRT) is the most commonly used radiation technique for primary CNS lymphoma",
        "context": [
            [
                "53_Primary Central Nervous System Lymphoma_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_79",
        "type": "factual",
        "question": "What are the two main treatment phases for primary CNS lymphoma?",
        "answer": [
            "Induction, consolidation"
        ],
        "original_answer": [
            "Treatment is typically given in phases: induction and consolidation."
        ],
        "evidence": "Treatment is typically given in phases: induction and consolidation",
        "context": [
            [
                "53_Primary Central Nervous System Lymphoma_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_81",
        "type": "factual",
        "question": "Which performance measure is evaluated to guide treatment decisions in primary CNS lymphoma?",
        "answer": [
            "Performance status"
        ],
        "original_answer": [
            "Performance status is evaluated to guide treatment decisions and eligibility for clinical trials."
        ],
        "evidence": "Performance status is evaluated to guide treatment decisions and eligibility for clinical trials",
        "context": [
            [
                "53_Primary Central Nervous System Lymphoma_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_82",
        "type": "factual",
        "question": "What is recommended for all patients with primary CNS lymphoma regarding research participation?",
        "answer": [
            "Clinical trial participation"
        ],
        "original_answer": [
            "Clinical trial participation is recommended for all patients."
        ],
        "evidence": "Clinical trial participation is recommended for all patients with primary CNS lymphoma",
        "context": [
            [
                "53_Primary Central Nervous System Lymphoma_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_83",
        "type": "factual",
        "question": "Name three neurological symptoms commonly caused by primary CNS lymphoma.",
        "answer": [
            "Leg weakness, confusion, seizures"
        ],
        "original_answer": [
            "Leg weakness, confusion, and seizures are common neurological symptoms."
        ],
        "evidence": "Primary CNS lymphoma can cause neurological symptoms such as leg or arm weakness, coordination or movement difficulties, personality or behavior changes, depression, confusion, memory problems, incontinence, difficulty speaking or swallowing, headaches, nausea, vomiting, seizures, and vision changes",
        "context": [
            [
                "53_Primary Central Nervous System Lymphoma_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_84",
        "type": "factual",
        "question": "Which diagnostic method is used to assess eye involvement in primary CNS lymphoma?",
        "answer": [
            "Eye exam"
        ],
        "original_answer": [
            "Eye exam is used to assess eye involvement."
        ],
        "evidence": "Primary CNS lymphoma is diagnosed using neurological exam, imaging (MRI or CT), biopsy, blood tests, eye exam, and lumbar puncture",
        "context": [
            [
                "53_Primary Central Nervous System Lymphoma_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_85",
        "type": "factual",
        "question": "What follow-up method is recommended for surveillance after treatment of primary CNS lymphoma?",
        "answer": [
            "Repeat MRI"
        ],
        "original_answer": [
            "Repeat MRI is recommended for follow-up surveillance."
        ],
        "evidence": "Follow-up/Surveillance includes Repeat MRI",
        "context": [
            [
                "53_Primary Central Nervous System Lymphoma_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_86",
        "type": "factual",
        "question": "Which age group is at higher risk for primary CNS lymphoma?",
        "answer": [
            "Older adults"
        ],
        "original_answer": [
            "Older adults are at higher risk."
        ],
        "evidence": "Older age is a risk factor for primary CNS lymphoma",
        "context": [
            [
                "53_Primary Central Nervous System Lymphoma_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_89",
        "type": "factual",
        "question": "Which procedure is included in laboratory tests for diagnosing primary CNS lymphoma?",
        "answer": [
            "Lactate dehydrogenase (LDH"
        ],
        "original_answer": [
            "Lactate dehydrogenase (LDH) testing is included in laboratory tests."
        ],
        "evidence": "Laboratory Tests include Lactate dehydrogenase (LDH)",
        "context": [
            [
                "53_Primary Central Nervous System Lymphoma_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_92",
        "type": "factual",
        "question": "Which imaging technique uses gadolinium contrast for better visualization in primary CNS lymphoma?",
        "answer": [
            "MRI"
        ],
        "original_answer": [
            "MRI uses gadolinium contrast for better visualization."
        ],
        "evidence": "MRI with gadolinium contrast is the most useful imaging technique for identifying primary CNS lymphoma",
        "context": [
            [
                "53_Primary Central Nervous System Lymphoma_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_94",
        "type": "factual",
        "question": "What is the second most common type of skin cancer?",
        "answer": [
            "Squamous cell skin cancer"
        ],
        "original_answer": [
            "Squamous cell skin cancer (CSCC) is the second most common type of skin cancer."
        ],
        "evidence": "Squamous cell skin cancer (CSCC) is the second most common type of skin cancer",
        "context": [
            [
                "38_Squamous Cell Skin Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_95",
        "type": "factual",
        "question": "Which cancer subtype is classified as a type of nonmelanoma skin cancer?",
        "answer": [
            "CSCC"
        ],
        "original_answer": [
            "CSCC is a type of nonmelanoma skin cancer."
        ],
        "evidence": "CSCC is a type of nonmelanoma skin cancer",
        "context": [
            [
                "38_Squamous Cell Skin Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_97",
        "type": "factual",
        "question": "What is a precancerous lesion that can progress to CSCC?",
        "answer": [
            "Actinic keratosis"
        ],
        "original_answer": [
            "Actinic keratosis is a precancerous lesion that can progress to CSCC."
        ],
        "evidence": "Actinic keratosis is a precancerous lesion that can progress to CSCC",
        "context": [
            [
                "38_Squamous Cell Skin Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_99",
        "type": "factual",
        "question": "Which genetic syndromes increase the risk for CSCC?",
        "answer": [
            "Xeroderma pigmentosum, RDE"
        ],
        "original_answer": [
            "Xeroderma pigmentosum and RDEB increase risk for CSCC."
        ],
        "evidence": "Genetic syndromes such as xeroderma pigmentosum and RDEB increase risk for CSCC",
        "context": [
            [
                "38_Squamous Cell Skin Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_106",
        "type": "factual",
        "question": "What is the preferred treatment for metastatic CSCC?",
        "answer": [
            "Immunotherapy"
        ],
        "original_answer": [
            "Metastatic CSCC is treated with systemic therapy (immunotherapy preferred), and surgery or radiation if feasible."
        ],
        "evidence": "Metastatic CSCC is treated with systemic therapy (immunotherapy preferred), and surgery or radiation if feasible",
        "context": [
            [
                "38_Squamous Cell Skin Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_108",
        "type": "factual",
        "question": "What therapies are used for actinic keratoses and superficial CSCC?",
        "answer": [
            "Photodynamic therapy"
        ],
        "original_answer": [
            "Photodynamic therapy, cryotherapy, and topical therapies (5-fluorouracil, imiquimod, tirbanibulin) are used for actinic keratoses and superficial CSCC."
        ],
        "evidence": "Photodynamic therapy, cryotherapy, and topical therapies (5-fluorouracil, imiquimod, tirbanibulin) are used for actinic keratoses and superficial CSCC",
        "context": [
            [
                "38_Squamous Cell Skin Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_110",
        "type": "factual",
        "question": "What is a key biomarker used in risk assessment for CSCC?",
        "answer": [
            "Perineural invasion"
        ],
        "original_answer": [
            "Perineural invasion is a key biomarker for CSCC risk assessment."
        ],
        "evidence": "Perineural invasion is listed as a biomarker in the ontology for CSCC",
        "context": [
            [
                "38_Squamous Cell Skin Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_115",
        "type": "factual",
        "question": "What are the main symptoms of CSCC in areas of chronic damage?",
        "answer": [
            "Lesions"
        ],
        "original_answer": [
            "Lesions in areas of chronic wounds or scars are a main symptom of CSCC."
        ],
        "evidence": "Symptoms of CSCC include lesions in areas of chronic damage",
        "context": [
            [
                "38_Squamous Cell Skin Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_117",
        "type": "factual",
        "question": "What is the preferred surgical method for high-risk local CSCC?",
        "answer": [
            "Mohs surgery"
        ],
        "original_answer": [
            "Mohs surgery/PDEMA is the preferred surgical method for high-risk local CSCC."
        ],
        "evidence": "Mohs surgery/PDEMA (preferred) is listed for high-risk local CSCC",
        "context": [
            [
                "38_Squamous Cell Skin Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_120",
        "type": "factual",
        "question": "Which immunotherapy agents are used for metastatic CSCC?",
        "answer": [
            "PD-1 inhibitors"
        ],
        "original_answer": [
            "PD-1 inhibitors such as cemiplimab and pembrolizumab are used for metastatic CSCC."
        ],
        "evidence": "PD-1 inhibitors (cemiplimab, pembrolizumab) are listed as systemic therapy options for metastatic CSCC",
        "context": [
            [
                "38_Squamous Cell Skin Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_122",
        "type": "factual",
        "question": "What is the preferred systemic therapy for metastatic CSCC?",
        "answer": [
            "PD-1 inhibitor"
        ],
        "original_answer": [
            "PD-1 inhibitor is the preferred systemic therapy for metastatic CSCC."
        ],
        "evidence": "Systemic therapy (PD-1 inhibitor preferred) is listed for metastatic CSCC",
        "context": [
            [
                "38_Squamous Cell Skin Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_124",
        "type": "factual",
        "question": "Which clinical management strategy is used for surveillance in high-risk or regional CSCC?",
        "answer": [
            "Surveillance"
        ],
        "original_answer": [
            "Surveillance involves regular skin and lymph node exams and imaging for high-risk or regional disease."
        ],
        "evidence": "Surveillance: Regular skin and lymph node exams, imaging for high-risk or regional disease",
        "context": [
            [
                "38_Squamous Cell Skin Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_125",
        "type": "factual",
        "question": "What type of cancer is chronic myeloid leukemia (CML)?",
        "answer": [
            "Chronic myeloid leukemia"
        ],
        "original_answer": [
            "CML is a type of blood cancer."
        ],
        "evidence": "Chronic myeloid leukemia (CML) is a type of blood cancer",
        "context": [
            [
                "7_Chronic Myeloid Leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_126",
        "type": "factual",
        "question": "What genetic alteration causes chronic myeloid leukemia?",
        "answer": [
            "BCR::ABL1 fusion gene"
        ],
        "original_answer": [
            "CML is caused by the BCR::ABL1 fusion gene."
        ],
        "evidence": "CML is caused by the BCR::ABL1 fusion gene",
        "context": [
            [
                "7_Chronic Myeloid Leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_128",
        "type": "factual",
        "question": "What is the Philadelphia chromosome?",
        "answer": [
            "Philadelphia chromosome"
        ],
        "original_answer": [
            "The Philadelphia chromosome (Ph) is the abnormal chromosome 22 resulting from the translocation."
        ],
        "evidence": "The Philadelphia chromosome (Ph) is the abnormal chromosome 22 resulting from this translocation",
        "context": [
            [
                "7_Chronic Myeloid Leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_129",
        "type": "factual",
        "question": "What is required for a diagnosis of CML?",
        "answer": [
            "Ph chromosome, BCR::ABL1 gene"
        ],
        "original_answer": [
            "Presence of the Ph chromosome or BCR::ABL1 gene is required for CML diagnosis."
        ],
        "evidence": "Presence of the Ph chromosome or BCR::ABL1 gene is required for CML diagnosis",
        "context": [
            [
                "7_Chronic Myeloid Leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_130",
        "type": "factual",
        "question": "From which cells does CML arise?",
        "answer": [
            "Blood stem cells"
        ],
        "original_answer": [
            "CML arises from blood stem cells producing increased myeloid progenitor cells."
        ],
        "evidence": "CML arises from blood stem cells producing increased myeloid progenitor cells",
        "context": [
            [
                "7_Chronic Myeloid Leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_131",
        "type": "factual",
        "question": "What are the two main diagnostic methods for CML?",
        "answer": [
            "Blood tests, bone marrow tests"
        ],
        "original_answer": [
            "Blood tests and bone marrow tests are used to diagnose CML."
        ],
        "evidence": "Blood tests and bone marrow tests are used to diagnose CML",
        "context": [
            [
                "7_Chronic Myeloid Leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_132",
        "type": "factual",
        "question": "Which biomarker is associated with CML?",
        "answer": [
            "BCR::ABL1 fusion gene"
        ],
        "original_answer": [
            "The BCR::ABL1 fusion gene is a biomarker for CML."
        ],
        "evidence": "Biomarker: BCR::ABL1 fusion gene",
        "context": [
            [
                "7_Chronic Myeloid Leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_133",
        "type": "factual",
        "question": "What is the abnormal chromosome found in most CML cases?",
        "answer": [
            "Philadelphia chromosome"
        ],
        "original_answer": [
            "The Philadelphia chromosome (Ph) is the abnormal chromosome found in CML."
        ],
        "evidence": "Biomarker: Philadelphia chromosome (Ph)",
        "context": [
            [
                "7_Chronic Myeloid Leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_135",
        "type": "factual",
        "question": "Which blood cell types are increased in CML?",
        "answer": [
            "White blood cells"
        ],
        "original_answer": [
            "CML is characterized by increased white blood cells (granulocytes) and abnormal platelet counts."
        ],
        "evidence": "CML is characterized by increased white blood cells (granulocytes) and abnormal platelet counts",
        "context": [
            [
                "7_Chronic Myeloid Leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_137",
        "type": "factual",
        "question": "Which chromosomes are involved in the translocation that creates the BCR::ABL1 fusion gene?",
        "answer": [
            "Chromosome 9, Chromosome 22"
        ],
        "original_answer": [
            "Chromosome 9 and chromosome 22 are involved in the translocation."
        ],
        "evidence": "The BCR::ABL1 gene is created by a translocation between chromosome 9 and chromosome 22",
        "context": [
            [
                "7_Chronic Myeloid Leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_138",
        "type": "factual",
        "question": "What is the abnormality found on chromosome 22 in CML?",
        "answer": [
            "Philadelphia chromosome"
        ],
        "original_answer": [
            "The Philadelphia chromosome (Ph) is the abnormality found on chromosome 22."
        ],
        "evidence": "The Philadelphia chromosome (Ph) is the abnormal chromosome 22 resulting from this translocation",
        "context": [
            [
                "7_Chronic Myeloid Leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_139",
        "type": "factual",
        "question": "Which fusion gene is necessary for the diagnosis of CML?",
        "answer": [
            "BCR::ABL1 fusion gene"
        ],
        "original_answer": [
            "The BCR::ABL1 fusion gene is necessary for the diagnosis of CML."
        ],
        "evidence": "Presence of the Ph chromosome or BCR::ABL1 gene is required for CML diagnosis",
        "context": [
            [
                "7_Chronic Myeloid Leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_140",
        "type": "factual",
        "question": "Which phase of CML is considered advanced?",
        "answer": [
            "Blast phase CML"
        ],
        "original_answer": [
            "Blast phase CML (BP-CML) is considered advanced."
        ],
        "evidence": "Blast phase CML (BP-CML) is an advanced form of CML with increased blasts",
        "context": [
            [
                "7_Chronic Myeloid Leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_144",
        "type": "factual",
        "question": "What chromosomal abnormality is characteristic of CML?",
        "answer": [
            "Philadelphia chromosome"
        ],
        "original_answer": [
            "The Philadelphia chromosome (Ph) is characteristic of CML."
        ],
        "evidence": "Chromosomal Abnormality: Philadelphia chromosome (Ph)",
        "context": [
            [
                "7_Chronic Myeloid Leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_145",
        "type": "factual",
        "question": "Which treatment strategy targets the abnormal protein in CML?",
        "answer": [
            "BCR::ABL1 protein inhibition"
        ],
        "original_answer": [
            "BCR::ABL1 protein inhibition is the treatment strategy."
        ],
        "evidence": "Treatment: BCR::ABL1 protein inhibition",
        "context": [
            [
                "7_Chronic Myeloid Leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_146",
        "type": "factual",
        "question": "What is the result of the translocation between chromosome 9 and 22?",
        "answer": [
            "Philadelphia chromosome"
        ],
        "original_answer": [
            "The result is the formation of the Philadelphia chromosome (Ph) and the BCR::ABL1 fusion gene."
        ],
        "evidence": "The BCR::ABL1 gene is created by a translocation between chromosome 9 and chromosome 22",
        "context": [
            [
                "7_Chronic Myeloid Leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_147",
        "type": "factual",
        "question": "Which phase of CML is associated with increased blasts in the blood or bone marrow?",
        "answer": [
            "Blast phase CML"
        ],
        "original_answer": [
            "Blast phase CML (BP-CML) is associated with increased blasts."
        ],
        "evidence": "Blast phase CML (BP-CML) is an advanced form of CML with increased blasts",
        "context": [
            [
                "7_Chronic Myeloid Leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_148",
        "type": "factual",
        "question": "Which two main laboratory methods are used for CML diagnosis?",
        "answer": [
            "Blood tests, bone marrow tests"
        ],
        "original_answer": [
            "Blood test and bone marrow test are the main methods."
        ],
        "evidence": "Blood tests and bone marrow tests are used to diagnose CML",
        "context": [
            [
                "7_Chronic Myeloid Leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_150",
        "type": "factual",
        "question": "Which blood cell types may show abnormal counts in CML?",
        "answer": [
            "White blood cells, platelets"
        ],
        "original_answer": [
            "White blood cells (granulocytes) and platelets (PLTs) may show abnormal counts."
        ],
        "evidence": "CML is characterized by increased white blood cells (granulocytes) and abnormal platelet counts",
        "context": [
            [
                "7_Chronic Myeloid Leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_153",
        "type": "factual",
        "question": "Which chromosomes are specifically mentioned as being involved in CML pathogenesis?",
        "answer": [
            "Chromosome 9, Chromosome 22"
        ],
        "original_answer": [
            "Chromosome 9 and chromosome 22 are involved."
        ],
        "evidence": "Chromosomal Abnormality: chromosome 9, chromosome 22",
        "context": [
            [
                "7_Chronic Myeloid Leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_156",
        "type": "factual",
        "question": "What is the most common type of lung cancer?",
        "answer": [
            "NSCLC"
        ],
        "original_answer": [
            "NSCLC is the most common type of lung cancer."
        ],
        "evidence": "NSCLC is the most common type of lung cancer",
        "context": [
            [
                "11_Lung Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_162",
        "type": "factual",
        "question": "What stages of NSCLC are considered locally advanced?",
        "answer": [
            "Stage 2, Stage 3 NSCLC"
        ],
        "original_answer": [
            "Stage 2 and Stage 3 NSCLC are considered locally advanced."
        ],
        "evidence": "Stage 2 and Stage 3 NSCLC are considered locally advanced",
        "context": [
            [
                "11_Lung Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_163",
        "type": "factual",
        "question": "What is the classification of Stage 4 NSCLC at diagnosis?",
        "answer": [
            "Stage 4 NSCLC"
        ],
        "original_answer": [
            "Stage 4 NSCLC is metastatic at diagnosis."
        ],
        "evidence": "Stage 4 NSCLC is metastatic at diagnosis",
        "context": [
            [
                "11_Lung Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_165",
        "type": "factual",
        "question": "What is the primary treatment for early or locally advanced NSCLC when possible?",
        "answer": [
            "Surgery"
        ],
        "original_answer": [
            "Surgery is a primary treatment for early or locally advanced NSCLC when possible."
        ],
        "evidence": "Surgery is a primary treatment for early or locally advanced NSCLC when possible",
        "context": [
            [
                "11_Lung Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_166",
        "type": "factual",
        "question": "Which treatment is used for some early NSCLC cases?",
        "answer": [
            "Radiation therapy"
        ],
        "original_answer": [
            "Radiation therapy is used for some early NSCLC cases."
        ],
        "evidence": "Radiation therapy is used for some early NSCLC cases",
        "context": [
            [
                "11_Lung Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_167",
        "type": "factual",
        "question": "What treatment is used for some locally advanced NSCLC cases?",
        "answer": [
            "Chemoradiation"
        ],
        "original_answer": [
            "Chemoradiation is used for some locally advanced NSCLC cases."
        ],
        "evidence": "Chemoradiation is used for some locally advanced NSCLC cases",
        "context": [
            [
                "11_Lung Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_168",
        "type": "factual",
        "question": "What type of care extends and enhances life for people with lung cancer?",
        "answer": [
            "Supportive care"
        ],
        "original_answer": [
            "Supportive care extends and enhances life for people with lung cancer."
        ],
        "evidence": "Supportive care extends and enhances life for people with lung cancer",
        "context": [
            [
                "11_Lung Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_170",
        "type": "factual",
        "question": "What diagnostic method is used to confirm lung cancer diagnosis?",
        "answer": [
            "Biopsy"
        ],
        "original_answer": [
            "Biopsy is used to confirm lung cancer diagnosis."
        ],
        "evidence": "Biopsy is used to confirm lung cancer diagnosis",
        "context": [
            [
                "11_Lung Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_171",
        "type": "factual",
        "question": "Who is recommended to undergo lung cancer screening?",
        "answer": [
            "High risk individuals"
        ],
        "original_answer": [
            "Lung cancer screening is recommended for people at high risk."
        ],
        "evidence": "Lung cancer screening is recommended for people at high risk",
        "context": [
            [
                "11_Lung Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_172",
        "type": "factual",
        "question": "What is the biggest risk factor for lung cancer?",
        "answer": [
            "Tobacco smoking"
        ],
        "original_answer": [
            "Tobacco smoking is the biggest risk factor for lung cancer."
        ],
        "evidence": "Tobacco smoking is the biggest risk factor for lung cancer",
        "context": [
            [
                "11_Lung Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_174",
        "type": "factual",
        "question": "List environmental risk factors for lung cancer besides tobacco.",
        "answer": [
            "Radon, asbestos, arsenic, air pollution"
        ],
        "original_answer": [
            "Exposure to radon, asbestos, arsenic, beryllium, cadmium, chromium, nickel, coal smoke, soot, silica, diesel fumes, and air pollution are risk factors for lung cancer."
        ],
        "evidence": "Exposure to radon, asbestos, arsenic, beryllium, cadmium, chromium, nickel, coal smoke, soot, silica, diesel fumes, and air pollution are risk factors for lung cancer",
        "context": [
            [
                "11_Lung Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_184",
        "type": "factual",
        "question": "Which symptoms are specifically associated with NSCLC?",
        "answer": [
            "Cough, chest pain"
        ],
        "original_answer": [
            "Cough and chest pain are symptoms associated with NSCLC."
        ],
        "evidence": "Symptoms of NSCLC include cough and chest pain",
        "context": [
            [
                "11_Lung Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_186",
        "type": "factual",
        "question": "What is the relationship between NSCLC and lung carcinoma?",
        "answer": [
            "NSCLC, lung carcinoma"
        ],
        "original_answer": [
            "NSCLC is a type of lung carcinoma."
        ],
        "evidence": "NSCLC is a type of lung carcinoma",
        "context": [
            [
                "11_Lung Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_187",
        "type": "factual",
        "question": "What type of cancer is nasopharyngeal carcinoma (NPC)?",
        "answer": [
            "Nasopharyngeal carcinoma"
        ],
        "original_answer": [
            "Nasopharyngeal carcinoma (NPC) is a type of head and neck cancer that affects the nasopharynx."
        ],
        "evidence": "Nasopharyngeal carcinoma (NPC) is a type of head and neck cancer that affects the nasopharynx",
        "context": [
            [
                "43_Nasopharyngeal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_188",
        "type": "factual",
        "question": "What is the most common subtype of nasopharyngeal cancer?",
        "answer": [
            "Squamous cell carcinoma"
        ],
        "original_answer": [
            "Squamous cell carcinoma (SCC) is the most common subtype of nasopharyngeal cancer."
        ],
        "evidence": "Squamous cell carcinoma (SCC) is the most common subtype of nasopharyngeal cancer",
        "context": [
            [
                "43_Nasopharyngeal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_189",
        "type": "factual",
        "question": "Which anatomical site is affected by nasopharyngeal carcinoma?",
        "answer": [
            "Nasopharynx"
        ],
        "original_answer": [
            "Nasopharyngeal carcinoma affects the nasopharynx."
        ],
        "evidence": "Nasopharyngeal carcinoma (NPC) is a type of head and neck cancer that affects the nasopharynx",
        "context": [
            [
                "43_Nasopharyngeal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_190",
        "type": "factual",
        "question": "What system is used to stage nasopharyngeal carcinoma?",
        "answer": [
            "AJCC TNM system"
        ],
        "original_answer": [
            "NPC is staged using the AJCC TNM system."
        ],
        "evidence": "NPC is staged using the AJCC TNM system, which includes tumor size (T), lymph node involvement (N), and distant metastasis (M)",
        "context": [
            [
                "43_Nasopharyngeal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_192",
        "type": "factual",
        "question": "Which virus is most commonly associated with nasopharyngeal carcinoma?",
        "answer": [
            "Epstein-Barr virus"
        ],
        "original_answer": [
            "Epstein-Barr virus (EBV) is most commonly associated with NPC."
        ],
        "evidence": "Most NPCs are related to Epstein-Barr virus (EBV) infection",
        "context": [
            [
                "43_Nasopharyngeal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_193",
        "type": "factual",
        "question": "List two risk factors for nasopharyngeal carcinoma.",
        "answer": [
            "Epstein-Barr virus, tobacco use"
        ],
        "original_answer": [
            "Epstein-Barr virus (EBV) infection and tobacco use are risk factors."
        ],
        "evidence": "Risk Factor: [\"Epstein-Barr virus (EBV)\", \"Tobacco use\", \"Alcohol use\", \"Geographic origin (Asia, Native America, North Africa)\"]",
        "context": [
            [
                "43_Nasopharyngeal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_195",
        "type": "factual",
        "question": "What are two common symptoms of nasopharyngeal carcinoma?",
        "answer": [
            "Enlarged lymph nodes, hearing loss"
        ],
        "original_answer": [
            "Enlarged lymph nodes and hearing loss are common symptoms."
        ],
        "evidence": "Symptom: [\"Enlarged lymph nodes\", \"Hearing loss\", \"Symptoms may be absent until advanced stage\"]",
        "context": [
            [
                "43_Nasopharyngeal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_196",
        "type": "factual",
        "question": "Which imaging methods are used for diagnosis of NPC?",
        "answer": [
            "CT, MRI, PET/CT, ultrasound"
        ],
        "original_answer": [
            "CT scan, MRI, PET/CT, and ultrasound are used for diagnosis."
        ],
        "evidence": "Diagnosis of NPC involves medical history, physical exam, imaging (CT, MRI, PET/CT, ultrasound), and biopsy",
        "context": [
            [
                "43_Nasopharyngeal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_198",
        "type": "factual",
        "question": "Which biomarker tests are recommended for nasopharyngeal carcinoma?",
        "answer": [
            "EBV DNA, MSI-H/dMMR"
        ],
        "original_answer": [
            "EBV DNA, MSI-H/dMMR, PD-L1, HPV, and tumor mutational burden are recommended biomarker tests."
        ],
        "evidence": "Biomarker testing for NPC includes EBV DNA, MSI-H/dMMR, PD-L1, HPV, and tumor mutational burden",
        "context": [
            [
                "43_Nasopharyngeal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_199",
        "type": "factual",
        "question": "Which performance measure is considered in NPC treatment planning?",
        "answer": [
            "Performance status"
        ],
        "original_answer": [
            "Performance status is considered in NPC treatment planning."
        ],
        "evidence": "Performance status is considered in NPC treatment planning",
        "context": [
            [
                "43_Nasopharyngeal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_201",
        "type": "factual",
        "question": "Which organs are common sites for metastasis from nasopharyngeal carcinoma?",
        "answer": [
            "Lymph nodes, lungs"
        ],
        "original_answer": [
            "NPC commonly spreads to lymph nodes in the neck and less frequently to the lungs."
        ],
        "evidence": "NPC commonly spreads to lymph nodes in the neck and less frequently to the lungs",
        "context": [
            [
                "43_Nasopharyngeal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_207",
        "type": "factual",
        "question": "Which factors are considered prognostic in NPC?",
        "answer": [
            "EBV DNA level, performance status"
        ],
        "original_answer": [
            "EBV DNA level and performance status are prognostic factors."
        ],
        "evidence": "Prognostic Factor: [\"EBV DNA level\", \"Performance status\"]",
        "context": [
            [
                "43_Nasopharyngeal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_213",
        "type": "factual",
        "question": "Which populations are at increased risk for NPC due to geographic origin?",
        "answer": [
            "Asia, Native America, North Africa"
        ],
        "original_answer": [
            "People from Asia, Native America, and North Africa are at increased risk."
        ],
        "evidence": "NPC most often occurs in people from parts of Asia, Native America, and North Africa",
        "context": [
            [
                "43_Nasopharyngeal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_215",
        "type": "factual",
        "question": "Which biomarker is tested both before and after NPC treatment?",
        "answer": [
            "EBV DNA"
        ],
        "original_answer": [
            "EBV DNA is tested both before and after NPC treatment."
        ],
        "evidence": "EBV DNA testing is performed before and after treatment for NPC",
        "context": [
            [
                "43_Nasopharyngeal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_216",
        "type": "factual",
        "question": "Which additional counseling is recommended for patients concerned about fertility before NPC treatment?",
        "answer": [
            "Fertility counseling"
        ],
        "original_answer": [
            "Fertility counseling is recommended before NPC treatment."
        ],
        "evidence": "Fertility counseling",
        "context": [
            [
                "43_Nasopharyngeal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_217",
        "type": "factual",
        "question": "What is the primary cancer subtype found in the nasopharynx?",
        "answer": [
            "Nasopharyngeal carcinoma"
        ],
        "original_answer": [
            "Nasopharyngeal carcinoma (NPC) is the primary cancer subtype found in the nasopharynx."
        ],
        "evidence": "Cancer Subtype: {\"Nasopharyngeal carcinoma (NPC)\"}",
        "context": [
            [
                "43_Nasopharyngeal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_218",
        "type": "factual",
        "question": "Which two lifestyle factors increase the risk of head and neck cancer?",
        "answer": [
            "Tobacco, alcohol"
        ],
        "original_answer": [
            "Tobacco and alcohol use are risk factors for head and neck cancer."
        ],
        "evidence": "Tobacco and alcohol use are risk factors for head and neck cancer",
        "context": [
            [
                "43_Nasopharyngeal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_219",
        "type": "factual",
        "question": "What type of cancer is colon cancer classified as?",
        "answer": [
            "Colorectal cancer"
        ],
        "original_answer": [
            "Colon cancer is a type of colorectal cancer."
        ],
        "evidence": "Colon cancer is a type of colorectal cancer",
        "context": [
            [
                "8_Colon Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_220",
        "type": "factual",
        "question": "What is the most common subtype of colon cancer?",
        "answer": [
            "Adenocarcinoma"
        ],
        "original_answer": [
            "Adenocarcinoma is the most common subtype of colon cancer."
        ],
        "evidence": "Adenocarcinoma is the most common subtype of colon cancer",
        "context": [
            [
                "8_Colon Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_221",
        "type": "factual",
        "question": "From which type of polyp do most colon cancers originate?",
        "answer": [
            "Adenomas"
        ],
        "original_answer": [
            "Most colon cancers start in polyps, especially adenomas."
        ],
        "evidence": "Most colon cancers start in polyps, especially adenomas",
        "context": [
            [
                "8_Colon Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_223",
        "type": "factual",
        "question": "Which types of polyps rarely become cancerous in the colon?",
        "answer": [
            "Hyperplastic polyps, inflammatory polyps"
        ],
        "original_answer": [
            "Hyperplastic and inflammatory polyps rarely become cancer."
        ],
        "evidence": "Hyperplastic and inflammatory polyps rarely become cancer",
        "context": [
            [
                "8_Colon Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_224",
        "type": "factual",
        "question": "What procedure is used to remove polyps during colonoscopy?",
        "answer": [
            "Polypectomy"
        ],
        "original_answer": [
            "Polypectomy removes polyps during colonoscopy."
        ],
        "evidence": "Polypectomy removes polyps during colonoscopy",
        "context": [
            [
                "8_Colon Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_225",
        "type": "factual",
        "question": "What surgery removes the cancerous part of the colon?",
        "answer": [
            "Colectomy"
        ],
        "original_answer": [
            "Colectomy is surgery to remove the cancerous part of the colon."
        ],
        "evidence": "Colectomy is surgery to remove the cancerous part of the colon",
        "context": [
            [
                "8_Colon Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_227",
        "type": "factual",
        "question": "Which system is used to stage colon cancer?",
        "answer": [
            "AJCC TNM system"
        ],
        "original_answer": [
            "AJCC TNM system is used to stage colon cancer."
        ],
        "evidence": "AJCC TNM system is used to stage colon cancer",
        "context": [
            [
                "8_Colon Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_233",
        "type": "factual",
        "question": "Which biomarker testing is recommended for all colon cancers?",
        "answer": [
            "dMMR, MSI-H"
        ],
        "original_answer": [
            "All colon cancers should be tested for mismatch repair deficiency (dMMR) or microsatellite instability-high (MSI-H)."
        ],
        "evidence": "All colon cancers should be tested for mismatch repair deficiency (dMMR) or microsatellite instability-high (MSI-H)",
        "context": [
            [
                "8_Colon Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_234",
        "type": "factual",
        "question": "Which biomarker guides immunotherapy in colon cancer?",
        "answer": [
            "dMMR/MSI-H"
        ],
        "original_answer": [
            "dMMR/MSI-H is a biomarker guiding immunotherapy."
        ],
        "evidence": "dMMR/MSI-H is a biomarker guiding immunotherapy",
        "context": [
            [
                "8_Colon Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_236",
        "type": "factual",
        "question": "Which inherited syndromes increase the risk of colon cancer?",
        "answer": [
            "Lynch syndrome, familial adenomatous polypos"
        ],
        "original_answer": [
            "Lynch syndrome and familial adenomatous polyposis (FAP) are inherited syndromes increasing colon cancer risk."
        ],
        "evidence": "Lynch syndrome and familial adenomatous polyposis (FAP) are inherited syndromes increasing colon cancer risk",
        "context": [
            [
                "8_Colon Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_237",
        "type": "factual",
        "question": "Is family history a risk factor for colon cancer?",
        "answer": [
            "Family history"
        ],
        "original_answer": [
            "Family history of colorectal cancer is a risk factor."
        ],
        "evidence": "Family history of colorectal cancer is a risk factor",
        "context": [
            [
                "8_Colon Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_239",
        "type": "factual",
        "question": "Which biomarker is used for monitoring colon cancer?",
        "answer": [
            "CEA"
        ],
        "original_answer": [
            "CEA is a biomarker for monitoring colon cancer."
        ],
        "evidence": "CEA is a biomarker for monitoring colon cancer",
        "context": [
            [
                "8_Colon Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_240",
        "type": "factual",
        "question": "What is the main imaging test for staging and surveillance of colon cancer?",
        "answer": [
            "CT with contrast"
        ],
        "original_answer": [
            "CT with contrast is the main imaging test for staging and surveillance."
        ],
        "evidence": "CT with contrast is the main imaging test for staging and surveillance",
        "context": [
            [
                "8_Colon Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_243",
        "type": "factual",
        "question": "What adjuvant therapy is recommended after colectomy for stage 3 colon cancer?",
        "answer": [
            "Chemotherapy"
        ],
        "original_answer": [
            "Chemotherapy is recommended after colectomy for all stage 3 and some stage 2 colon cancers."
        ],
        "evidence": "Chemotherapy is recommended after colectomy for all stage 3 and some stage 2 colon cancers",
        "context": [
            [
                "8_Colon Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_247",
        "type": "factual",
        "question": "Which surgical procedures are included in colon cancer treatment?",
        "answer": [
            "Polypectomy, colectomy, colostomy"
        ],
        "original_answer": [
            "Polypectomy, colectomy, and colostomy are surgical procedures used in colon cancer treatment."
        ],
        "evidence": "Polypectomy, colectomy, and colostomy are surgical procedures used in colon cancer treatment",
        "context": [
            [
                "8_Colon Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_249",
        "type": "factual",
        "question": "Which checkpoint inhibitors are used in immunotherapy for colon cancer?",
        "answer": [
            "Pembrolizumab, Nivolumab"
        ],
        "original_answer": [
            "Pembrolizumab (Keytruda), Nivolumab (Opdivo), and Ipilimumab (Yervoy) are checkpoint inhibitors used."
        ],
        "evidence": "Pembrolizumab (Keytruda), Nivolumab (Opdivo), Ipilimumab (Yervoy)",
        "context": [
            [
                "8_Colon Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_250",
        "type": "factual",
        "question": "What is the primary cancer type affecting the esophagus?",
        "answer": [
            "Esophageal cancer"
        ],
        "original_answer": [
            "Esophageal cancer is the primary type."
        ],
        "evidence": "Esophageal cancer starts in the inner lining of the esophagus",
        "context": [
            [
                "12_Esophageal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_251",
        "type": "factual",
        "question": "Which cancer subtype originates in the squamous cells of the esophagus?",
        "answer": [
            "Esophageal squamous cell carcinoma"
        ],
        "original_answer": [
            "Esophageal squamous cell carcinoma originates in squamous cells."
        ],
        "evidence": "Esophageal squamous cell carcinoma starts in squamous cells of the esophagus",
        "context": [
            [
                "12_Esophageal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_252",
        "type": "factual",
        "question": "Which cancer subtype arises from mucus-secreting cells in the esophagus?",
        "answer": [
            "Esophageal adenocarcinoma"
        ],
        "original_answer": [
            "Esophageal adenocarcinoma arises from mucus-secreting cells."
        ],
        "evidence": "Esophageal adenocarcinoma starts in mucus-secreting cells of the esophagus",
        "context": [
            [
                "12_Esophageal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_255",
        "type": "factual",
        "question": "Which anatomical sites are included for esophageal cancer in general?",
        "answer": [
            "Esophagus, esophagogastric junction"
        ],
        "original_answer": [
            "Esophagus and esophagogastric junction are included."
        ],
        "evidence": "Anatomical Location: Esophagus, Esophagogastric junction",
        "context": [
            [
                "12_Esophageal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_259",
        "type": "factual",
        "question": "What are the common metastatic sites for esophageal cancer?",
        "answer": [
            "Liver, lung, bone, brain, lymph"
        ],
        "original_answer": [
            "Liver, lung, bone, brain, and distant lymph nodes are common sites."
        ],
        "evidence": "Metastatic: Metastatic Site: Liver, Lung, Bone, Brain, Distant lymph nodes",
        "context": [
            [
                "12_Esophageal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_260",
        "type": "factual",
        "question": "What is a precancerous condition for esophageal adenocarcinoma?",
        "answer": [
            "Barrett esophagus"
        ],
        "original_answer": [
            "Barrett esophagus is a precancerous condition."
        ],
        "evidence": "Barrett esophagus is a precancerous condition that increases risk for esophageal adenocarcinoma",
        "context": [
            [
                "12_Esophageal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_261",
        "type": "factual",
        "question": "Which risk factor increases the likelihood of developing esophageal adenocarcinoma?",
        "answer": [
            "Barrett esophagus"
        ],
        "original_answer": [
            "Barrett esophagus increases the risk."
        ],
        "evidence": "Barrett esophagus is a precancerous condition that increases risk for esophageal adenocarcinoma",
        "context": [
            [
                "12_Esophageal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_268",
        "type": "factual",
        "question": "Which genetic assessments are part of esophageal cancer diagnosis?",
        "answer": [
            "Biomarker testing, genetic risk testing"
        ],
        "original_answer": [
            "Biomarker testing and genetic risk testing are part of the diagnosis."
        ],
        "evidence": "Diagnosis involves blood tests, imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing",
        "context": [
            [
                "12_Esophageal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_270",
        "type": "factual",
        "question": "Which organs are potential metastatic sites for esophageal cancer?",
        "answer": [
            "Liver, lung, bone, brain, lymph"
        ],
        "original_answer": [
            "Liver, lung, bone, brain, and distant lymph nodes are potential metastatic sites."
        ],
        "evidence": "Metastatic: Metastatic Site: Liver, Lung, Bone, Brain, Distant lymph nodes",
        "context": [
            [
                "12_Esophageal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_271",
        "type": "factual",
        "question": "Which part of the esophagus is most commonly affected by esophageal adenocarcinoma?",
        "answer": [
            "Lower esophagus"
        ],
        "original_answer": [
            "The lower esophagus is most commonly affected."
        ],
        "evidence": "Esophageal adenocarcinoma: Anatomical Location: Lower esophagus, Middle esophagus",
        "context": [
            [
                "12_Esophageal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_272",
        "type": "factual",
        "question": "What is the anatomical location of the esophagogastric junction in esophageal cancer?",
        "answer": [
            "Esophagogastric junction"
        ],
        "original_answer": [
            "The esophagogastric junction is an anatomical location considered in esophageal cancer."
        ],
        "evidence": "Anatomical Location: Esophagus, Esophagogastric junction",
        "context": [
            [
                "12_Esophageal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_274",
        "type": "factual",
        "question": "Which subtype of esophageal cancer is associated with Barrett esophagus as a risk factor?",
        "answer": [
            "Esophageal adenocarcinoma"
        ],
        "original_answer": [
            "Esophageal adenocarcinoma is associated with Barrett esophagus."
        ],
        "evidence": "Esophageal adenocarcinoma: Risk Factor: Barrett esophagus",
        "context": [
            [
                "12_Esophageal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_276",
        "type": "factual",
        "question": "What is the initial site of origin for esophageal cancer?",
        "answer": [
            "Esophagus lining"
        ],
        "original_answer": [
            "It starts in the inner lining of the esophagus."
        ],
        "evidence": "Esophageal cancer starts in the inner lining of the esophagus",
        "context": [
            [
                "12_Esophageal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_277",
        "type": "factual",
        "question": "How are tumors at the esophagogastric junction staged?",
        "answer": [
            "Siewert types"
        ],
        "original_answer": [
            "They are staged using Siewert types."
        ],
        "evidence": "Siewert types are used to stage tumors at the esophagogastric junction",
        "context": [
            [
                "12_Esophageal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_279",
        "type": "factual",
        "question": "What is a key factor in planning treatment for esophageal cancer located at the esophagogastric junction?",
        "answer": [
            "Siewert types"
        ],
        "original_answer": [
            "Siewert types are a key factor for EGJ tumors."
        ],
        "evidence": "Treatment Planning: Based on: Siewert types (for EGJ tumors)",
        "context": [
            [
                "12_Esophageal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_280",
        "type": "factual",
        "question": "What type of carcinoma starts in the mucus-secreting cells of the esophagus?",
        "answer": [
            "Esophageal adenocarcinoma"
        ],
        "original_answer": [
            "Esophageal adenocarcinoma starts in mucus-secreting cells."
        ],
        "evidence": "Esophageal adenocarcinoma starts in mucus-secreting cells of the esophagus",
        "context": [
            [
                "12_Esophageal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_281",
        "type": "factual",
        "question": "What is the main cancer type discussed in this dataset?",
        "answer": [
            "Gray zone lymphoma"
        ],
        "original_answer": [
            "Gray zone lymphoma is the main cancer type."
        ],
        "evidence": "Gray zone lymphoma is listed as a Cancer Type in the ontology.",
        "context": [
            [
                "9_Diffuse Large B-Cell Lymphomas_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_282",
        "type": "factual",
        "question": "Which subtype of gray zone lymphoma is characterized by a large mediastinal mass?",
        "answer": [
            "Mediastinal gray zone lymphoma"
        ],
        "original_answer": [
            "Mediastinal gray zone lymphoma (MGZL) is characterized by a large mediastinal mass."
        ],
        "evidence": "MGZL is characterized by a large mediastinal mass",
        "context": [
            [
                "9_Diffuse Large B-Cell Lymphomas_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_284",
        "type": "factual",
        "question": "Which histopathological feature is characteristic of MGZL?",
        "answer": [
            "Reed-Sternberg cells"
        ],
        "original_answer": [
            "Reed-Sternberg cells are characteristic histopathological features in MGZL."
        ],
        "evidence": "Reed-Sternberg cells are characteristic histopathological features in MGZL",
        "context": [
            [
                "9_Diffuse Large B-Cell Lymphomas_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_285",
        "type": "factual",
        "question": "What is the recommended initial treatment for MGZL?",
        "answer": [
            "Chemotherapy"
        ],
        "original_answer": [
            "MGZL is usually treated with chemotherapy."
        ],
        "evidence": "MGZL is usually treated with chemotherapy",
        "context": [
            [
                "9_Diffuse Large B-Cell Lymphomas_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_286",
        "type": "factual",
        "question": "Which immunotherapy agent may be added to chemotherapy for MGZL?",
        "answer": [
            "Rituximab"
        ],
        "original_answer": [
            "Rituximab may be added to chemotherapy for chemoimmunotherapy."
        ],
        "evidence": "Rituximab may be added to chemotherapy for chemoimmunotherapy",
        "context": [
            [
                "9_Diffuse Large B-Cell Lymphomas_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_287",
        "type": "factual",
        "question": "What type of radiation therapy may be used in localized MGZL?",
        "answer": [
            "Involved-site radiation therapy"
        ],
        "original_answer": [
            "Involved-site radiation therapy (ISRT) may be added in localized MGZL."
        ],
        "evidence": "Involved-site radiation therapy (ISRT) may be added in localized MGZL",
        "context": [
            [
                "9_Diffuse Large B-Cell Lymphomas_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_290",
        "type": "factual",
        "question": "Which sex assigned at birth is more commonly affected by MGZL?",
        "answer": [
            "Assigned male at birth"
        ],
        "original_answer": [
            "MGZL commonly affects individuals assigned male at birth."
        ],
        "evidence": "MGZL commonly affects individuals aged 20 to 40 years, assigned male at birth",
        "context": [
            [
                "9_Diffuse Large B-Cell Lymphomas_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_292",
        "type": "factual",
        "question": "What is a common presenting symptom of MGZL?",
        "answer": [
            "Mediastinal mass"
        ],
        "original_answer": [
            "A large mediastinal mass is a common presenting symptom of MGZL."
        ],
        "evidence": "MGZL is characterized by a large mediastinal mass",
        "context": [
            [
                "9_Diffuse Large B-Cell Lymphomas_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_295",
        "type": "factual",
        "question": "Which lymphoma subtype is diagnosed as DLBCL-NOS if extra-mediastinal disease is present?",
        "answer": [
            "DLBCL-NOS"
        ],
        "original_answer": [
            "Non-mediastinal gray zone lymphoma is diagnosed as DLBCL-NOS if extra-mediastinal disease is present."
        ],
        "evidence": "If extra-mediastinal disease: Diagnose as DLBCL-NOS",
        "context": [
            [
                "9_Diffuse Large B-Cell Lymphomas_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_300",
        "type": "factual",
        "question": "Which professional is required for the diagnosis of MGZL?",
        "answer": [
            "Hematopathologist"
        ],
        "original_answer": [
            "Expert hematopathologist review is required for diagnosis of MGZL."
        ],
        "evidence": "Diagnosis of MGZL requires expert hematopathologist review",
        "context": [
            [
                "9_Diffuse Large B-Cell Lymphomas_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_303",
        "type": "factual",
        "question": "Which cells are a histopathological hallmark of MGZL?",
        "answer": [
            "Reed-Sternberg cells"
        ],
        "original_answer": [
            "Reed-Sternberg cells are a histopathological hallmark of MGZL."
        ],
        "evidence": "Reed-Sternberg cells are characteristic histopathological features in MGZL",
        "context": [
            [
                "9_Diffuse Large B-Cell Lymphomas_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_304",
        "type": "factual",
        "question": "Which lymphoma is a subtype of gray zone lymphomas?",
        "answer": [
            "Mediastinal gray zone lymphoma"
        ],
        "original_answer": [
            "Mediastinal gray zone lymphoma (MGZL) is a subtype of gray zone lymphomas."
        ],
        "evidence": "Mediastinal gray zone lymphoma (MGZL) is a subtype of gray zone lymphomas",
        "context": [
            [
                "9_Diffuse Large B-Cell Lymphomas_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_306",
        "type": "factual",
        "question": "Which lymphoma is diagnosed if gray zone lymphoma presents with extra-mediastinal disease?",
        "answer": [
            "DLBCL-NOS"
        ],
        "original_answer": [
            "DLBCL, not otherwise specified (DLBCL-NOS) is diagnosed if there is extra-mediastinal disease."
        ],
        "evidence": "If extra-mediastinal disease: Diagnose as DLBCL-NOS",
        "context": [
            [
                "9_Diffuse Large B-Cell Lymphomas_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_308",
        "type": "factual",
        "question": "Which lymph nodes are typically involved in MGZL?",
        "answer": [
            "Supraclavicular lymph nodes"
        ],
        "original_answer": [
            "Lymph nodes above the collar bone (supraclavicular) are typically involved in MGZL."
        ],
        "evidence": "Sites of involvement for MGZL include Lymph nodes above the collar bone (supraclavicular)",
        "context": [
            [
                "9_Diffuse Large B-Cell Lymphomas_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_309",
        "type": "factual",
        "question": "What is the main diagnostic method for gray zone lymphoma?",
        "answer": [
            "Expert hematopathologist review"
        ],
        "original_answer": [
            "Expert hematopathologist review is the main diagnostic method."
        ],
        "evidence": "Diagnostic Method for MGZL: Expert hematopathologist review",
        "context": [
            [
                "9_Diffuse Large B-Cell Lymphomas_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_312",
        "type": "factual",
        "question": "What is the most common subtype of cervical cancer?",
        "answer": [
            "Squamous cell carcinoma"
        ],
        "original_answer": [
            "Squamous cell carcinoma is the most common subtype."
        ],
        "evidence": "Squamous cell carcinoma is the most common subtype of cervical cancer",
        "context": [
            [
                "62_Cervical Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_313",
        "type": "factual",
        "question": "Which virus is most commonly associated with cervical cancer?",
        "answer": [
            "Human papillomavirus (HPV)"
        ],
        "original_answer": [
            "Human papillomavirus (HPV) is most commonly associated."
        ],
        "evidence": "Most cervical cancers are caused by long-term infection with human papillomavirus (HPV)",
        "context": [
            [
                "62_Cervical Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_314",
        "type": "factual",
        "question": "Which HPV types are considered high-risk for cervical cancer?",
        "answer": [
            "HPV16, HPV18"
        ],
        "original_answer": [
            "HPV16 and HPV18 are high-risk types."
        ],
        "evidence": "HPV16 and HPV18 are high-risk HPV types associated with cervical cancer",
        "context": [
            [
                "62_Cervical Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_315",
        "type": "factual",
        "question": "What screening method is used for cervical cancer?",
        "answer": [
            "Pap smear"
        ],
        "original_answer": [
            "Pap smear is used for cervical cancer screening."
        ],
        "evidence": "Pap smear is used for cervical cancer screening",
        "context": [
            [
                "62_Cervical Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_316",
        "type": "factual",
        "question": "What is the primary diagnostic method for cervical cancer?",
        "answer": [
            "Cervical biopsy"
        ],
        "original_answer": [
            "Cervical biopsy is the primary diagnostic method."
        ],
        "evidence": "Cervical biopsy is the primary diagnostic method for cervical cancer",
        "context": [
            [
                "62_Cervical Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_317",
        "type": "factual",
        "question": "Which imaging modalities are used for staging cervical cancer?",
        "answer": [
            "CT, MRI, PET/CT, ultrasound"
        ],
        "original_answer": [
            "CT scan, MRI, PET/CT, and transvaginal ultrasound are used."
        ],
        "evidence": "Imaging methods such as CT, MRI, PET/CT, and transvaginal ultrasound are used for staging and assessment",
        "context": [
            [
                "62_Cervical Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_318",
        "type": "factual",
        "question": "What system is used to stage cervical cancer?",
        "answer": [
            "FIGO system"
        ],
        "original_answer": [
            "The FIGO system is used to stage cervical cancer."
        ],
        "evidence": "The FIGO system is used to stage cervical cancer (Stages I-IV with sub-stages)",
        "context": [
            [
                "62_Cervical Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_319",
        "type": "factual",
        "question": "What is the main treatment for early-stage cervical cancer?",
        "answer": [
            "Surgery"
        ],
        "original_answer": [
            "Surgery is the main treatment for early-stage cervical cancer."
        ],
        "evidence": "Surgery is the main treatment for early-stage cervical cancer",
        "context": [
            [
                "62_Cervical Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_320",
        "type": "factual",
        "question": "Which surgical procedure can be both diagnostic and therapeutic for early-stage cervical cancer?",
        "answer": [
            "Cone biopsy"
        ],
        "original_answer": [
            "Cone biopsy can be both diagnostic and therapeutic."
        ],
        "evidence": "Cone biopsy can be both diagnostic and therapeutic for early-stage cervical cancer",
        "context": [
            [
                "62_Cervical Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_321",
        "type": "factual",
        "question": "Which fertility-sparing surgical option is available for selected early-stage cervical cancer cases?",
        "answer": [
            "Trachelectomy"
        ],
        "original_answer": [
            "Trachelectomy is an option for selected early-stage cases."
        ],
        "evidence": "Fertility-sparing surgery (e.g., trachelectomy) is an option for selected early-stage cases",
        "context": [
            [
                "62_Cervical Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_322",
        "type": "factual",
        "question": "What is the recommended treatment for locally advanced cervical cancer?",
        "answer": [
            "Chemoradiation"
        ],
        "original_answer": [
            "Chemoradiation is recommended for locally advanced cervical cancer."
        ],
        "evidence": "Chemoradiation (concurrent EBRT and platinum-based chemotherapy) is recommended for locally advanced cervical cancer",
        "context": [
            [
                "62_Cervical Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_323",
        "type": "factual",
        "question": "Which radiation therapies are used for local control in cervical cancer?",
        "answer": [
            "EBRT, brachytherapy"
        ],
        "original_answer": [
            "External beam radiation therapy (EBRT) and brachytherapy are used."
        ],
        "evidence": "External beam radiation therapy (EBRT) and brachytherapy are used for local control",
        "context": [
            [
                "62_Cervical Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_326",
        "type": "factual",
        "question": "What biomarker guides the use of pembrolizumab in cervical cancer?",
        "answer": [
            "PD-L1 positivity"
        ],
        "original_answer": [
            "PD-L1 positivity guides the use of pembrolizumab."
        ],
        "evidence": "PD-L1 positivity guides the use of immunotherapy (e.g., pembrolizumab)",
        "context": [
            [
                "62_Cervical Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_327",
        "type": "factual",
        "question": "Which drug may be added to chemotherapy for metastatic cervical cancer?",
        "answer": [
            "Bevacizumab"
        ],
        "original_answer": [
            "Bevacizumab may be added to chemotherapy for metastatic cervical cancer."
        ],
        "evidence": "Bevacizumab may be added to chemotherapy for metastatic cervical cancer",
        "context": [
            [
                "62_Cervical Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_332",
        "type": "factual",
        "question": "What corresponds to a low-grade squamous intraepithelial lesion (LSIL) in cervical pathology?",
        "answer": [
            "CIN 1"
        ],
        "original_answer": [
            "LSIL corresponds to CIN 1."
        ],
        "evidence": "Low-grade squamous intraepithelial lesion (LSIL) corresponds to CIN 1",
        "context": [
            [
                "62_Cervical Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_337",
        "type": "factual",
        "question": "Are clinical trials an option for cervical cancer patients?",
        "answer": [
            "Clinical trials"
        ],
        "original_answer": [
            "Clinical trials are an option for all stages of cervical cancer."
        ],
        "evidence": "Clinical trials are an option for all stages of cervical cancer",
        "context": [
            [
                "62_Cervical Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_338",
        "type": "factual",
        "question": "Which rare and aggressive subtype of cervical cancer is noted in the ontology?",
        "answer": [
            "Neuroendocrine carcinoma"
        ],
        "original_answer": [
            "Neuroendocrine carcinoma of the cervix (NECC) is a rare and aggressive subtype."
        ],
        "evidence": "Neuroendocrine carcinoma of the cervix (NECC) is a rare and aggressive subtype",
        "context": [
            [
                "62_Cervical Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_343",
        "type": "factual",
        "question": "What type of cancer is Hodgkin lymphoma?",
        "answer": [
            "Hodgkin lymphoma"
        ],
        "original_answer": [
            "Hodgkin lymphoma is a type of lymphoma."
        ],
        "evidence": "Hodgkin lymphoma is a type of lymphoma",
        "context": [
            [
                "15_Hodgkin Lymphoma - Hodgkin Lymphoma in Adults_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_344",
        "type": "factual",
        "question": "What is the most common subtype of Hodgkin lymphoma?",
        "answer": [
            "Classic Hodgkin lymphoma"
        ],
        "original_answer": [
            "Classic Hodgkin lymphoma (CHL) is the most common subtype."
        ],
        "evidence": "Classic Hodgkin lymphoma (CHL) is the most common subtype of Hodgkin lymphoma",
        "context": [
            [
                "15_Hodgkin Lymphoma - Hodgkin Lymphoma in Adults_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_345",
        "type": "factual",
        "question": "Which cell type characterizes Classic Hodgkin lymphoma (CHL)?",
        "answer": [
            "Reed-Sternberg cells"
        ],
        "original_answer": [
            "CHL is characterized by Reed-Sternberg cells."
        ],
        "evidence": "CHL is characterized by Reed-Sternberg cells",
        "context": [
            [
                "15_Hodgkin Lymphoma - Hodgkin Lymphoma in Adults_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_346",
        "type": "factual",
        "question": "What is a rare subtype of Hodgkin lymphoma?",
        "answer": [
            "Nodular lymphocyte-predominant Hodg"
        ],
        "original_answer": [
            "Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare subtype."
        ],
        "evidence": "Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare subtype of Hodgkin lymphoma",
        "context": [
            [
                "15_Hodgkin Lymphoma - Hodgkin Lymphoma in Adults_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_347",
        "type": "factual",
        "question": "Which cell type is characteristic of NLPHL?",
        "answer": [
            "Popcorn-shaped cells"
        ],
        "original_answer": [
            "NLPHL is characterized by popcorn-shaped cells."
        ],
        "evidence": "NLPHL is characterized by popcorn-shaped cells",
        "context": [
            [
                "15_Hodgkin Lymphoma - Hodgkin Lymphoma in Adults_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_348",
        "type": "factual",
        "question": "Into which disease can NLPHL transform?",
        "answer": [
            "DLBCL"
        ],
        "original_answer": [
            "NLPHL can transform into diffuse large B-cell lymphoma (DLBCL)."
        ],
        "evidence": "NLPHL can transform into diffuse large B-cell lymphoma (DLBCL)",
        "context": [
            [
                "15_Hodgkin Lymphoma - Hodgkin Lymphoma in Adults_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_349",
        "type": "factual",
        "question": "What is the primary diagnostic method for Hodgkin lymphoma?",
        "answer": [
            "Excisional lymph node biopsy"
        ],
        "original_answer": [
            "Diagnosis of Hodgkin lymphoma is made by excisional lymph node biopsy."
        ],
        "evidence": "Diagnosis of Hodgkin lymphoma is made by excisional lymph node biopsy",
        "context": [
            [
                "15_Hodgkin Lymphoma - Hodgkin Lymphoma in Adults_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_350",
        "type": "factual",
        "question": "Which biopsy method may be used for Hodgkin lymphoma diagnosis in some cases?",
        "answer": [
            "Core needle biopsy"
        ],
        "original_answer": [
            "Core needle biopsy may be used for diagnosis in some cases."
        ],
        "evidence": "Core needle biopsy may be used for diagnosis in some cases",
        "context": [
            [
                "15_Hodgkin Lymphoma - Hodgkin Lymphoma in Adults_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_353",
        "type": "factual",
        "question": "Where does Hodgkin lymphoma usually start?",
        "answer": [
            "Lymph nodes"
        ],
        "original_answer": [
            "Hodgkin lymphoma usually starts in lymph nodes in the upper body."
        ],
        "evidence": "Hodgkin lymphoma usually starts in lymph nodes in the upper body",
        "context": [
            [
                "15_Hodgkin Lymphoma - Hodgkin Lymphoma in Adults_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_355",
        "type": "factual",
        "question": "What are the common sites involved in Hodgkin lymphoma?",
        "answer": [
            "Lymph nodes"
        ],
        "original_answer": [
            "Common sites include lymph nodes in the upper body."
        ],
        "evidence": "Common Sites: lymph nodes in upper body",
        "context": [
            [
                "15_Hodgkin Lymphoma - Hodgkin Lymphoma in Adults_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_357",
        "type": "factual",
        "question": "Which two biopsy methods are listed for diagnosing CHL?",
        "answer": [
            "Excisional lymph node biopsy, core needle biopsy"
        ],
        "original_answer": [
            "Excisional lymph node biopsy and core needle biopsy are listed for CHL diagnosis."
        ],
        "evidence": "Diagnostic Method: excisional lymph node biopsy, core needle biopsy",
        "context": [
            [
                "15_Hodgkin Lymphoma - Hodgkin Lymphoma in Adults_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_358",
        "type": "factual",
        "question": "What cell type is associated with Classic Hodgkin lymphoma according to the ontology?",
        "answer": [
            "Reed-Sternberg cells"
        ],
        "original_answer": [
            "Reed-Sternberg cells are associated with Classic Hodgkin lymphoma."
        ],
        "evidence": "Cell Type: Reed-Sternberg cells",
        "context": [
            [
                "15_Hodgkin Lymphoma - Hodgkin Lymphoma in Adults_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_359",
        "type": "factual",
        "question": "What cell type is associated with NLPHL according to the ontology?",
        "answer": [
            "Popcorn-shaped cells"
        ],
        "original_answer": [
            "Popcorn-shaped cells are associated with NLPHL."
        ],
        "evidence": "Cell Type: popcorn-shaped cells",
        "context": [
            [
                "15_Hodgkin Lymphoma - Hodgkin Lymphoma in Adults_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_361",
        "type": "factual",
        "question": "What disease transformation is noted for NLPHL?",
        "answer": [
            "diffuse large B-cell lymphoma"
        ],
        "original_answer": [
            "NLPHL can transform into diffuse large B-cell lymphoma (DLBCL)."
        ],
        "evidence": "Disease Transformation: diffuse large B-cell lymphoma (DLBCL)",
        "context": [
            [
                "15_Hodgkin Lymphoma - Hodgkin Lymphoma in Adults_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_362",
        "type": "factual",
        "question": "Which lymphoma subtype is most frequently associated with Reed-Sternberg cells?",
        "answer": [
            "Classic Hodgkin lymphoma"
        ],
        "original_answer": [
            "Classic Hodgkin lymphoma (CHL) is most frequently associated with Reed-Sternberg cells."
        ],
        "evidence": "CHL is characterized by Reed-Sternberg cells",
        "context": [
            [
                "15_Hodgkin Lymphoma - Hodgkin Lymphoma in Adults_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_363",
        "type": "factual",
        "question": "What is the main cell type that distinguishes NLPHL from CHL?",
        "answer": [
            "Popcorn-shaped cells"
        ],
        "original_answer": [
            "Popcorn-shaped cells distinguish NLPHL from CHL."
        ],
        "evidence": "NLPHL is characterized by popcorn-shaped cells",
        "context": [
            [
                "15_Hodgkin Lymphoma - Hodgkin Lymphoma in Adults_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_364",
        "type": "factual",
        "question": "Which cancer type does Hodgkin lymphoma belong to?",
        "answer": [
            "Lymphoma"
        ],
        "original_answer": [
            "Hodgkin lymphoma belongs to the lymphoma cancer type."
        ],
        "evidence": "Hodgkin lymphoma is a type of lymphoma",
        "context": [
            [
                "15_Hodgkin Lymphoma - Hodgkin Lymphoma in Adults_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_365",
        "type": "factual",
        "question": "What physical examination is included in the diagnostic process for Hodgkin lymphoma?",
        "answer": [
            "Physical exam"
        ],
        "original_answer": [
            "Physical exam is part of the diagnostic process."
        ],
        "evidence": "Health history and physical exam are part of the diagnostic process",
        "context": [
            [
                "15_Hodgkin Lymphoma - Hodgkin Lymphoma in Adults_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_366",
        "type": "factual",
        "question": "Which lymphoma subtype can transform into another lymphoma, and what is the resulting disease?",
        "answer": [
            "NLPHL, DLBCL"
        ],
        "original_answer": [
            "NLPHL can transform into diffuse large B-cell lymphoma (DLBCL)."
        ],
        "evidence": "NLPHL can transform into diffuse large B-cell lymphoma (DLBCL)",
        "context": [
            [
                "15_Hodgkin Lymphoma - Hodgkin Lymphoma in Adults_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_368",
        "type": "factual",
        "question": "What is the typical anatomical location where Hodgkin lymphoma begins?",
        "answer": [
            "Lymph nodes"
        ],
        "original_answer": [
            "Hodgkin lymphoma usually starts in lymph nodes in the upper body."
        ],
        "evidence": "Hodgkin lymphoma usually starts in lymph nodes in the upper body",
        "context": [
            [
                "15_Hodgkin Lymphoma - Hodgkin Lymphoma in Adults_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_371",
        "type": "factual",
        "question": "Which subtype of Hodgkin lymphoma is rare according to the relations?",
        "answer": [
            "Nodular lymphocyte-predominant Hodg"
        ],
        "original_answer": [
            "Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is rare."
        ],
        "evidence": "Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare subtype of Hodgkin lymphoma",
        "context": [
            [
                "15_Hodgkin Lymphoma - Hodgkin Lymphoma in Adults_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_374",
        "type": "factual",
        "question": "What are the main cancer types associated with the gallbladder and bile ducts?",
        "answer": [
            "Intrahepatic bile duct cancer"
        ],
        "original_answer": [
            "Intrahepatic bile duct cancer is a main cancer type."
        ],
        "evidence": "intrahepatic bile duct cancer",
        "context": [
            [
                "47_Gallbladder and Bile Duct Cancers_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_375",
        "type": "factual",
        "question": "Which anatomical structures are covered by a thin, moist epithelial layer?",
        "answer": [
            "Gallbladder, bile ducts"
        ],
        "original_answer": [
            "The gallbladder and bile ducts are covered by a thin, moist epithelial layer."
        ],
        "evidence": "The gallbladder and bile ducts are lined by a thin, moist epithelial layer",
        "context": [
            [
                "47_Gallbladder and Bile Duct Cancers_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_376",
        "type": "factual",
        "question": "What is the outermost membrane covering the gallbladder and bile ducts?",
        "answer": [
            "Serosa"
        ],
        "original_answer": [
            "Serosa is the outer membrane covering the gallbladder and bile ducts."
        ],
        "evidence": "Serosa is the outer membrane covering the gallbladder and bile ducts",
        "context": [
            [
                "47_Gallbladder and Bile Duct Cancers_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_378",
        "type": "factual",
        "question": "Which connective tissue is located under the epithelium in the gallbladder and bile duct?",
        "answer": [
            "Lamina propria"
        ],
        "original_answer": [
            "Lamina propria is the connective tissue found under the epithelium."
        ],
        "evidence": "Lamina propria is a connective tissue found under the epithelium",
        "context": [
            [
                "47_Gallbladder and Bile Duct Cancers_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_380",
        "type": "factual",
        "question": "What tissue surrounds the muscle layer in the bile duct and gallbladder?",
        "answer": [
            "Perimuscular fibrous tissue"
        ],
        "original_answer": [
            "Perimuscular fibrous tissue surrounds the muscle layer."
        ],
        "evidence": "Perimuscular fibrous tissue surrounds the muscle layer",
        "context": [
            [
                "47_Gallbladder and Bile Duct Cancers_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_383",
        "type": "factual",
        "question": "What are the tumor characteristics of Tis stage in intrahepatic bile duct cancer?",
        "answer": [
            "Carcinoma in situ"
        ],
        "original_answer": [
            "Tis is characterized by carcinoma in situ, intraductal tumor, and confinement to the epithelium."
        ],
        "evidence": "Tis: Tumor Characteristic: carcinoma in situ, intraductal tumor, confined to epithelium",
        "context": [
            [
                "47_Gallbladder and Bile Duct Cancers_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_386",
        "type": "factual",
        "question": "Which cancer type is classified under the anatomical structure of the bile duct?",
        "answer": [
            "Intrahepatic bile duct cancer"
        ],
        "original_answer": [
            "Intrahepatic bile duct cancer is classified under the bile duct."
        ],
        "evidence": "Cancer Type: intrahepatic bile duct cancer under bile duct",
        "context": [
            [
                "47_Gallbladder and Bile Duct Cancers_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_388",
        "type": "factual",
        "question": "Which layer directly covers the muscularis in the gallbladder and bile duct?",
        "answer": [
            "Perimuscular fibrous tissue"
        ],
        "original_answer": [
            "Perimuscular fibrous tissue directly covers the muscularis."
        ],
        "evidence": "Perimuscular fibrous tissue surrounds the muscle layer",
        "context": [
            [
                "47_Gallbladder and Bile Duct Cancers_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_390",
        "type": "factual",
        "question": "Which layer is the innermost lining of the gallbladder and bile ducts?",
        "answer": [
            "Epithelium"
        ],
        "original_answer": [
            "The epithelium is the innermost lining."
        ],
        "evidence": "The gallbladder and bile ducts are lined by a thin, moist epithelial layer",
        "context": [
            [
                "47_Gallbladder and Bile Duct Cancers_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_394",
        "type": "factual",
        "question": "Which anatomical structures are included in the ontology for intrahepatic bile duct cancer?",
        "answer": [
            "Bile duct, gallbladder"
        ],
        "original_answer": [
            "Bile duct and gallbladder are included as anatomical structures."
        ],
        "evidence": "Anatomical Structure: bile duct, gallbladder",
        "context": [
            [
                "47_Gallbladder and Bile Duct Cancers_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_396",
        "type": "factual",
        "question": "Which tumor characteristic involves the measurement in centimeters or millimeters?",
        "answer": [
            "Primary tumor size"
        ],
        "original_answer": [
            "Primary tumor size (cm or mm) is a tumor characteristic."
        ],
        "evidence": "Tumor Characteristic: primary tumor size (cm or mm)",
        "context": [
            [
                "47_Gallbladder and Bile Duct Cancers_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_398",
        "type": "factual",
        "question": "What does the term 'confined to epithelium' indicate in tumor staging?",
        "answer": [
            "Carcinoma in situ"
        ],
        "original_answer": [
            "It indicates that the tumor is limited to the epithelial layer without invasion."
        ],
        "evidence": "Tis (carcinoma in situ) is an intraductal tumor confined to the epithelium",
        "context": [
            [
                "47_Gallbladder and Bile Duct Cancers_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_399",
        "type": "factual",
        "question": "Which histological layer provides structural support under the epithelium?",
        "answer": [
            "Lamina propria"
        ],
        "original_answer": [
            "Lamina propria provides structural support under the epithelium."
        ],
        "evidence": "Lamina propria is a connective tissue found under the epithelium",
        "context": [
            [
                "47_Gallbladder and Bile Duct Cancers_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_401",
        "type": "factual",
        "question": "Which cancer stage is defined by a tumor that is only within the epithelial layer?",
        "answer": [
            "Tis (carcinoma in situ)"
        ],
        "original_answer": [
            "Tis (carcinoma in situ) is defined by a tumor confined to the epithelium."
        ],
        "evidence": "Tis (carcinoma in situ) is an intraductal tumor confined to the epithelium",
        "context": [
            [
                "47_Gallbladder and Bile Duct Cancers_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_404",
        "type": "factual",
        "question": "Which layer is described as a membrane in the anatomical structure of the gallbladder and bile ducts?",
        "answer": [
            "Serosa"
        ],
        "original_answer": [
            "Serosa is described as a membrane covering the gallbladder and bile ducts."
        ],
        "evidence": "Serosa is the outer membrane covering the gallbladder and bile ducts",
        "context": [
            [
                "47_Gallbladder and Bile Duct Cancers_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_406",
        "type": "factual",
        "question": "From which cell type does follicular lymphoma (FL) develop?",
        "answer": [
            "B lymphocytes"
        ],
        "original_answer": [
            "FL develops from abnormal B lymphocytes."
        ],
        "evidence": "FL develops from abnormal B lymphocytes forming clusters in lymph nodes and other tissues",
        "context": [
            [
                "13_Follicular Lymphoma_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_409",
        "type": "factual",
        "question": "Which grades of FL are classified as classic FL (cFL) according to ICC?",
        "answer": [
            "Grades 1 and 2 FL"
        ],
        "original_answer": [
            "Grades 1 and 2 FL are classified as classic FL (cFL)."
        ],
        "evidence": "Grades 1 and 2 FL are classified as classic FL (cFL) according to ICC",
        "context": [
            [
                "13_Follicular Lymphoma_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_412",
        "type": "factual",
        "question": "What is the characteristic genetic alteration in uncommon FL (uFL)?",
        "answer": [
            "t(14;18)-negative"
        ],
        "original_answer": [
            "Uncommon FL (uFL) is t(14;18)-negative or has uncommon pathologic features."
        ],
        "evidence": "Uncommon FL (uFL) is t(14;18)-negative or has uncommon pathologic features",
        "context": [
            [
                "13_Follicular Lymphoma_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_415",
        "type": "factual",
        "question": "What can follicular lymphoma (FL) transform into?",
        "answer": [
            "DLBCL"
        ],
        "original_answer": [
            "FL can transform into diffuse large B-cell lymphoma (DLBCL), a more aggressive lymphoma."
        ],
        "evidence": "FL can transform into DLBCL, a more aggressive lymphoma",
        "context": [
            [
                "13_Follicular Lymphoma_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_420",
        "type": "factual",
        "question": "What are the main cell types found in follicular lymphoma (FL)?",
        "answer": [
            "Centrocytes, centroblasts"
        ],
        "original_answer": [
            "The main cell types in FL are centrocytes and centroblasts."
        ],
        "evidence": "FL is graded based on the proportion of centrocytes and centroblasts",
        "context": [
            [
                "13_Follicular Lymphoma_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_421",
        "type": "factual",
        "question": "Which biomarker is commonly associated with follicular lymphoma (FL)?",
        "answer": [
            "BCL2 protein"
        ],
        "original_answer": [
            "BCL2 protein is a biomarker commonly associated with FL."
        ],
        "evidence": "Biomarker: BCL2 protein",
        "context": [
            [
                "13_Follicular Lymphoma_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_423",
        "type": "factual",
        "question": "Which FL subtype is defined by t(14;18)-negativity?",
        "answer": [
            "Uncommon FL (uFL)"
        ],
        "original_answer": [
            "Uncommon FL (uFL) is defined by t(14;18)-negativity."
        ],
        "evidence": "Uncommon FL (uFL) is t(14;18)-negative",
        "context": [
            [
                "13_Follicular Lymphoma_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_425",
        "type": "factual",
        "question": "Which FL subtype is associated with minimal symptoms?",
        "answer": [
            "Pediatric-type FL (PTFL)"
        ],
        "original_answer": [
            "Pediatric-type FL (PTFL) is associated with minimal symptoms."
        ],
        "evidence": "Pediatric-type FL (PTFL) usually presents with a single enlarged lymph node in the head and neck and minimal symptoms",
        "context": [
            [
                "13_Follicular Lymphoma_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_427",
        "type": "factual",
        "question": "What is the cell type origin of follicular lymphoma?",
        "answer": [
            "B lymphocytes"
        ],
        "original_answer": [
            "Follicular lymphoma originates from B lymphocytes."
        ],
        "evidence": "Cell Type: B lymphocyte",
        "context": [
            [
                "13_Follicular Lymphoma_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_430",
        "type": "factual",
        "question": "Which grades of FL are characterized by both centrocytes and centroblasts?",
        "answer": [
            "Grades 1, 2, 3A"
        ],
        "original_answer": [
            "Grades 1, 2, and 3A FL are characterized by both centrocytes and centroblasts."
        ],
        "evidence": "Grade 1, grade 2, and grade 3A have Cell Type: centrocyte, centroblast",
        "context": [
            [
                "13_Follicular Lymphoma_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_431",
        "type": "factual",
        "question": "Which grade of FL is characterized only by centroblasts?",
        "answer": [
            "Grade 3B FL"
        ],
        "original_answer": [
            "Grade 3B FL is characterized only by centroblasts."
        ],
        "evidence": "Grade 3B: Cell Type: centroblast",
        "context": [
            [
                "13_Follicular Lymphoma_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_433",
        "type": "factual",
        "question": "What is the disease site for extranodal FL?",
        "answer": [
            "Extranodal FL"
        ],
        "original_answer": [
            "Extranodal FL occurs in tissues outside the lymph nodes."
        ],
        "evidence": "FL can present as nodal or extranodal disease",
        "context": [
            [
                "13_Follicular Lymphoma_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_434",
        "type": "factual",
        "question": "Which lymphoma subtype can FL transform into?",
        "answer": [
            "DLBCL"
        ],
        "original_answer": [
            "FL can transform into diffuse large B-cell lymphoma (DLBCL)."
        ],
        "evidence": "FL can transform into DLBCL, a more aggressive lymphoma",
        "context": [
            [
                "13_Follicular Lymphoma_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_436",
        "type": "factual",
        "question": "Which organ is commonly enlarged in FL patients?",
        "answer": [
            "Spleen"
        ],
        "original_answer": [
            "The spleen is commonly enlarged in FL patients."
        ],
        "evidence": "Symptoms of FL include swollen lymph nodes, enlarged spleen, fever, night sweats, fatigue, and weight loss (B symptoms)",
        "context": [
            [
                "13_Follicular Lymphoma_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_437",
        "type": "factual",
        "question": "What is the most common type of primary liver cancer?",
        "answer": [
            "Hepatocellular carcinoma"
        ],
        "original_answer": [
            "Hepatocellular carcinoma (HCC) is the most common type."
        ],
        "evidence": "Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer",
        "context": [
            [
                "14_Liver Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_438",
        "type": "factual",
        "question": "Which subtype of hepatocellular carcinoma occurs at a younger age?",
        "answer": [
            "Fibrolamellar hepatocellular carcinoma"
        ],
        "original_answer": [
            "Fibrolamellar hepatocellular carcinoma (FLHC) occurs at a younger age."
        ],
        "evidence": "Fibrolamellar hepatocellular carcinoma (FLHC) is a subtype of HCC that occurs at a younger age",
        "context": [
            [
                "14_Liver Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_441",
        "type": "factual",
        "question": "Where does primary liver cancer originate?",
        "answer": [
            "Liver"
        ],
        "original_answer": [
            "Primary liver cancer originates in the liver."
        ],
        "evidence": "Primary liver cancer originates in the liver",
        "context": [
            [
                "14_Liver Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_443",
        "type": "factual",
        "question": "What is a major risk factor for developing liver cancer?",
        "answer": [
            "Cirrhosis"
        ],
        "original_answer": [
            "Cirrhosis is a major risk factor for developing liver cancer."
        ],
        "evidence": "Cirrhosis is a major risk factor for developing liver cancer",
        "context": [
            [
                "14_Liver Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_446",
        "type": "factual",
        "question": "Is alcohol use a risk factor for liver cancer?",
        "answer": [
            "Alcohol use"
        ],
        "original_answer": [
            "Alcohol use is a risk factor for cirrhosis and liver cancer."
        ],
        "evidence": "Alcohol use is a risk factor for cirrhosis and liver cancer",
        "context": [
            [
                "14_Liver Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_453",
        "type": "factual",
        "question": "Which biomarker may indicate primary liver cancer?",
        "answer": [
            "Alpha-fetoprotein (AFP)"
        ],
        "original_answer": [
            "Elevated alpha-fetoprotein (AFP) may indicate primary liver cancer."
        ],
        "evidence": "Elevated AFP may indicate primary liver cancer",
        "context": [
            [
                "14_Liver Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_454",
        "type": "factual",
        "question": "What tests are usually used to confirm the diagnosis of liver cancer?",
        "answer": [
            "Imaging tests"
        ],
        "original_answer": [
            "Diagnosis of liver cancer is usually confirmed with imaging tests."
        ],
        "evidence": "Diagnosis of liver cancer is usually confirmed with imaging tests",
        "context": [
            [
                "14_Liver Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_457",
        "type": "factual",
        "question": "What are common sites of liver cancer metastasis?",
        "answer": [
            "Lung, bone"
        ],
        "original_answer": [
            "Liver cancer most often metastasizes to the lung or bone."
        ],
        "evidence": "Liver cancer most often metastasizes to the lung or bone",
        "context": [
            [
                "14_Liver Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_458",
        "type": "factual",
        "question": "What anatomical structure is the origin of primary liver cancer?",
        "answer": [
            "Liver"
        ],
        "original_answer": [
            "The liver is the origin of primary liver cancer."
        ],
        "evidence": "Primary liver cancer originates in the liver",
        "context": [
            [
                "14_Liver Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_459",
        "type": "factual",
        "question": "Which anatomical structure is affected in intrahepatic cholangiocarcinoma?",
        "answer": [
            "Bile ducts"
        ],
        "original_answer": [
            "The bile ducts are affected in intrahepatic cholangiocarcinoma."
        ],
        "evidence": "Intrahepatic cholangiocarcinoma is a primary liver cancer of the bile ducts",
        "context": [
            [
                "14_Liver Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_463",
        "type": "factual",
        "question": "Which genetic alteration is a risk factor for liver cancer?",
        "answer": [
            "Genetic hemochromatosis"
        ],
        "original_answer": [
            "Genetic hemochromatosis is a risk factor for cirrhosis and liver cancer."
        ],
        "evidence": "Genetic hemochromatosis is a risk factor for cirrhosis and liver cancer",
        "context": [
            [
                "14_Liver Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_465",
        "type": "factual",
        "question": "Which diagnostic methods are listed for liver cancer in the ontology?",
        "answer": [
            "Imaging tests, biopsy"
        ],
        "original_answer": [
            "Imaging tests and biopsy are diagnostic methods for liver cancer."
        ],
        "evidence": "Diagnosis of liver cancer is usually confirmed with imaging tests; Biopsy may be needed to confirm liver cancer",
        "context": [
            [
                "14_Liver Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_466",
        "type": "factual",
        "question": "Which liver cancer subtype is listed under hepatocellular carcinoma in the ontology?",
        "answer": [
            "Fibrolamellar hepatocellular carcinoma"
        ],
        "original_answer": [
            "Fibrolamellar hepatocellular carcinoma (FLHC) is a subtype of hepatocellular carcinoma."
        ],
        "evidence": "Fibrolamellar hepatocellular carcinoma (FLHC) is a subtype of HCC that occurs at a younger age",
        "context": [
            [
                "14_Liver Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_468",
        "type": "factual",
        "question": "Which thyroid cancer subtype is the most common?",
        "answer": [
            "Papillary thyroid carcinoma"
        ],
        "original_answer": [
            "Papillary thyroid carcinoma is the most common thyroid cancer."
        ],
        "evidence": "Papillary thyroid carcinoma is the most common thyroid cancer",
        "context": [
            [
                "40_Thyroid Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_469",
        "type": "factual",
        "question": "What is another name for oncocytic carcinoma?",
        "answer": [
            "Hürthle cell carcinoma"
        ],
        "original_answer": [
            "Oncocytic carcinoma is also known as Hürthle cell carcinoma."
        ],
        "evidence": "Oncocytic carcinoma is also known as Hürthle cell carcinoma",
        "context": [
            [
                "40_Thyroid Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_470",
        "type": "factual",
        "question": "Which thyroid cancer subtype is the rarest and most aggressive?",
        "answer": [
            "Anaplastic thyroid cancer"
        ],
        "original_answer": [
            "Anaplastic thyroid cancer is the most aggressive and rarest subtype."
        ],
        "evidence": "Anaplastic thyroid cancer is the most aggressive and rarest subtype",
        "context": [
            [
                "40_Thyroid Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_471",
        "type": "factual",
        "question": "What genetic alteration is associated with medullary thyroid cancer?",
        "answer": [
            "RET gene fusion"
        ],
        "original_answer": [
            "Medullary thyroid cancer is associated with RET gene fusion."
        ],
        "evidence": "Medullary thyroid cancer can be inherited and is associated with RET gene fusion",
        "context": [
            [
                "40_Thyroid Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_476",
        "type": "factual",
        "question": "What procedure is used to sample suspicious thyroid nodules?",
        "answer": [
            "Fine-needle aspiration biopsy"
        ],
        "original_answer": [
            "Fine-needle aspiration biopsy is used to sample suspicious thyroid nodules."
        ],
        "evidence": "Fine-needle aspiration biopsy is used to sample suspicious thyroid nodules",
        "context": [
            [
                "40_Thyroid Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_477",
        "type": "factual",
        "question": "What is the main treatment for most thyroid cancers?",
        "answer": [
            "Surgery"
        ],
        "original_answer": [
            "Surgery is the main treatment for most thyroid cancers."
        ],
        "evidence": "Surgery is the main treatment for most thyroid cancers",
        "context": [
            [
                "40_Thyroid Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_479",
        "type": "factual",
        "question": "What is the recommended surgery for larger or invasive thyroid cancers?",
        "answer": [
            "Total thyroidectomy"
        ],
        "original_answer": [
            "Total thyroidectomy is recommended for larger, invasive, or high-risk cancers."
        ],
        "evidence": "Total thyroidectomy is recommended for larger, invasive, or high-risk cancers",
        "context": [
            [
                "40_Thyroid Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_480",
        "type": "factual",
        "question": "What additional surgical procedure is performed if lymph nodes are involved in thyroid cancer?",
        "answer": [
            "Neck dissection"
        ],
        "original_answer": [
            "Neck dissection is performed if lymph nodes are involved."
        ],
        "evidence": "Neck dissection is performed if lymph nodes are involved",
        "context": [
            [
                "40_Thyroid Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_481",
        "type": "factual",
        "question": "What therapy is required after total thyroidectomy?",
        "answer": [
            "Thyroid hormone replacement therapy"
        ],
        "original_answer": [
            "Thyroid hormone replacement therapy is required after total thyroidectomy."
        ],
        "evidence": "Thyroid hormone replacement therapy is required after total thyroidectomy",
        "context": [
            [
                "40_Thyroid Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_482",
        "type": "factual",
        "question": "What is the standard medication for thyroid hormone replacement?",
        "answer": [
            "Levothyroxine"
        ],
        "original_answer": [
            "Levothyroxine is the standard thyroid hormone replacement."
        ],
        "evidence": "Levothyroxine is the standard thyroid hormone replacement",
        "context": [
            [
                "40_Thyroid Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_483",
        "type": "factual",
        "question": "For which thyroid cancer subtypes is RAI therapy not effective?",
        "answer": [
            "Medullary thyroid cancer"
        ],
        "original_answer": [
            "RAI therapy is not effective for medullary or anaplastic thyroid cancer."
        ],
        "evidence": "RAI therapy is not effective for medullary or anaplastic thyroid cancer",
        "context": [
            [
                "40_Thyroid Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_484",
        "type": "factual",
        "question": "What treatment is used for anaplastic, recurrent, or metastatic thyroid cancers not amenable to surgery or RAI?",
        "answer": [
            "External beam radiation therapy"
        ],
        "original_answer": [
            "External beam radiation therapy is used for anaplastic, recurrent, or metastatic cancers not amenable to surgery or RAI."
        ],
        "evidence": "External beam radiation therapy is used for anaplastic, recurrent, or metastatic cancers not amenable to surgery or RAI",
        "context": [
            [
                "40_Thyroid Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_486",
        "type": "factual",
        "question": "Which targeted therapies are used for progressive, unresectable, or metastatic thyroid cancer?",
        "answer": [
            "Lenvatinib, sorafenib, cab"
        ],
        "original_answer": [
            "Lenvatinib, sorafenib, and cabozantinib are targeted therapies for progressive, unresectable, or metastatic thyroid cancer."
        ],
        "evidence": "Lenvatinib, sorafenib, and cabozantinib are targeted therapies for progressive, unresectable, or metastatic thyroid cancer",
        "context": [
            [
                "40_Thyroid Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_491",
        "type": "factual",
        "question": "To which organs does metastatic thyroid cancer most commonly spread?",
        "answer": [
            "Lungs, liver, bones, brain, spinal"
        ],
        "original_answer": [
            "Metastatic thyroid cancer most commonly spreads to lungs, liver, bones, brain, and spinal cord."
        ],
        "evidence": "Metastatic thyroid cancer most commonly spreads to lungs, liver, bones, brain, and spinal cord",
        "context": [
            [
                "40_Thyroid Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_492",
        "type": "factual",
        "question": "What is an option for very-low-risk papillary thyroid cancers?",
        "answer": [
            "Active surveillance"
        ],
        "original_answer": [
            "Active surveillance is an option for very-low-risk papillary thyroid cancers."
        ],
        "evidence": "Active surveillance is an option for very-low-risk papillary thyroid cancers",
        "context": [
            [
                "40_Thyroid Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_494",
        "type": "factual",
        "question": "Which imaging methods are used for thyroid cancer diagnosis?",
        "answer": [
            "Ultrasound, CT scan, MRI"
        ],
        "original_answer": [
            "Imaging methods include ultrasound, neck ultrasound, CT scan, MRI, and whole-body RAI scan."
        ],
        "evidence": "Imaging: [\"Ultrasound\", \"Neck ultrasound\", \"CT scan\", \"MRI\", \"Whole-body RAI scan\"]",
        "context": [
            [
                "40_Thyroid Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_499",
        "type": "factual",
        "question": "Which gene mutations are considered actionable biomarkers in thyroid cancer?",
        "answer": [
            "BRAF gene mutation"
        ],
        "original_answer": [
            "Actionable biomarkers include BRAF gene mutation, RET gene fusion, ALK gene fusion, and NTRK gene fusion."
        ],
        "evidence": "Biomarker: [\"BRAF gene mutation\", \"RET gene fusion\", \"ALK gene fusion\", \"NTRK gene fusion\"]",
        "context": [
            [
                "40_Thyroid Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_500",
        "type": "factual",
        "question": "What is the primary method for detecting recurrence in thyroid cancer?",
        "answer": [
            "Rising thyroglobulin"
        ],
        "original_answer": [
            "Detection of recurrence is primarily by rising thyroglobulin, neck ultrasound, and imaging (CT, MRI)."
        ],
        "evidence": "Recurrence: {\"Detection\": [\"Rising thyroglobulin\", \"Neck ultrasound\", \"Imaging (CT, MRI)\"]}",
        "context": [
            [
                "40_Thyroid Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_503",
        "type": "factual",
        "question": "Which cancers commonly metastasize to bone?",
        "answer": [
            "Breast cancer, lung cancer, kidney cancer"
        ],
        "original_answer": [
            "Breast cancer, lung cancer, and kidney cancer can metastasize to bone."
        ],
        "evidence": "Secondary bone malignancy: Origin: [Breast cancer, Lung cancer, Kidney cancer]",
        "context": [
            [
                "51_Bone Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_505",
        "type": "factual",
        "question": "Where does osteosarcoma most commonly arise?",
        "answer": [
            "Metaphysis"
        ],
        "original_answer": [
            "Osteosarcoma commonly arises in the metaphysis near growth plates."
        ],
        "evidence": "Osteosarcoma commonly arises in the metaphysis near growth plates",
        "context": [
            [
                "51_Bone Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_506",
        "type": "factual",
        "question": "What is the characteristic genetic alteration in Ewing sarcoma?",
        "answer": [
            "EWSR1-ETS gene fusions"
        ],
        "original_answer": [
            "Ewing sarcoma is characterized by EWSR1-ETS gene fusions, most commonly EWSR1-FLI1."
        ],
        "evidence": "Ewing sarcoma is characterized by EWSR1-ETS gene fusions, most commonly EWSR1-FLI1",
        "context": [
            [
                "51_Bone Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_507",
        "type": "factual",
        "question": "Which bone cancer subtype starts in cartilage-forming cells?",
        "answer": [
            "Chondrosarcoma"
        ],
        "original_answer": [
            "Chondrosarcoma starts in cartilage-forming cells."
        ],
        "evidence": "Chondrosarcoma starts in cartilage-forming cells",
        "context": [
            [
                "51_Bone Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_508",
        "type": "factual",
        "question": "From which cells does chordoma arise?",
        "answer": [
            "Notochordal cells"
        ],
        "original_answer": [
            "Chordoma arises from notochordal cells."
        ],
        "evidence": "Chordoma arises from notochordal cells, typically in the sacrum or base of skull",
        "context": [
            [
                "51_Bone Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_509",
        "type": "factual",
        "question": "What anatomic locations are typical for chordoma?",
        "answer": [
            "Sacrum, base of skull"
        ],
        "original_answer": [
            "Chordoma typically arises in the sacrum or base of skull."
        ],
        "evidence": "Chordoma arises from notochordal cells, typically in the sacrum or base of skull",
        "context": [
            [
                "51_Bone Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_510",
        "type": "factual",
        "question": "Where does giant cell tumor of bone often occur?",
        "answer": [
            "Metaphysis, epiphysis"
        ],
        "original_answer": [
            "Giant cell tumor of bone often occurs in the metaphysis and epiphysis."
        ],
        "evidence": "Giant cell tumor of bone often occurs in the metaphysis and epiphysis",
        "context": [
            [
                "51_Bone Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_516",
        "type": "factual",
        "question": "Which mutation in chondrosarcoma can be targeted with ivosidenib?",
        "answer": [
            "IDH1 mutation"
        ],
        "original_answer": [
            "IDH1 mutation in chondrosarcoma can be targeted with ivosidenib."
        ],
        "evidence": "IDH1 mutation in chondrosarcoma can be targeted with ivosidenib",
        "context": [
            [
                "51_Bone Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_517",
        "type": "factual",
        "question": "Which status may be treated with pembrolizumab in bone cancer?",
        "answer": [
            "MSI-H/dMMR status"
        ],
        "original_answer": [
            "MSI-H/dMMR status may be treated with pembrolizumab."
        ],
        "evidence": "MSI-H/dMMR status may be treated with pembrolizumab",
        "context": [
            [
                "51_Bone Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_519",
        "type": "factual",
        "question": "What system is used for staging bone cancer?",
        "answer": [
            "TNM system"
        ],
        "original_answer": [
            "Staging uses the TNM system: T (tumor size/location), N (lymph node involvement), M (metastasis)."
        ],
        "evidence": "Staging uses the TNM system: T (tumor size/location), N (lymph node involvement), M (metastasis)",
        "context": [
            [
                "51_Bone Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_522",
        "type": "factual",
        "question": "Which performance status scales are used in bone cancer treatment planning?",
        "answer": [
            "ECOG, KPS"
        ],
        "original_answer": [
            "ECOG performance status and Karnofsky Performance Status (KPS) are considered in treatment planning."
        ],
        "evidence": "Performance status (ECOG or KPS) is considered in treatment planning",
        "context": [
            [
                "51_Bone Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_524",
        "type": "factual",
        "question": "What metabolic complication can bone cancer cause?",
        "answer": [
            "Hypercalcemia"
        ],
        "original_answer": [
            "Bone cancer can cause hypercalcemia due to bone destruction."
        ],
        "evidence": "Bone cancer can cause hypercalcemia due to bone destruction",
        "context": [
            [
                "51_Bone Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_525",
        "type": "factual",
        "question": "Where can bone cancer spread?",
        "answer": [
            "Lungs, bones, organs"
        ],
        "original_answer": [
            "Bone cancer can spread to lungs, other bones, or distant organs."
        ],
        "evidence": "Bone cancer can spread to lungs, other bones, or distant organs",
        "context": [
            [
                "51_Bone Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_526",
        "type": "factual",
        "question": "Which gene fusions are biomarkers for Ewing sarcoma?",
        "answer": [
            "EWSR1-FLI1 fusion"
        ],
        "original_answer": [
            "EWSR1-FLI1 fusion and EWSR1-ERG fusion are biomarkers for Ewing sarcoma."
        ],
        "evidence": "Ewing sarcoma is characterized by EWSR1-ETS gene fusions, most commonly EWSR1-FLI1",
        "context": [
            [
                "51_Bone Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_529",
        "type": "factual",
        "question": "Which genetic alteration is associated with Ewing sarcoma?",
        "answer": [
            "t(11;22) translocation"
        ],
        "original_answer": [
            "Ewing sarcoma is associated with the t(11;22) translocation."
        ],
        "evidence": "Ewing sarcoma: Genetic Alteration: [t(11;22) translocation]",
        "context": [
            [
                "51_Bone Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_532",
        "type": "factual",
        "question": "What is the most common subtype of mouth cancer?",
        "answer": [
            "Squamous cell carcinoma"
        ],
        "original_answer": [
            "Squamous cell carcinoma (SCC) is the most common subtype."
        ],
        "evidence": "Squamous cell carcinoma (SCC) is the most common subtype of mouth cancer",
        "context": [
            [
                "31_Mouth Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_533",
        "type": "factual",
        "question": "Which cancer type does mouth cancer belong to?",
        "answer": [
            "Head and neck cancer"
        ],
        "original_answer": [
            "Mouth cancer is a type of head and neck cancer."
        ],
        "evidence": "Mouth cancer is a type of head and neck cancer",
        "context": [
            [
                "31_Mouth Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_534",
        "type": "factual",
        "question": "What are alternative names for mouth cancer?",
        "answer": [
            "Oral cavity cancer"
        ],
        "original_answer": [
            "Mouth cancer is also known as oral cavity cancer."
        ],
        "evidence": "Mouth cancer: Also known as Oral cavity cancer",
        "context": [
            [
                "31_Mouth Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_536",
        "type": "factual",
        "question": "What is the basis for cancer staging in mouth cancer?",
        "answer": [
            "TNM system"
        ],
        "original_answer": [
            "Cancer staging is based on the TNM system, which includes tumor size and depth (T), lymph node involvement (N), and distant metastasis (M)."
        ],
        "evidence": "Cancer staging is based on the TNM system, which includes tumor size and depth (T), lymph node involvement (N), and distant metastasis (M)",
        "context": [
            [
                "31_Mouth Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_545",
        "type": "factual",
        "question": "What procedure is required to confirm the diagnosis of mouth cancer?",
        "answer": [
            "Biopsy"
        ],
        "original_answer": [
            "Biopsy is required to confirm diagnosis and determine histology."
        ],
        "evidence": "Biopsy is required to confirm diagnosis and determine histology",
        "context": [
            [
                "31_Mouth Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_547",
        "type": "factual",
        "question": "What biomarkers may be tested in mouth cancer?",
        "answer": [
            "PD-L1, MSI-H/dMMR"
        ],
        "original_answer": [
            "Biomarker testing may include PD-L1, MSI-H/dMMR, and tumor mutational burden (TMB)."
        ],
        "evidence": "Biomarker testing may include PD-L1, MSI-H/dMMR, and tumor mutational burden (TMB)",
        "context": [
            [
                "31_Mouth Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_548",
        "type": "factual",
        "question": "Which risk factors are associated with mouth cancer?",
        "answer": [
            "Tobacco, alcohol"
        ],
        "original_answer": [
            "Tobacco use and alcohol use are risk factors for mouth cancer."
        ],
        "evidence": "Tobacco and alcohol use are risk factors for mouth cancer",
        "context": [
            [
                "31_Mouth Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_551",
        "type": "factual",
        "question": "What factors are considered in treatment planning for mouth cancer?",
        "answer": [
            "Tumor location, stage"
        ],
        "original_answer": [
            "Treatment planning is based on tumor location and stage."
        ],
        "evidence": "Treatment planning is based on tumor location and stage",
        "context": [
            [
                "31_Mouth Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_552",
        "type": "factual",
        "question": "Which clinical assessment is important for treatment selection in mouth cancer?",
        "answer": [
            "Performance status (ECOG)"
        ],
        "original_answer": [
            "Performance status (ECOG) is considered in treatment selection."
        ],
        "evidence": "Performance status (ECOG) is considered in treatment selection",
        "context": [
            [
                "31_Mouth Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_560",
        "type": "factual",
        "question": "What fertility consideration should be addressed in mouth cancer patients?",
        "answer": [
            "Fertility preservation"
        ],
        "original_answer": [
            "Fertility preservation is a fertility consideration in mouth cancer."
        ],
        "evidence": "Fertility Consideration: [Fertility preservation]",
        "context": [
            [
                "31_Mouth Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_564",
        "type": "factual",
        "question": "What is the most common subtype of stomach cancer?",
        "answer": [
            "Adenocarcinomas"
        ],
        "original_answer": [
            "Most stomach cancers are adenocarcinomas."
        ],
        "evidence": "Most stomach cancers are adenocarcinomas",
        "context": [
            [
                "39_Stomach Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_566",
        "type": "factual",
        "question": "What are the two major subtypes of stomach adenocarcinoma?",
        "answer": [
            "Intestinal, diffuse"
        ],
        "original_answer": [
            "The two major subtypes are intestinal type adenocarcinoma and diffuse type adenocarcinoma."
        ],
        "evidence": "There are two major subtypes of stomach adenocarcinoma: intestinal and diffuse",
        "context": [
            [
                "39_Stomach Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_567",
        "type": "factual",
        "question": "Which stomach adenocarcinoma subtype forms tube- and gland-shaped structures?",
        "answer": [
            "Intestinal type adenocarcinoma"
        ],
        "original_answer": [
            "Intestinal type adenocarcinoma forms tube- and gland-shaped structures."
        ],
        "evidence": "Intestinal type adenocarcinoma forms tube- and gland-shaped structures",
        "context": [
            [
                "39_Stomach Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_569",
        "type": "factual",
        "question": "Which subtype of stomach adenocarcinoma consists of scattered cells and is less common?",
        "answer": [
            "Diffuse type adenocarcinoma"
        ],
        "original_answer": [
            "Diffuse type adenocarcinoma consists of scattered cells and is less common."
        ],
        "evidence": "Diffuse type adenocarcinoma consists of scattered cells and is less common",
        "context": [
            [
                "39_Stomach Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_573",
        "type": "factual",
        "question": "Through which layers does stomach cancer spread outward?",
        "answer": [
            "Stomach wall layers"
        ],
        "original_answer": [
            "Stomach cancer spreads outward through the layers of the stomach wall."
        ],
        "evidence": "Stomach cancer spreads outward through the layers of the stomach wall",
        "context": [
            [
                "39_Stomach Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_574",
        "type": "factual",
        "question": "Where do precancerous changes often occur before stomach cancer develops?",
        "answer": [
            "Mucosa"
        ],
        "original_answer": [
            "Precancerous changes often occur in the mucosa before cancer develops."
        ],
        "evidence": "Precancerous changes often occur in the mucosa before cancer develops",
        "context": [
            [
                "39_Stomach Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_575",
        "type": "factual",
        "question": "To which organs can stomach cancer spread?",
        "answer": [
            "Liver, pancreas, spleen"
        ],
        "original_answer": [
            "Cancer can spread to lymph nodes, veins, arteries, and organs such as the liver, pancreas, and spleen."
        ],
        "evidence": "Cancer can spread to lymph nodes, veins, arteries, and organs such as the liver, pancreas, and spleen",
        "context": [
            [
                "39_Stomach Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_577",
        "type": "factual",
        "question": "What is a risk factor for stomach cancer related to infection?",
        "answer": [
            "H. pylori infection"
        ],
        "original_answer": [
            "H. pylori infection is a risk factor for stomach cancer."
        ],
        "evidence": "H. pylori infection is a risk factor for stomach cancer",
        "context": [
            [
                "39_Stomach Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_578",
        "type": "factual",
        "question": "Is family history a risk factor for stomach cancer?",
        "answer": [
            "Family history"
        ],
        "original_answer": [
            "Family history is a risk factor for stomach cancer."
        ],
        "evidence": "Family history is a risk factor for stomach cancer",
        "context": [
            [
                "39_Stomach Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_580",
        "type": "factual",
        "question": "What are the anatomical locations within the stomach relevant to stomach cancer?",
        "answer": [
            "Cardia, fundus, body, antr"
        ],
        "original_answer": [
            "The anatomical locations are cardia, fundus, body, antrum, pylorus, and esophagogastric junction."
        ],
        "evidence": "The anatomical locations are cardia, fundus, body, antrum, pylorus, and esophagogastric junction",
        "context": [
            [
                "39_Stomach Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_582",
        "type": "factual",
        "question": "Which diagnostic method is used to visually examine the stomach?",
        "answer": [
            "Endoscopy"
        ],
        "original_answer": [
            "Endoscopy is used to visually examine the stomach."
        ],
        "evidence": "Diagnosis involves imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing",
        "context": [
            [
                "39_Stomach Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_583",
        "type": "factual",
        "question": "Which diagnostic method involves sampling tissue for analysis in stomach cancer?",
        "answer": [
            "Biopsy"
        ],
        "original_answer": [
            "Biopsy is used to sample tissue for analysis."
        ],
        "evidence": "Diagnosis involves imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing",
        "context": [
            [
                "39_Stomach Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_585",
        "type": "factual",
        "question": "What is the distant spread pattern of stomach cancer?",
        "answer": [
            "Liver, peritoneum, lymph nodes"
        ],
        "original_answer": [
            "Distant spread involves the liver, peritoneum, distant lymph nodes, pancreas, and spleen."
        ],
        "evidence": "Distant spread involves the liver, peritoneum, distant lymph nodes, pancreas, and spleen",
        "context": [
            [
                "39_Stomach Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_587",
        "type": "factual",
        "question": "What genetic risk factor is listed for stomach cancer?",
        "answer": [
            "Family history"
        ],
        "original_answer": [
            "Family history is listed as a genetic risk factor."
        ],
        "evidence": "Family history is a risk factor for stomach cancer",
        "context": [
            [
                "39_Stomach Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_588",
        "type": "factual",
        "question": "Which stomach cancer subtype is less common?",
        "answer": [
            "Diffuse type adenocarcinoma"
        ],
        "original_answer": [
            "Diffuse type adenocarcinoma is less common."
        ],
        "evidence": "Diffuse type adenocarcinoma consists of scattered cells and is less common",
        "context": [
            [
                "39_Stomach Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_589",
        "type": "factual",
        "question": "Which stomach wall layer is the initial site for early-stage stomach cancer?",
        "answer": [
            "Mucosa"
        ],
        "original_answer": [
            "The mucosa is the initial site for early-stage stomach cancer."
        ],
        "evidence": "Early-stage stomach cancer is confined to the mucosa and is not present in lymph nodes",
        "context": [
            [
                "39_Stomach Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_590",
        "type": "factual",
        "question": "Which subtype of stomach adenocarcinoma is more likely to benefit from targeted therapy?",
        "answer": [
            "Intestinal type adenocarcinoma"
        ],
        "original_answer": [
            "Intestinal type adenocarcinoma is more likely to benefit from targeted therapy."
        ],
        "evidence": "Intestinal type adenocarcinoma forms tube- and gland-shaped structures and is more likely to have mutations treatable with targeted therapy",
        "context": [
            [
                "39_Stomach Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_591",
        "type": "factual",
        "question": "Which organs are commonly involved in metastatic stomach cancer?",
        "answer": [
            "Liver, peritoneum, lymph nodes"
        ],
        "original_answer": [
            "The liver, peritoneum, and distant lymph nodes are commonly involved."
        ],
        "evidence": "Metastatic stomach cancer has spread to distant organs such as the liver, peritoneum, or distant lymph nodes",
        "context": [
            [
                "39_Stomach Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_592",
        "type": "factual",
        "question": "What are two main symptoms of stomach cancer listed in the ontology?",
        "answer": [
            "Ulcer, mass"
        ],
        "original_answer": [
            "Ulcer and mass are two main symptoms."
        ],
        "evidence": "Symptoms can include ulcer or mass formation in the stomach",
        "context": [
            [
                "39_Stomach Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_594",
        "type": "factual",
        "question": "What type of tumor is glioma?",
        "answer": [
            "Glioma"
        ],
        "original_answer": [
            "Glioma is a type of malignant brain tumor."
        ],
        "evidence": "Glioma is a type of malignant brain tumor",
        "context": [
            [
                "5_Brain Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_595",
        "type": "factual",
        "question": "From which cells do gliomas develop?",
        "answer": [
            "Glial cells"
        ],
        "original_answer": [
            "Gliomas develop from glial cells in the central nervous system."
        ],
        "evidence": "Gliomas develop from glial cells in the central nervous system",
        "context": [
            [
                "5_Brain Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_597",
        "type": "factual",
        "question": "Which glioma subtype is the most aggressive?",
        "answer": [
            "Glioblastoma"
        ],
        "original_answer": [
            "Glioblastoma is the most aggressive subtype of glioma."
        ],
        "evidence": "Glioblastoma is the most aggressive subtype of glioma",
        "context": [
            [
                "5_Brain Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_599",
        "type": "factual",
        "question": "Which grades are considered low-grade gliomas?",
        "answer": [
            "Grades 1 and 2"
        ],
        "original_answer": [
            "Grades 1 and 2 are low-grade gliomas."
        ],
        "evidence": "Grades 1 and 2 are low-grade gliomas; grades 3 and 4 are high-grade gliomas",
        "context": [
            [
                "5_Brain Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_600",
        "type": "factual",
        "question": "Which grades are classified as high-grade gliomas?",
        "answer": [
            "Grades 3 and 4"
        ],
        "original_answer": [
            "Grades 3 and 4 are high-grade gliomas."
        ],
        "evidence": "Grades 1 and 2 are low-grade gliomas; grades 3 and 4 are high-grade gliomas",
        "context": [
            [
                "5_Brain Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_601",
        "type": "factual",
        "question": "What is the most common grade of glioblastoma?",
        "answer": [
            "Grade 4 gliomas"
        ],
        "original_answer": [
            "Grade 4 gliomas are most commonly glioblastomas."
        ],
        "evidence": "Grade 4 gliomas are most commonly glioblastomas",
        "context": [
            [
                "5_Brain Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_602",
        "type": "factual",
        "question": "What biomarker is used to classify gliomas?",
        "answer": [
            "IDH mutation"
        ],
        "original_answer": [
            "IDH mutation is a biomarker used to classify gliomas."
        ],
        "evidence": "IDH mutation is a biomarker used to classify gliomas",
        "context": [
            [
                "5_Brain Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_603",
        "type": "factual",
        "question": "What is the most useful imaging test for identifying glioma?",
        "answer": [
            "MRI"
        ],
        "original_answer": [
            "MRI is the most useful imaging test for identifying glioma."
        ],
        "evidence": "MRI is the most useful imaging test for identifying glioma",
        "context": [
            [
                "5_Brain Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_604",
        "type": "factual",
        "question": "What procedures are required for the definitive diagnosis and molecular testing of glioma?",
        "answer": [
            "Biopsy"
        ],
        "original_answer": [
            "Biopsy is required for definitive diagnosis and molecular testing."
        ],
        "evidence": "Biopsy is required for definitive diagnosis and molecular testing",
        "context": [
            [
                "5_Brain Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_608",
        "type": "factual",
        "question": "What surgical procedures may be performed for glioma?",
        "answer": [
            "Resection, biopsy"
        ],
        "original_answer": [
            "Surgery may involve resection or biopsy."
        ],
        "evidence": "Surgery may involve resection or biopsy",
        "context": [
            [
                "5_Brain Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_611",
        "type": "factual",
        "question": "What is recommended for follow-up after glioma treatment?",
        "answer": [
            "Periodic imaging (MRI)"
        ],
        "original_answer": [
            "Follow-up with periodic imaging (MRI) is recommended to monitor for recurrence."
        ],
        "evidence": "Follow-up with periodic imaging (MRI) is recommended to monitor for recurrence",
        "context": [
            [
                "5_Brain Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_612",
        "type": "factual",
        "question": "What is assessed to determine treatment eligibility for glioma?",
        "answer": [
            "Performance status"
        ],
        "original_answer": [
            "Performance status is assessed to determine treatment eligibility."
        ],
        "evidence": "Performance status is assessed to determine treatment eligibility",
        "context": [
            [
                "5_Brain Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_613",
        "type": "factual",
        "question": "In which age group are gliomas more common?",
        "answer": [
            "Adults"
        ],
        "original_answer": [
            "Gliomas are more common in adults than children."
        ],
        "evidence": "Gliomas are more common in adults than children",
        "context": [
            [
                "5_Brain Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_615",
        "type": "factual",
        "question": "Which grades are included in low-grade gliomas according to the ontology?",
        "answer": [
            "Grade 1, Grade 2"
        ],
        "original_answer": [
            "Low-grade gliomas include Grade 1 and Grade 2."
        ],
        "evidence": "Low-grade gliomas include Grade 1 and Grade 2",
        "context": [
            [
                "5_Brain Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_616",
        "type": "factual",
        "question": "Which grades are included in high-grade gliomas according to the ontology?",
        "answer": [
            "Grade 3, Grade 4"
        ],
        "original_answer": [
            "High-grade gliomas include Grade 3 and Grade 4."
        ],
        "evidence": "High-grade gliomas include Grade 3 and Grade 4",
        "context": [
            [
                "5_Brain Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_618",
        "type": "factual",
        "question": "Which imaging methods are used for glioma diagnosis according to the ontology?",
        "answer": [
            "MRI, CT scan"
        ],
        "original_answer": [
            "MRI and CT scan are imaging methods used for glioma diagnosis."
        ],
        "evidence": "Imaging for glioma diagnosis includes MRI and CT scan",
        "context": [
            [
                "5_Brain Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_622",
        "type": "factual",
        "question": "Which biomarker is used for both astrocytoma and oligodendroglioma classification?",
        "answer": [
            "IDH mutation"
        ],
        "original_answer": [
            "IDH mutation is used as a biomarker for both astrocytoma and oligodendroglioma."
        ],
        "evidence": "IDH mutation is a biomarker for astrocytoma and oligodendroglioma",
        "context": [
            [
                "5_Brain Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_629",
        "type": "factual",
        "question": "Which gene fusion characterizes Acute promyelocytic leukemia (APL)?",
        "answer": [
            "PML::RARA fusion gene"
        ],
        "original_answer": [
            "The PML::RARA fusion gene characterizes APL."
        ],
        "evidence": "Acute promyelocytic leukemia (APL) is a subtype of AML characterized by the PML::RARA fusion gene",
        "context": [
            [
                "2_Acute Myeloid Leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_635",
        "type": "factual",
        "question": "What molecular and cytogenetic tests are used in AML workup?",
        "answer": [
            "Karyotype, FISH, NGS"
        ],
        "original_answer": [
            "Karyotype, FISH, next-generation sequencing (NGS), and PCR are used."
        ],
        "evidence": "Molecular and cytogenetic testing for AML includes karyotype, FISH, next-generation sequencing (NGS), and PCR",
        "context": [
            [
                "2_Acute Myeloid Leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_636",
        "type": "factual",
        "question": "Which imaging modalities assess extramedullary disease in AML?",
        "answer": [
            "CT, MRI, PET/CT"
        ],
        "original_answer": [
            "CT scan, MRI, and PET/CT are used to assess extramedullary disease or complications."
        ],
        "evidence": "Imaging (CT, MRI, PET/CT) is used to assess extramedullary disease or complications",
        "context": [
            [
                "2_Acute Myeloid Leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_637",
        "type": "factual",
        "question": "What is the standard of care for AML treatment?",
        "answer": [
            "Chemotherapy"
        ],
        "original_answer": [
            "Chemotherapy is the standard of care for AML."
        ],
        "evidence": "Chemotherapy is the standard of care for AML",
        "context": [
            [
                "2_Acute Myeloid Leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_638",
        "type": "factual",
        "question": "Which chemotherapy agents are commonly used in AML?",
        "answer": [
            "Cytarabine, daunorubicin"
        ],
        "original_answer": [
            "Chemotherapy regimens may include cytarabine, daunorubicin, idarubicin, and hypomethylating agents such as azacitidine and decitabine."
        ],
        "evidence": "Chemotherapy regimens may include antimetabolites (e.g., cytarabine), anthracyclines (e.g., daunorubicin, idarubicin), and hypomethylating agents (e.g., azacitidine, decitabine)",
        "context": [
            [
                "2_Acute Myeloid Leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_641",
        "type": "factual",
        "question": "Which biomarker is targeted by gemtuzumab ozogamicin in AML?",
        "answer": [
            "CD33"
        ],
        "original_answer": [
            "CD33 is the biomarker targeted by gemtuzumab ozogamicin."
        ],
        "evidence": "Targeted therapies are used for AML with specific genetic alterations, such as gemtuzumab ozogamicin for CD33-positive AML",
        "context": [
            [
                "2_Acute Myeloid Leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_645",
        "type": "factual",
        "question": "What should be discussed before starting systemic therapy for AML regarding fertility?",
        "answer": [
            "Fertility preservation"
        ],
        "original_answer": [
            "Fertility preservation should be discussed before starting systemic therapy."
        ],
        "evidence": "Fertility preservation should be discussed before starting systemic therapy",
        "context": [
            [
                "2_Acute Myeloid Leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_649",
        "type": "factual",
        "question": "What is the cell of origin for AML?",
        "answer": [
            "Myeloid blasts"
        ],
        "original_answer": [
            "AML originates from myeloid blasts and bone marrow stem cells."
        ],
        "evidence": "Cell of Origin for AML includes myeloid blasts and bone marrow stem cells",
        "context": [
            [
                "2_Acute Myeloid Leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_651",
        "type": "factual",
        "question": "What genetic alteration is characteristic of APL?",
        "answer": [
            "PML::RARA"
        ],
        "original_answer": [
            "PML::RARA is the genetic alteration characteristic of APL."
        ],
        "evidence": "Acute promyelocytic leukemia (APL) is a subtype of AML characterized by the PML::RARA fusion gene",
        "context": [
            [
                "2_Acute Myeloid Leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_652",
        "type": "factual",
        "question": "Which AML subtype commonly involves the skin?",
        "answer": [
            "BPDCN"
        ],
        "original_answer": [
            "Blastic plasmacytoid dendritic cell neoplasm (BPDCN) commonly involves the skin."
        ],
        "evidence": "BPDCN is a subtype of AML with sites of involvement including skin",
        "context": [
            [
                "2_Acute Myeloid Leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_653",
        "type": "factual",
        "question": "Which agents are classified as hypomethylating agents in AML treatment?",
        "answer": [
            "Azacitidine, decitabine"
        ],
        "original_answer": [
            "Azacitidine (Vidaza) and decitabine (Dacogen) are hypomethylating agents used in AML."
        ],
        "evidence": "Hypomethylating Agents for AML include azacitidine (Vidaza) and decitabine (Dacogen)",
        "context": [
            [
                "2_Acute Myeloid Leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_654",
        "type": "factual",
        "question": "What are the main phases of AML treatment?",
        "answer": [
            "Induction, consolidation, maintenance"
        ],
        "original_answer": [
            "The main treatment phases are induction, consolidation, and maintenance."
        ],
        "evidence": "Treatment Phase for AML includes induction, consolidation, and maintenance",
        "context": [
            [
                "2_Acute Myeloid Leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_658",
        "type": "factual",
        "question": "What is the most common type of ovarian cancer?",
        "answer": [
            "Epithelial cancer"
        ],
        "original_answer": [
            "Ovarian cancer is most commonly an epithelial cancer arising from the ovary surface epithelium."
        ],
        "evidence": "Ovarian cancer is most commonly an epithelial cancer arising from the ovary surface epithelium",
        "context": [
            [
                "32_Ovarian Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_659",
        "type": "factual",
        "question": "Which subtypes are most common in epithelial ovarian cancer?",
        "answer": [
            "High-grade serous carcinoma"
        ],
        "original_answer": [
            "High-grade serous carcinoma and high-grade endometrioid carcinoma are the most common subtypes."
        ],
        "evidence": "High-grade serous carcinoma and high-grade endometrioid carcinoma are the most common subtypes of epithelial ovarian cancer",
        "context": [
            [
                "32_Ovarian Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_661",
        "type": "factual",
        "question": "Which cancers are managed similarly to ovarian cancer?",
        "answer": [
            "Primary peritoneal cancer, fallopian tube cancer"
        ],
        "original_answer": [
            "Primary peritoneal cancer and fallopian tube cancer are managed similarly to ovarian cancer."
        ],
        "evidence": "Primary peritoneal cancer and fallopian tube cancer are managed similarly to ovarian cancer",
        "context": [
            [
                "32_Ovarian Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_667",
        "type": "factual",
        "question": "What staging system is used for ovarian cancer?",
        "answer": [
            "FIGO system"
        ],
        "original_answer": [
            "Staging is based on the FIGO system (Stages I-IV) and requires surgical staging."
        ],
        "evidence": "Staging is based on the FIGO system (Stages I-IV) and requires surgical staging",
        "context": [
            [
                "32_Ovarian Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_668",
        "type": "factual",
        "question": "What is the standard initial treatment for most ovarian cancers?",
        "answer": [
            "Surgery"
        ],
        "original_answer": [
            "Surgery (hysterectomy with bilateral salpingo-oophorectomy) is the standard initial treatment for most ovarian cancers."
        ],
        "evidence": "Surgery (hysterectomy with bilateral salpingo-oophorectomy) is the standard initial treatment for most ovarian cancers",
        "context": [
            [
                "32_Ovarian Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_670",
        "type": "factual",
        "question": "What chemotherapy regimen is typically recommended after surgery for ovarian cancer?",
        "answer": [
            "Paclitaxel and carboplatin"
        ],
        "original_answer": [
            "Chemotherapy (typically paclitaxel and carboplatin) is recommended after surgery for most stages."
        ],
        "evidence": "Chemotherapy (typically paclitaxel and carboplatin) is recommended after surgery for most stages",
        "context": [
            [
                "32_Ovarian Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_671",
        "type": "factual",
        "question": "Which drug may be added to chemotherapy in some ovarian cancer cases?",
        "answer": [
            "Bevacizumab"
        ],
        "original_answer": [
            "Bevacizumab may be added to chemotherapy in some cases."
        ],
        "evidence": "Bevacizumab may be added to chemotherapy in some cases",
        "context": [
            [
                "32_Ovarian Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_672",
        "type": "factual",
        "question": "Which maintenance therapies are recommended for advanced or BRCA-mutated/HRD-positive ovarian cancers after initial treatment?",
        "answer": [
            "PARP inhibitors"
        ],
        "original_answer": [
            "Maintenance therapy with PARP inhibitors (olaparib, niraparib, rucaparib) is recommended for advanced or BRCA-mutated/HRD-positive cancers after initial treatment."
        ],
        "evidence": "Maintenance therapy with PARP inhibitors (olaparib, niraparib, rucaparib) is recommended for advanced or BRCA-mutated/HRD-positive cancers after initial treatment",
        "context": [
            [
                "32_Ovarian Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_678",
        "type": "factual",
        "question": "Which tumor markers are used in ovarian cancer diagnosis?",
        "answer": [
            "CA-125"
        ],
        "original_answer": [
            "Tumor markers include CA-125, Inhibin, Beta-human chorionic gonadotropin (β-hCG), Alpha-fetoprotein (AFP), Lactate dehydrogenase (LDH), Carcinoembryonic antigen (CEA), CA 19-9, and HE4."
        ],
        "evidence": "Tumor marker tests include CA-125, Inhibin, Beta-human chorionic gonadotropin (β-hCG), Alpha-fetoprotein (AFP), Lactate dehydrogenase (LDH), Carcinoembryonic antigen (CEA), CA 19-9, HE4",
        "context": [
            [
                "32_Ovarian Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_683",
        "type": "factual",
        "question": "What genetic alterations are tested for in ovarian cancer?",
        "answer": [
            "BRCA1 mutation"
        ],
        "original_answer": [
            "Genetic alterations tested include BRCA1 mutation, BRCA2 mutation, HRD, MSI, MMR, HER2 expression, TMB, BRAF V600E, FRα, RET mutation, and NTRK gene fusion."
        ],
        "evidence": "Genetic Alteration includes BRCA1 mutation, BRCA2 mutation, homologous recombination deficiency (HRD), microsatellite instability (MSI), mismatch repair (MMR), HER2 expression, tumor mutational burden (TMB), BRAF V600E mutation, folate receptor alpha (FRα), RET mutation, NTRK gene fusion",
        "context": [
            [
                "32_Ovarian Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_684",
        "type": "factual",
        "question": "What are the main risk factors for ovarian cancer?",
        "answer": [
            "BRCA1 mutation"
        ],
        "original_answer": [
            "Risk factors include BRCA1 mutation, BRCA2 mutation, Lynch syndrome, and family history."
        ],
        "evidence": "Risk Factor includes BRCA1 mutation, BRCA2 mutation, Lynch syndrome, Family history",
        "context": [
            [
                "32_Ovarian Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_689",
        "type": "factual",
        "question": "What is the recommended management for recurrent or persistent ovarian cancer?",
        "answer": [
            "Clinical trial enrollment"
        ],
        "original_answer": [
            "Clinical trial enrollment is recommended for recurrent or persistent disease."
        ],
        "evidence": "Clinical trial enrollment for recurrent or persistent disease",
        "context": [
            [
                "32_Ovarian Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_690",
        "type": "factual",
        "question": "What type of cancer is chronic lymphocytic leukemia (CLL)?",
        "answer": [
            "Chronic lymphocytic leukemia"
        ],
        "original_answer": [
            "CLL is a type of blood cancer affecting B lymphocytes."
        ],
        "evidence": "Chronic lymphocytic leukemia (CLL) is a type of blood cancer affecting B lymphocytes",
        "context": [
            [
                "61_Colorectal Cancer Screening_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_692",
        "type": "factual",
        "question": "Which cells are affected in CLL?",
        "answer": [
            "B lymphocytes"
        ],
        "original_answer": [
            "B lymphocytes are affected in CLL."
        ],
        "evidence": "Chronic lymphocytic leukemia (CLL) is a type of blood cancer affecting B lymphocytes",
        "context": [
            [
                "61_Colorectal Cancer Screening_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_699",
        "type": "factual",
        "question": "What surface proteins are identified in CLL cells by immunophenotyping?",
        "answer": [
            "CD20, CD200, LEF1"
        ],
        "original_answer": [
            "Immunophenotyping identifies CLL cells by surface proteins such as CD20, CD200, and LEF1."
        ],
        "evidence": "Immunophenotyping identifies CLL cells by surface proteins such as CD20, CD200, and LEF1",
        "context": [
            [
                "61_Colorectal Cancer Screening_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_706",
        "type": "factual",
        "question": "What imaging method is used to assess lymph node involvement in CLL?",
        "answer": [
            "Diagnostic CT scans"
        ],
        "original_answer": [
            "Diagnostic CT scans may be used to assess lymph node involvement and disease extent."
        ],
        "evidence": "Diagnostic CT scans may be used to assess lymph node involvement and disease extent",
        "context": [
            [
                "61_Colorectal Cancer Screening_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_714",
        "type": "factual",
        "question": "Which complication of CLL involves transformation to DLBCL?",
        "answer": [
            "Richter transformation"
        ],
        "original_answer": [
            "Richter transformation is a complication where CLL transforms into diffuse large B-cell lymphoma (DLBCL)."
        ],
        "evidence": "Richter transformation is a complication where CLL transforms into a more aggressive lymphoma such as DLBCL or Hodgkin lymphoma",
        "context": [
            [
                "61_Colorectal Cancer Screening_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_720",
        "type": "factual",
        "question": "What is the most common type of throat cancer?",
        "answer": [
            "Squamous cell carcinoma"
        ],
        "original_answer": [
            "Squamous cell carcinoma is the most common type of throat cancer."
        ],
        "evidence": "Squamous cell carcinoma is the most common type of throat cancer",
        "context": [
            [
                "44_Throat Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_721",
        "type": "factual",
        "question": "Which cancer type does throat cancer belong to?",
        "answer": [
            "Head and neck cancer"
        ],
        "original_answer": [
            "Throat cancer is a type of head and neck cancer."
        ],
        "evidence": "Throat cancer is a type of head and neck cancer",
        "context": [
            [
                "44_Throat Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_722",
        "type": "factual",
        "question": "What is a major risk factor for oropharyngeal squamous cell carcinoma?",
        "answer": [
            "HPV infection"
        ],
        "original_answer": [
            "HPV infection, especially HPV16, is a major risk factor."
        ],
        "evidence": "HPV infection, especially HPV16, is a major risk factor for oropharyngeal squamous cell carcinoma",
        "context": [
            [
                "44_Throat Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_723",
        "type": "factual",
        "question": "Which protein is a surrogate biomarker for HPV-mediated throat cancer?",
        "answer": [
            "p16 protein"
        ],
        "original_answer": [
            "p16 protein overexpression is a surrogate biomarker."
        ],
        "evidence": "p16 protein overexpression is a surrogate biomarker for HPV-mediated throat cancer",
        "context": [
            [
                "44_Throat Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_724",
        "type": "factual",
        "question": "What diagnostic method is required for definitive diagnosis and biomarker testing in throat cancer?",
        "answer": [
            "Biopsy"
        ],
        "original_answer": [
            "Biopsy is required for definitive diagnosis and biomarker testing."
        ],
        "evidence": "Biopsy is required for definitive diagnosis and biomarker testing",
        "context": [
            [
                "44_Throat Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_725",
        "type": "factual",
        "question": "Which imaging studies are used for diagnosis and staging of throat cancer?",
        "answer": [
            "CT scan, MRI, PET/CT, ultrasound"
        ],
        "original_answer": [
            "CT scan, MRI, PET/CT, and ultrasound are used for diagnosis and staging."
        ],
        "evidence": "Imaging studies such as CT scan, MRI, PET/CT, and ultrasound are used for diagnosis and staging",
        "context": [
            [
                "44_Throat Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_727",
        "type": "factual",
        "question": "What is the recommended biomarker test for all patients with oropharyngeal cancer?",
        "answer": [
            "p16 (HPV) testing"
        ],
        "original_answer": [
            "p16 (HPV) testing is recommended for all patients with oropharyngeal cancer."
        ],
        "evidence": "p16 (HPV) testing is recommended for all patients with oropharyngeal cancer",
        "context": [
            [
                "44_Throat Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_728",
        "type": "factual",
        "question": "Which factors are considered risk factors for head and neck cancers?",
        "answer": [
            "Tobacco, alcohol"
        ],
        "original_answer": [
            "Tobacco and alcohol use are risk factors."
        ],
        "evidence": "Tobacco and alcohol use are risk factors for head and neck cancers",
        "context": [
            [
                "44_Throat Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_730",
        "type": "factual",
        "question": "Which system is used for staging throat cancer?",
        "answer": [
            "AJCC TNM system"
        ],
        "original_answer": [
            "Cancer staging uses the AJCC TNM system."
        ],
        "evidence": "Cancer staging uses the AJCC TNM system, incorporating tumor size (T), lymph node involvement (N), and metastasis (M)",
        "context": [
            [
                "44_Throat Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_737",
        "type": "factual",
        "question": "Which biomarker expressions may guide immunotherapy treatment decisions in throat cancer?",
        "answer": [
            "PD-L1 expression"
        ],
        "original_answer": [
            "PD-L1 expression may guide immunotherapy treatment decisions."
        ],
        "evidence": "PD-L1 expression may guide immunotherapy treatment decisions",
        "context": [
            [
                "44_Throat Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_740",
        "type": "factual",
        "question": "What are the common sites of metastasis for throat cancer?",
        "answer": [
            "Lungs, liver, spine"
        ],
        "original_answer": [
            "Common sites of metastasis are the lungs, liver, or spine."
        ],
        "evidence": "Cancer can spread to lymph nodes in the neck and to distant sites such as lungs, liver, or spine",
        "context": [
            [
                "44_Throat Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_743",
        "type": "factual",
        "question": "Which assessment is important before treatment of throat cancer?",
        "answer": [
            "Dental health assessment"
        ],
        "original_answer": [
            "Dental health assessment is important before treatment."
        ],
        "evidence": "Dental health assessment is important before treatment",
        "context": [
            [
                "44_Throat Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_744",
        "type": "factual",
        "question": "Which performance status is considered a prognostic factor in throat cancer treatment planning?",
        "answer": [
            "ECOG performance status"
        ],
        "original_answer": [
            "ECOG performance status is a prognostic factor considered in treatment planning."
        ],
        "evidence": "Performance status (ECOG) is a prognostic factor considered in treatment planning",
        "context": [
            [
                "44_Throat Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_746",
        "type": "factual",
        "question": "Which scoping procedures are used as diagnostic methods for throat cancer?",
        "answer": [
            "Endoscopy, laryngoscopy, nasolaryng"
        ],
        "original_answer": [
            "Endoscopy, laryngoscopy, nasolaryngoscopy, esophagoscopy, bronchoscopy, and panendoscopy are used."
        ],
        "evidence": "Scoping procedures: [\"Endoscopy\", \"Laryngoscopy\", \"Nasolaryngoscopy\", \"Esophagoscopy\", \"Bronchoscopy\", \"Panendoscopy\"]",
        "context": [
            [
                "44_Throat Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_752",
        "type": "factual",
        "question": "What type of lymphoma is found primarily in the skin?",
        "answer": [
            "Primary cutaneous lymphoma"
        ],
        "original_answer": [
            "Primary cutaneous lymphoma (PCL) is found in the skin."
        ],
        "evidence": "Primary cutaneous lymphoma (PCL) is a type of non-Hodgkin lymphoma found in the skin",
        "context": [
            [
                "55_Cutaneous B-Cell Lymphomas_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_753",
        "type": "factual",
        "question": "Which cell type is the origin of cutaneous B-cell lymphoma (CBCL)?",
        "answer": [
            "B lymphocytes"
        ],
        "original_answer": [
            "CBCL originates from B lymphocytes."
        ],
        "evidence": "Cutaneous B-cell lymphoma (CBCL) starts in B cells",
        "context": [
            [
                "55_Cutaneous B-Cell Lymphomas_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_755",
        "type": "factual",
        "question": "What are common symptoms of cutaneous B-cell lymphoma?",
        "answer": [
            "Skin nodules, papules"
        ],
        "original_answer": [
            "Symptoms include skin nodules and papules."
        ],
        "evidence": "Symptoms of CBCL include skin nodules and papules",
        "context": [
            [
                "55_Cutaneous B-Cell Lymphomas_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_757",
        "type": "factual",
        "question": "What is the cell of origin for cutaneous T-cell lymphoma (CTCL)?",
        "answer": [
            "T lymphocytes"
        ],
        "original_answer": [
            "CTCL develops from abnormal T lymphocytes."
        ],
        "evidence": "Cutaneous T-cell lymphoma (CTCL) develops from abnormal T cells",
        "context": [
            [
                "55_Cutaneous B-Cell Lymphomas_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_758",
        "type": "factual",
        "question": "Which cancer type does primary cutaneous lymphoma (PCL) belong to?",
        "answer": [
            "Non-Hodgkin lymphoma"
        ],
        "original_answer": [
            "PCL is a type of non-Hodgkin lymphoma (NHL)."
        ],
        "evidence": "Primary cutaneous lymphoma (PCL) is a type of non-Hodgkin lymphoma found in the skin",
        "context": [
            [
                "55_Cutaneous B-Cell Lymphomas_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_759",
        "type": "factual",
        "question": "What type of blood cell are lymphocytes?",
        "answer": [
            "Lymphocytes"
        ],
        "original_answer": [
            "Lymphocytes are a type of white blood cell."
        ],
        "evidence": "Lymphocytes are a type of white blood cell that help fight infection",
        "context": [
            [
                "55_Cutaneous B-Cell Lymphomas_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_760",
        "type": "factual",
        "question": "What can unregulated growth of lymphocytes lead to?",
        "answer": [
            "Lymphoma"
        ],
        "original_answer": [
            "Unregulated growth of lymphocytes can develop into lymphoma."
        ],
        "evidence": "Unregulated growth of lymphocytes can develop into lymphoma",
        "context": [
            [
                "55_Cutaneous B-Cell Lymphomas_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_762",
        "type": "factual",
        "question": "What are the typical clinical appearances of CBCL on the skin?",
        "answer": [
            "CBCL, nodules, papules"
        ],
        "original_answer": [
            "CBCL appears as nodules or papules under the skin."
        ],
        "evidence": "CBCL appears as nodules or papules under the skin",
        "context": [
            [
                "55_Cutaneous B-Cell Lymphomas_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_765",
        "type": "factual",
        "question": "Which lymphocyte subtype gives rise to cutaneous T-cell lymphoma?",
        "answer": [
            "T lymphocytes"
        ],
        "original_answer": [
            "T lymphocytes give rise to cutaneous T-cell lymphoma."
        ],
        "evidence": "Cutaneous T-cell lymphoma (CTCL) develops from abnormal T cells",
        "context": [
            [
                "55_Cutaneous B-Cell Lymphomas_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_767",
        "type": "factual",
        "question": "What diagnostic method involves microscopic examination of tissue for CBCL?",
        "answer": [
            "Biopsy"
        ],
        "original_answer": [
            "Biopsy is used for microscopic examination of tissue in CBCL diagnosis."
        ],
        "evidence": "Diagnosis of CBCL involves skin exam, blood tests, imaging tests, biopsy, and immunophenotyping",
        "context": [
            [
                "55_Cutaneous B-Cell Lymphomas_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_768",
        "type": "factual",
        "question": "Which cancer subtype starts specifically in B cells?",
        "answer": [
            "Cutaneous B-cell lymphoma"
        ],
        "original_answer": [
            "Cutaneous B-cell lymphoma (CBCL) starts in B cells."
        ],
        "evidence": "Cutaneous B-cell lymphoma (CBCL) starts in B cells",
        "context": [
            [
                "55_Cutaneous B-Cell Lymphomas_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_769",
        "type": "factual",
        "question": "What are the two main cell origins for primary cutaneous lymphoma?",
        "answer": [
            "B lymphocytes, T lymphocytes"
        ],
        "original_answer": [
            "Primary cutaneous lymphoma develops from abnormal B or T lymphocytes."
        ],
        "evidence": "PCL develops from abnormal B or T lymphocytes",
        "context": [
            [
                "55_Cutaneous B-Cell Lymphomas_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_771",
        "type": "factual",
        "question": "Which test is used to analyze cell surface proteins in CBCL diagnosis?",
        "answer": [
            "Immunophenotyping"
        ],
        "original_answer": [
            "Immunophenotyping is used to analyze cell surface proteins."
        ],
        "evidence": "Diagnosis of CBCL involves skin exam, blood tests, imaging tests, biopsy, and immunophenotyping",
        "context": [
            [
                "55_Cutaneous B-Cell Lymphomas_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_772",
        "type": "factual",
        "question": "What laboratory test is commonly performed for CBCL diagnosis?",
        "answer": [
            "Blood test"
        ],
        "original_answer": [
            "Blood test is commonly performed for CBCL diagnosis."
        ],
        "evidence": "Diagnosis of CBCL involves skin exam, blood tests, imaging tests, biopsy, and immunophenotyping",
        "context": [
            [
                "55_Cutaneous B-Cell Lymphomas_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_773",
        "type": "factual",
        "question": "What type of lymphoma is cutaneous T-cell lymphoma (CTCL)?",
        "answer": [
            "Cutaneous T-cell lymphoma"
        ],
        "original_answer": [
            "CTCL is a cancer subtype of primary cutaneous lymphoma derived from T lymphocytes."
        ],
        "evidence": "Cutaneous T-cell lymphoma (CTCL) develops from abnormal T cells",
        "context": [
            [
                "55_Cutaneous B-Cell Lymphomas_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_774",
        "type": "factual",
        "question": "What are the characteristic skin lesions seen in CBCL?",
        "answer": [
            "Nodules, papules"
        ],
        "original_answer": [
            "Nodules and papules are characteristic skin lesions in CBCL."
        ],
        "evidence": "Symptoms of CBCL include skin nodules and papules",
        "context": [
            [
                "55_Cutaneous B-Cell Lymphomas_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_775",
        "type": "factual",
        "question": "Which white blood cell type can develop into lymphoma when growth is unregulated?",
        "answer": [
            "Lymphocytes"
        ],
        "original_answer": [
            "Lymphocytes can develop into lymphoma when growth is unregulated."
        ],
        "evidence": "Unregulated growth of lymphocytes can develop into lymphoma",
        "context": [
            [
                "55_Cutaneous B-Cell Lymphomas_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_776",
        "type": "factual",
        "question": "Which diagnostic method involves examining the skin for CBCL?",
        "answer": [
            "Skin exam"
        ],
        "original_answer": [
            "Skin exam is a diagnostic method for CBCL."
        ],
        "evidence": "Diagnosis of CBCL involves skin exam, blood tests, imaging tests, biopsy, and immunophenotyping",
        "context": [
            [
                "55_Cutaneous B-Cell Lymphomas_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_779",
        "type": "factual",
        "question": "Which subtype of cutaneous lymphoma is associated with B lymphocytes in the ontology?",
        "answer": [
            "Cutaneous B-cell lymphoma"
        ],
        "original_answer": [
            "Cutaneous B-cell lymphoma (CBCL) is associated with B lymphocytes."
        ],
        "evidence": "The ontology lists CBCL under B lymphocyte as cell of origin",
        "context": [
            [
                "55_Cutaneous B-Cell Lymphomas_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_780",
        "type": "factual",
        "question": "Which diagnostic method is used to identify genetic changes in CBCL?",
        "answer": [
            "Immunophenotyping"
        ],
        "original_answer": [
            "Immunophenotyping is used to identify genetic changes in CBCL."
        ],
        "evidence": "Diagnosis of CBCL involves skin exam, blood tests, imaging tests, biopsy, and immunophenotyping",
        "context": [
            [
                "55_Cutaneous B-Cell Lymphomas_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_783",
        "type": "factual",
        "question": "Which cell type is the origin of acute lymphoblastic leukemia (ALL)?",
        "answer": [
            "Lymphocytes"
        ],
        "original_answer": [
            "ALL starts in lymphocytes."
        ],
        "evidence": "Acute lymphoblastic leukemia (ALL) is a fast-growing blood cancer that starts in lymphocytes",
        "context": [
            [
                "48_Acute Lymphoblastic Leukemia in Children_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_784",
        "type": "factual",
        "question": "What are the two main subtypes of ALL?",
        "answer": [
            "B-cell ALL, T-cell ALL"
        ],
        "original_answer": [
            "The two main subtypes of ALL are B-cell ALL (B-ALL) and T-cell ALL (T-ALL)."
        ],
        "evidence": "ALL has two main subtypes: B-cell ALL (B-ALL) and T-cell ALL (T-ALL)",
        "context": [
            [
                "48_Acute Lymphoblastic Leukemia in Children_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_785",
        "type": "factual",
        "question": "Which subtype of ALL is more common, B-ALL or T-ALL?",
        "answer": [
            "B-ALL"
        ],
        "original_answer": [
            "B-ALL is more common than T-ALL."
        ],
        "evidence": "B-ALL starts in B-cell lymphocytes and is more common than T-ALL",
        "context": [
            [
                "48_Acute Lymphoblastic Leukemia in Children_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_787",
        "type": "factual",
        "question": "What is B-cell lymphoblastic lymphoma also called?",
        "answer": [
            "B-LL, B-LBL"
        ],
        "original_answer": [
            "B-cell lymphoblastic lymphoma is also called B-LL or B-LBL."
        ],
        "evidence": "B-cell lymphoblasts growing in lymph nodes is called B-cell lymphoblastic lymphoma (B-LL or B-LBL)",
        "context": [
            [
                "48_Acute Lymphoblastic Leukemia in Children_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_790",
        "type": "factual",
        "question": "What is the minimum percentage of lymphoblasts in bone marrow required for ALL diagnosis?",
        "answer": [
            "20 percent lymphoblasts"
        ],
        "original_answer": [
            "Diagnosis of ALL generally requires 20 percent or more lymphoblasts in the bone marrow."
        ],
        "evidence": "Diagnosis of ALL generally requires 20 percent or more lymphoblasts in the bone marrow",
        "context": [
            [
                "48_Acute Lymphoblastic Leukemia in Children_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_791",
        "type": "factual",
        "question": "What are the possible disease sites for ALL?",
        "answer": [
            "Bone marrow, blood, testicles, CNS"
        ],
        "original_answer": [
            "ALL can be found in bone marrow, blood, testicles, or central nervous system (CNS)."
        ],
        "evidence": "ALL can be found in bone marrow, blood, testicles, or central nervous system (CNS)",
        "context": [
            [
                "48_Acute Lymphoblastic Leukemia in Children_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_792",
        "type": "factual",
        "question": "Which subtype of ALL can cause an enlarged thymus?",
        "answer": [
            "T-cell ALL"
        ],
        "original_answer": [
            "T-cell ALL (T-ALL) can cause an enlarged thymus."
        ],
        "evidence": "T-ALL starts in T-cell lymphocytes and can cause an enlarged thymus",
        "context": [
            [
                "48_Acute Lymphoblastic Leukemia in Children_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_793",
        "type": "factual",
        "question": "What symptom can T-ALL cause due to an enlarged thymus?",
        "answer": [
            "Breathing problems"
        ],
        "original_answer": [
            "T-ALL can cause breathing problems due to an enlarged thymus."
        ],
        "evidence": "T-ALL can cause breathing problems due to an enlarged thymus",
        "context": [
            [
                "48_Acute Lymphoblastic Leukemia in Children_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_796",
        "type": "factual",
        "question": "Which subtype of B-ALL requires intensive systemic therapies?",
        "answer": [
            "BCR::ABL1-positive B-ALL"
        ],
        "original_answer": [
            "BCR::ABL1-positive B-ALL is treated with intensive systemic therapies."
        ],
        "evidence": "BCR::ABL1-positive B-ALL is treated with intensive systemic therapies",
        "context": [
            [
                "48_Acute Lymphoblastic Leukemia in Children_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_797",
        "type": "factual",
        "question": "For which cases are clinical trials preferred in ALL?",
        "answer": [
            "B-ALL, T-ALL"
        ],
        "original_answer": [
            "Clinical trials are preferred for certain B-ALL and T-ALL cases."
        ],
        "evidence": "Clinical trials are preferred for certain B-ALL and T-ALL cases",
        "context": [
            [
                "48_Acute Lymphoblastic Leukemia in Children_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_801",
        "type": "factual",
        "question": "Which lymphocyte subtype is the cell of origin for B-ALL?",
        "answer": [
            "B-cell lymphocytes"
        ],
        "original_answer": [
            "B-ALL starts in B-cell lymphocytes."
        ],
        "evidence": "B-ALL starts in B-cell lymphocytes and is more common than T-ALL",
        "context": [
            [
                "48_Acute Lymphoblastic Leukemia in Children_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_802",
        "type": "factual",
        "question": "Which lymphocyte subtype is the cell of origin for T-ALL?",
        "answer": [
            "T-cell lymphocytes"
        ],
        "original_answer": [
            "T-ALL starts in T-cell lymphocytes."
        ],
        "evidence": "T-ALL starts in T-cell lymphocytes and can cause an enlarged thymus",
        "context": [
            [
                "48_Acute Lymphoblastic Leukemia in Children_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_804",
        "type": "factual",
        "question": "Name two types of testing used to identify biomarkers in ALL.",
        "answer": [
            "Biomarker testing, pharmacogenomic testing"
        ],
        "original_answer": [
            "Biomarker testing and pharmacogenomic testing are used."
        ],
        "evidence": "Pharmacogenomic testing and biomarker/genetic testing are used in ALL management",
        "context": [
            [
                "48_Acute Lymphoblastic Leukemia in Children_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_807",
        "type": "factual",
        "question": "Which genetic alteration is a biomarker for B-ALL?",
        "answer": [
            "BCR::ABL1-positive"
        ],
        "original_answer": [
            "BCR::ABL1-positive is a biomarker for B-ALL."
        ],
        "evidence": "BCR::ABL1-positive B-ALL is treated with intensive systemic therapies",
        "context": [
            [
                "48_Acute Lymphoblastic Leukemia in Children_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_808",
        "type": "factual",
        "question": "What cancer type is characterized by fast growth and origin in lymphocytes?",
        "answer": [
            "Acute lymphoblastic leukemia"
        ],
        "original_answer": [
            "Acute lymphoblastic leukemia (ALL) is a fast-growing blood cancer that starts in lymphocytes."
        ],
        "evidence": "Acute lymphoblastic leukemia (ALL) is a fast-growing blood cancer that starts in lymphocytes",
        "context": [
            [
                "48_Acute Lymphoblastic Leukemia in Children_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_810",
        "type": "factual",
        "question": "Which site is affected in T-cell lymphoblastic lymphoma?",
        "answer": [
            "Thymus"
        ],
        "original_answer": [
            "T-cell lymphoblastic lymphoma involves the thymus."
        ],
        "evidence": "T-cell lymphoblasts growing in the thymus is called T-cell lymphoblastic lymphoma (T-LL or T-LBL)",
        "context": [
            [
                "48_Acute Lymphoblastic Leukemia in Children_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_811",
        "type": "factual",
        "question": "What symptom may result from T-ALL affecting the thymus?",
        "answer": [
            "Breathing problems"
        ],
        "original_answer": [
            "Breathing problems may result from T-ALL affecting the thymus."
        ],
        "evidence": "T-ALL can cause breathing problems due to an enlarged thymus",
        "context": [
            [
                "48_Acute Lymphoblastic Leukemia in Children_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_812",
        "type": "factual",
        "question": "Which age group requires a different treatment approach for ALL?",
        "answer": [
            "Infants"
        ],
        "original_answer": [
            "Infants (under 12 months) require a different treatment approach for ALL."
        ],
        "evidence": "Infant ALL (under 12 months) is treated differently than other age groups",
        "context": [
            [
                "48_Acute Lymphoblastic Leukemia in Children_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_814",
        "type": "factual",
        "question": "What is the most common subtype of rectal cancer?",
        "answer": [
            "Adenocarcinoma"
        ],
        "original_answer": [
            "Adenocarcinoma is the most common subtype of rectal cancer."
        ],
        "evidence": "Adenocarcinoma is the most common subtype of rectal cancer",
        "context": [
            [
                "36_Rectal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_815",
        "type": "factual",
        "question": "From which type of polyp do most rectal cancers originate?",
        "answer": [
            "Adenomatous polyps"
        ],
        "original_answer": [
            "Most rectal cancers start in adenomatous polyps."
        ],
        "evidence": "Most rectal cancers start in adenomatous polyps",
        "context": [
            [
                "36_Rectal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_816",
        "type": "factual",
        "question": "Which polyps rarely become cancerous in the rectum?",
        "answer": [
            "Hyperplastic polyps, inflammatory polyps"
        ],
        "original_answer": [
            "Hyperplastic and inflammatory polyps rarely turn into cancer."
        ],
        "evidence": "Hyperplastic and inflammatory polyps rarely turn into cancer",
        "context": [
            [
                "36_Rectal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_817",
        "type": "factual",
        "question": "How can most polyps be removed to prevent rectal cancer?",
        "answer": [
            "Polypectomy"
        ],
        "original_answer": [
            "Polypectomy during colonoscopy can remove most polyps and prevent cancer."
        ],
        "evidence": "Polypectomy during colonoscopy can remove most polyps and prevent cancer",
        "context": [
            [
                "36_Rectal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_818",
        "type": "factual",
        "question": "What are the recommended biomarkers to test in all rectal tumors?",
        "answer": [
            "dMMR, MSI-H"
        ],
        "original_answer": [
            "All rectal tumors should be tested for dMMR or MSI-H."
        ],
        "evidence": "All rectal tumors should be tested for dMMR or MSI-H",
        "context": [
            [
                "36_Rectal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_819",
        "type": "factual",
        "question": "Which biomarkers are associated with rectal cancer?",
        "answer": [
            "dMMR, MSI-H"
        ],
        "original_answer": [
            "Mismatch repair deficiency (dMMR) or microsatellite instability-high (MSI-H) are biomarkers in rectal cancer."
        ],
        "evidence": "Mismatch repair deficiency (dMMR) or microsatellite instability-high (MSI-H) are biomarkers in rectal cancer",
        "context": [
            [
                "36_Rectal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_820",
        "type": "factual",
        "question": "What genetic syndrome is a risk factor for rectal cancer?",
        "answer": [
            "Lynch syndrome"
        ],
        "original_answer": [
            "Lynch syndrome is a genetic risk factor for rectal cancer."
        ],
        "evidence": "Lynch syndrome is a genetic risk factor for rectal cancer",
        "context": [
            [
                "36_Rectal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_821",
        "type": "factual",
        "question": "Which genetic syndrome causes multiple polyps and increases rectal cancer risk?",
        "answer": [
            "Familial adenomatous polyposis"
        ],
        "original_answer": [
            "Familial adenomatous polyposis (FAP) is a genetic syndrome causing multiple polyps and increased rectal cancer risk."
        ],
        "evidence": "Familial adenomatous polyposis (FAP) is a genetic syndrome causing multiple polyps and increased rectal cancer risk",
        "context": [
            [
                "36_Rectal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_822",
        "type": "factual",
        "question": "What blood test is used for monitoring rectal cancer?",
        "answer": [
            "CEA"
        ],
        "original_answer": [
            "Blood tests such as CEA are used for monitoring rectal cancer."
        ],
        "evidence": "Blood tests such as CEA are used for monitoring rectal cancer",
        "context": [
            [
                "36_Rectal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_823",
        "type": "factual",
        "question": "Which imaging method is recommended for staging rectal cancer?",
        "answer": [
            "MRI"
        ],
        "original_answer": [
            "MRI of the pelvis is recommended for staging rectal cancer."
        ],
        "evidence": "MRI of the pelvis is recommended for staging rectal cancer",
        "context": [
            [
                "36_Rectal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_824",
        "type": "factual",
        "question": "What diagnostic tool can assess tumor extent and guide biopsy in rectal cancer?",
        "answer": [
            "Endorectal ultrasound"
        ],
        "original_answer": [
            "Endorectal ultrasound (EUS) can assess tumor extent and guide biopsy."
        ],
        "evidence": "Endorectal ultrasound (EUS) can assess tumor extent and guide biopsy",
        "context": [
            [
                "36_Rectal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_825",
        "type": "factual",
        "question": "Which scan is used to detect metastasis in rectal cancer?",
        "answer": [
            "CT scan"
        ],
        "original_answer": [
            "CT scan of chest and abdomen is used to detect metastasis."
        ],
        "evidence": "CT scan of chest and abdomen is used to detect metastasis",
        "context": [
            [
                "36_Rectal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_827",
        "type": "factual",
        "question": "Which surgical procedure is an option for T1 tumors at the end of the rectum?",
        "answer": [
            "Transanal local excision"
        ],
        "original_answer": [
            "Transanal local excision is an option for T1 tumors at the end of the rectum."
        ],
        "evidence": "Transanal local excision is an option for T1 tumors at the end of the rectum",
        "context": [
            [
                "36_Rectal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_828",
        "type": "factual",
        "question": "What surgical treatment is recommended for T2 and some T1/T3 rectal tumors?",
        "answer": [
            "Transabdominal surgery"
        ],
        "original_answer": [
            "Transabdominal surgery is recommended for T2 and some T1/T3 tumors."
        ],
        "evidence": "Transabdominal surgery is recommended for T2 and some T1/T3 tumors",
        "context": [
            [
                "36_Rectal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_829",
        "type": "factual",
        "question": "Which surgical procedure is used for tumors in the mid to upper rectum?",
        "answer": [
            "Low anterior resection"
        ],
        "original_answer": [
            "Low anterior resection (LAR) is used for tumors in the mid to upper rectum."
        ],
        "evidence": "Low anterior resection (LAR) is used for tumors in the mid to upper rectum",
        "context": [
            [
                "36_Rectal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_830",
        "type": "factual",
        "question": "What surgery is performed for tumors in the lower rectum?",
        "answer": [
            "Abdominoperineal resection"
        ],
        "original_answer": [
            "Abdominoperineal resection (APR) is used for tumors in the lower rectum."
        ],
        "evidence": "Abdominoperineal resection (APR) is used for tumors in the lower rectum",
        "context": [
            [
                "36_Rectal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_831",
        "type": "factual",
        "question": "What treatment is used for locally advanced rectal cancer?",
        "answer": [
            "Chemoradiation"
        ],
        "original_answer": [
            "Chemoradiation is used for locally advanced rectal cancer."
        ],
        "evidence": "Chemoradiation is used for locally advanced rectal cancer",
        "context": [
            [
                "36_Rectal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_832",
        "type": "factual",
        "question": "Which chemotherapy drugs may be included in rectal cancer regimens?",
        "answer": [
            "Oxaliplatin, Irinotecan"
        ],
        "original_answer": [
            "Chemotherapy regimens may include oxaliplatin or irinotecan."
        ],
        "evidence": "Chemotherapy regimens may include oxaliplatin or irinotecan",
        "context": [
            [
                "36_Rectal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_834",
        "type": "factual",
        "question": "Which procedure is recommended after surgery for surveillance of rectal cancer?",
        "answer": [
            "Colonoscopy"
        ],
        "original_answer": [
            "Colonoscopy is recommended after surgery for surveillance."
        ],
        "evidence": "Colonoscopy is recommended after surgery for surveillance",
        "context": [
            [
                "36_Rectal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_838",
        "type": "factual",
        "question": "Which genetic alterations are risk factors for rectal cancer?",
        "answer": [
            "Lynch syndrome, familial adenomatous polypos"
        ],
        "original_answer": [
            "Lynch syndrome and familial adenomatous polyposis (FAP) are risk factors for rectal cancer."
        ],
        "evidence": "Lynch syndrome is a genetic risk factor for rectal cancer; Familial adenomatous polyposis (FAP) is a genetic syndrome causing multiple polyps and increased rectal cancer risk",
        "context": [
            [
                "36_Rectal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_842",
        "type": "factual",
        "question": "What are the main symptoms of rectal cancer according to the ontology?",
        "answer": [
            "Rectal bleeding"
        ],
        "original_answer": [
            "The main symptoms are rectal bleeding, abdominal pain, and changes in bowel habits."
        ],
        "evidence": "Symptom: Rectal bleeding, Abdominal pain, Changes in bowel habits",
        "context": [
            [
                "36_Rectal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_843",
        "type": "factual",
        "question": "Which biomarkers are used for monitoring rectal cancer?",
        "answer": [
            "CEA blood test, ctDNA"
        ],
        "original_answer": [
            "CEA blood test and ctDNA are used for monitoring rectal cancer."
        ],
        "evidence": "Biomarker: CEA blood test, ctDNA",
        "context": [
            [
                "36_Rectal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_844",
        "type": "factual",
        "question": "What is the recommended imaging for surveillance after local excision of rectal cancer?",
        "answer": [
            "EUS or MRI"
        ],
        "original_answer": [
            "Imaging with EUS or MRI is recommended for surveillance after local excision."
        ],
        "evidence": "Imaging (EUS or MRI) every 3-6 months for 2 years, then every 6 months through year 5",
        "context": [
            [
                "36_Rectal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_845",
        "type": "factual",
        "question": "What is the most common subtype of bladder cancer?",
        "answer": [
            "Urothelial carcinoma"
        ],
        "original_answer": [
            "Urothelial carcinoma is the most common subtype."
        ],
        "evidence": "Urothelial carcinoma is the most common subtype of bladder cancer",
        "context": [
            [
                "4_Bladder Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_848",
        "type": "factual",
        "question": "Which stages of bladder cancer are considered non–muscle-invasive?",
        "answer": [
            "Stage 0, Stage 1"
        ],
        "original_answer": [
            "Stage 0 and Stage 1 bladder cancers are non–muscle-invasive."
        ],
        "evidence": "Stage 0 and Stage 1 bladder cancers are non–muscle-invasive",
        "context": [
            [
                "4_Bladder Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_849",
        "type": "factual",
        "question": "Which stages of bladder cancer are muscle-invasive?",
        "answer": [
            "Stages 2, 3, 4"
        ],
        "original_answer": [
            "Stages 2, 3, and 4 bladder cancers are muscle-invasive."
        ],
        "evidence": "Stages 2, 3, and 4 bladder cancers are muscle-invasive",
        "context": [
            [
                "4_Bladder Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_852",
        "type": "factual",
        "question": "What is the greatest risk factor for bladder cancer?",
        "answer": [
            "Smoking"
        ],
        "original_answer": [
            "Smoking is the greatest risk factor for bladder cancer."
        ],
        "evidence": "Smoking is the greatest risk factor for bladder cancer",
        "context": [
            [
                "4_Bladder Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_854",
        "type": "factual",
        "question": "What is the most common symptom of bladder cancer?",
        "answer": [
            "Hematuria"
        ],
        "original_answer": [
            "Blood in urine (hematuria) is the most common symptom."
        ],
        "evidence": "Blood in urine (hematuria) is the most common symptom of bladder cancer",
        "context": [
            [
                "4_Bladder Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_859",
        "type": "factual",
        "question": "What surgical procedures are used to treat bladder cancer?",
        "answer": [
            "TURBT, radical cystectomy, partial cyst"
        ],
        "original_answer": [
            "Surgery includes TURBT, radical cystectomy, and partial cystectomy."
        ],
        "evidence": "Surgery is a primary treatment for bladder cancer and includes TURBT, radical cystectomy, and partial cystectomy",
        "context": [
            [
                "4_Bladder Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_861",
        "type": "factual",
        "question": "What is the standard surgery for muscle-invasive bladder cancer?",
        "answer": [
            "Radical cystectomy"
        ],
        "original_answer": [
            "Radical cystectomy is the standard surgery for muscle-invasive bladder cancer."
        ],
        "evidence": "Radical cystectomy is the standard surgery for muscle-invasive bladder cancer",
        "context": [
            [
                "4_Bladder Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_862",
        "type": "factual",
        "question": "List urinary diversion procedures after bladder surgery.",
        "answer": [
            "Ileal conduit, neobladder"
        ],
        "original_answer": [
            "Urinary diversion procedures include ileal conduit, neobladder, and continent cutaneous pouch."
        ],
        "evidence": "Urinary diversion procedures include ileal conduit, neobladder, and continent cutaneous pouch",
        "context": [
            [
                "4_Bladder Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_867",
        "type": "factual",
        "question": "Which targeted therapies are available for bladder cancer?",
        "answer": [
            "Enfortumab vedotin, erdafitinib"
        ],
        "original_answer": [
            "Targeted therapies include enfortumab vedotin-ejfv (Padcev), erdafitinib (Balversa), and sacituzumab govitecan-hziy (Trodelvy)."
        ],
        "evidence": "Targeted therapies include enfortumab vedotin-ejfv (Padcev), erdafitinib (Balversa), and sacituzumab govitecan-hziy (Trodelvy)",
        "context": [
            [
                "4_Bladder Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_870",
        "type": "factual",
        "question": "Are clinical trials available for bladder cancer patients?",
        "answer": [
            "Clinical trials"
        ],
        "original_answer": [
            "Clinical trials are available at all stages of bladder cancer."
        ],
        "evidence": "Clinical trials are available at all stages of bladder cancer",
        "context": [
            [
                "4_Bladder Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_875",
        "type": "factual",
        "question": "Which procedures are included in follow-up and surveillance for bladder cancer?",
        "answer": [
            "Cystoscopy, urine cytology, imaging"
        ],
        "original_answer": [
            "Regular cystoscopy, urine cytology, imaging, and biomarker surveillance are included in follow-up and surveillance."
        ],
        "evidence": "Follow-up/Surveillance: [Regular cystoscopy, Urine cytology, Imaging, Biomarker surveillance]",
        "context": [
            [
                "4_Bladder Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_876",
        "type": "factual",
        "question": "What is the most common type of kidney cancer?",
        "answer": [
            "Renal cell carcinoma"
        ],
        "original_answer": [
            "Renal cell carcinoma (RCC) is the most common type."
        ],
        "evidence": "Renal cell carcinoma (RCC) is the most common type of kidney cancer",
        "context": [
            [
                "17_Kidney Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_877",
        "type": "factual",
        "question": "Which subtype is most common within renal cell carcinoma?",
        "answer": [
            "Clear cell RCC"
        ],
        "original_answer": [
            "Clear cell RCC is the most common subtype of RCC."
        ],
        "evidence": "Clear cell RCC is the most common subtype of RCC",
        "context": [
            [
                "17_Kidney Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_880",
        "type": "factual",
        "question": "Where does renal cell carcinoma originate in the kidney?",
        "answer": [
            "Renal tubules"
        ],
        "original_answer": [
            "RCC starts in the cells that line the renal tubules."
        ],
        "evidence": "RCC starts in the cells that line the renal tubules",
        "context": [
            [
                "17_Kidney Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_881",
        "type": "factual",
        "question": "Which kidney cancer type starts in the renal pelvis and ureter?",
        "answer": [
            "Urothelial carcinoma"
        ],
        "original_answer": [
            "Urothelial carcinoma starts in the cells lining the renal pelvis and ureter."
        ],
        "evidence": "Urothelial carcinoma starts in the cells lining the renal pelvis and ureter",
        "context": [
            [
                "17_Kidney Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_882",
        "type": "factual",
        "question": "Which kidney cancer type is most commonly seen in young children?",
        "answer": [
            "Wilms tumor"
        ],
        "original_answer": [
            "Wilms tumor usually occurs in young children and is a distinct kidney cancer type."
        ],
        "evidence": "Wilms tumor usually occurs in young children and is a distinct kidney cancer type",
        "context": [
            [
                "17_Kidney Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_883",
        "type": "factual",
        "question": "What kidney cancer type arises from the blood vessels or connective tissue?",
        "answer": [
            "Renal sarcoma"
        ],
        "original_answer": [
            "Renal sarcoma starts in the blood vessels or connective tissue of the kidney."
        ],
        "evidence": "Renal sarcoma starts in the blood vessels or connective tissue of the kidney",
        "context": [
            [
                "17_Kidney Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_884",
        "type": "factual",
        "question": "Name two anatomical structures in the kidney where cancer can spread locally.",
        "answer": [
            "Surrounding fat, blood vessels"
        ],
        "original_answer": [
            "Kidney cancer can spread locally to surrounding fat and blood vessels."
        ],
        "evidence": "Kidney cancer can spread locally to surrounding fat, blood vessels, lymph nodes, adrenal glands, and Gerota’s fascia",
        "context": [
            [
                "17_Kidney Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_885",
        "type": "factual",
        "question": "Which distant organs are common sites for kidney cancer metastasis?",
        "answer": [
            "Lungs, lymph nodes, bones, liver"
        ],
        "original_answer": [
            "Lungs, lymph nodes, bones, liver, and brain are common sites for metastasis."
        ],
        "evidence": "Kidney cancer can metastasize to distant sites such as lungs, lymph nodes, bones, liver, and brain",
        "context": [
            [
                "17_Kidney Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_889",
        "type": "factual",
        "question": "Which anatomical structure is the origin of RCC according to the ontology?",
        "answer": [
            "Renal tubules"
        ],
        "original_answer": [
            "RCC originates from the renal tubules."
        ],
        "evidence": "RCC starts in the cells that line the renal tubules",
        "context": [
            [
                "17_Kidney Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_890",
        "type": "factual",
        "question": "What is the anatomical location for urothelial carcinoma in the kidney?",
        "answer": [
            "Renal pelvis"
        ],
        "original_answer": [
            "Urothelial carcinoma originates from the renal pelvis."
        ],
        "evidence": "Urothelial carcinoma starts in the cells lining the renal pelvis and ureter",
        "context": [
            [
                "17_Kidney Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_891",
        "type": "factual",
        "question": "List three diagnostic tests for kidney cancer.",
        "answer": [
            "Imaging tests, blood tests, urine tests"
        ],
        "original_answer": [
            "Imaging tests, blood tests, and urine tests are diagnostic methods."
        ],
        "evidence": "Diagnosis of kidney cancer involves imaging tests, blood tests, urine tests, biopsy, biomarker testing, and genetic risk testing",
        "context": [
            [
                "17_Kidney Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_892",
        "type": "factual",
        "question": "Which subtype of RCC includes papillary and chromophobe RCC?",
        "answer": [
            "Non-clear cell RCC"
        ],
        "original_answer": [
            "Non-clear cell RCC includes papillary RCC and chromophobe RCC."
        ],
        "evidence": "Non-clear cell RCC includes papillary RCC, chromophobe RCC, collecting duct RCC, and renal medullary carcinoma",
        "context": [
            [
                "17_Kidney Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_893",
        "type": "factual",
        "question": "What is a histological subtype of non-clear cell RCC?",
        "answer": [
            "Papillary RCC"
        ],
        "original_answer": [
            "Papillary RCC is a histological subtype of non-clear cell RCC."
        ],
        "evidence": "Non-clear cell RCC includes papillary RCC, chromophobe RCC, collecting duct RCC, and renal medullary carcinoma",
        "context": [
            [
                "17_Kidney Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_894",
        "type": "factual",
        "question": "Which anatomical structure surrounds the kidney and can be invaded by cancer?",
        "answer": [
            "Gerota’s fascia"
        ],
        "original_answer": [
            "Gerota’s fascia surrounds the kidney and can be invaded by cancer."
        ],
        "evidence": "Kidney cancer can spread locally to surrounding fat, blood vessels, lymph nodes, adrenal glands, and Gerota’s fascia",
        "context": [
            [
                "17_Kidney Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_895",
        "type": "factual",
        "question": "What is a potential local spread site for kidney cancer besides fat and vessels?",
        "answer": [
            "Adrenal glands"
        ],
        "original_answer": [
            "Adrenal glands are a potential local spread site for kidney cancer."
        ],
        "evidence": "Kidney cancer can spread locally to surrounding fat, blood vessels, lymph nodes, adrenal glands, and Gerota’s fascia",
        "context": [
            [
                "17_Kidney Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_896",
        "type": "factual",
        "question": "Which diagnostic method is used to test for genetic risk in kidney cancer?",
        "answer": [
            "Genetic risk testing"
        ],
        "original_answer": [
            "Genetic risk testing is used for diagnosis."
        ],
        "evidence": "Diagnosis of kidney cancer involves imaging tests, blood tests, urine tests, biopsy, biomarker testing, and genetic risk testing",
        "context": [
            [
                "17_Kidney Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_898",
        "type": "factual",
        "question": "Which kidney cancer subtype is described as fumarate hydratase-deficient?",
        "answer": [
            "Fumarate hydratase-deficient RCC"
        ],
        "original_answer": [
            "Fumarate hydratase-deficient RCC is a non-clear cell RCC subtype."
        ],
        "evidence": "Fumarate hydratase-deficient RCC is listed under non-clear cell RCC in the ontology",
        "context": [
            [
                "17_Kidney Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_899",
        "type": "factual",
        "question": "Which cancer subtype is called nephroblastoma?",
        "answer": [
            "Wilms tumor"
        ],
        "original_answer": [
            "Wilms tumor is also known as nephroblastoma."
        ],
        "evidence": "Wilms tumor (nephroblastoma) is listed in the ontology",
        "context": [
            [
                "17_Kidney Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_900",
        "type": "factual",
        "question": "Which kidney cancer arises from the connective tissue?",
        "answer": [
            "Renal sarcoma"
        ],
        "original_answer": [
            "Renal sarcoma starts in the blood vessels or connective tissue of the kidney."
        ],
        "evidence": "Renal sarcoma starts in the blood vessels or connective tissue of the kidney",
        "context": [
            [
                "17_Kidney Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_902",
        "type": "factual",
        "question": "Which diagnostic method provides tissue for histology in kidney cancer?",
        "answer": [
            "Biopsy"
        ],
        "original_answer": [
            "Biopsy is the diagnostic method that provides tissue for histology."
        ],
        "evidence": "Diagnosis of kidney cancer involves imaging tests, blood tests, urine tests, biopsy, biomarker testing, and genetic risk testing",
        "context": [
            [
                "17_Kidney Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_903",
        "type": "factual",
        "question": "Which anatomical structure is a common site of distant metastasis from kidney cancer?",
        "answer": [
            "Lungs"
        ],
        "original_answer": [
            "The lungs are a common site of distant metastasis."
        ],
        "evidence": "Kidney cancer can metastasize to distant sites such as lungs, lymph nodes, bones, liver, and brain",
        "context": [
            [
                "17_Kidney Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_906",
        "type": "factual",
        "question": "Which anatomical structure is part of the kidney's blood supply and can be involved in local spread?",
        "answer": [
            "Renal vein"
        ],
        "original_answer": [
            "The renal vein is part of the blood supply and can be involved in local spread."
        ],
        "evidence": "Local spread includes blood vessels such as the renal vein",
        "context": [
            [
                "17_Kidney Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_907",
        "type": "factual",
        "question": "Which test is used to evaluate biomarkers in kidney cancer?",
        "answer": [
            "Biomarker testing"
        ],
        "original_answer": [
            "Biomarker testing is used to evaluate biomarkers."
        ],
        "evidence": "Diagnosis of kidney cancer involves imaging tests, blood tests, urine tests, biopsy, biomarker testing, and genetic risk testing",
        "context": [
            [
                "17_Kidney Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_908",
        "type": "factual",
        "question": "What is the most common subtype of anal cancer?",
        "answer": [
            "Anal squamous cell carcinoma"
        ],
        "original_answer": [
            "Anal squamous cell carcinoma is the most common subtype."
        ],
        "evidence": "Anal squamous cell carcinoma is the most common subtype of anal cancer",
        "context": [
            [
                "58_Anal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_909",
        "type": "factual",
        "question": "Which virus is the strongest risk factor for anal cancer?",
        "answer": [
            "HPV infection"
        ],
        "original_answer": [
            "HPV infection is the strongest risk factor."
        ],
        "evidence": "HPV infection is the strongest risk factor for anal cancer",
        "context": [
            [
                "58_Anal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_910",
        "type": "factual",
        "question": "Which high-risk HPV strain is associated with anal cancer?",
        "answer": [
            "HPV16"
        ],
        "original_answer": [
            "HPV16 is a high-risk strain associated with anal cancer."
        ],
        "evidence": "HPV16 is a high-risk strain associated with anal cancer",
        "context": [
            [
                "58_Anal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_911",
        "type": "factual",
        "question": "What is the primary treatment for most non-metastatic anal cancers (stages I-III)?",
        "answer": [
            "Chemoradiation"
        ],
        "original_answer": [
            "Chemoradiation is the recommended primary treatment."
        ],
        "evidence": "Chemoradiation is the recommended primary treatment for most non-metastatic anal cancers (stages I-III)",
        "context": [
            [
                "58_Anal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_912",
        "type": "factual",
        "question": "What chemotherapy regimens are recommended with radiation for anal cancer?",
        "answer": [
            "Mitomycin, capecitabine"
        ],
        "original_answer": [
            "Mitomycin and capecitabine, mitomycin and 5-FU, or 5-FU and cisplatin are recommended."
        ],
        "evidence": "Recommended chemotherapy regimens with radiation include mitomycin and capecitabine, mitomycin and 5-FU, or 5-FU and cisplatin",
        "context": [
            [
                "58_Anal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_914",
        "type": "factual",
        "question": "What is the AJCC TNM stage for distant metastasis in anal cancer?",
        "answer": [
            "Stage IV"
        ],
        "original_answer": [
            "Stage IV is defined as distant metastasis."
        ],
        "evidence": "Stage IV: distant metastasis",
        "context": [
            [
                "58_Anal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_915",
        "type": "factual",
        "question": "Which surgical procedure results in a permanent colostomy for anal cancer patients?",
        "answer": [
            "Abdominoperineal resection"
        ],
        "original_answer": [
            "Abdominoperineal resection (APR) results in a permanent colostomy."
        ],
        "evidence": "APR results in a permanent colostomy",
        "context": [
            [
                "58_Anal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_917",
        "type": "factual",
        "question": "Which imaging techniques are used in the diagnosis of anal cancer?",
        "answer": [
            "CT scan, MRI, PET scan"
        ],
        "original_answer": [
            "CT scan, MRI, and PET scan are used for diagnosis."
        ],
        "evidence": "CT scan, MRI, PET scan are used for diagnosis",
        "context": [
            [
                "58_Anal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_918",
        "type": "factual",
        "question": "What is the indication for local excision in anal cancer treatment?",
        "answer": [
            "Local excision"
        ],
        "original_answer": [
            "Local excision is an option for some early-stage, low-grade perianal cancers."
        ],
        "evidence": "Local excision is an option for some early-stage, low-grade perianal cancers",
        "context": [
            [
                "58_Anal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_919",
        "type": "factual",
        "question": "Which immunotherapy drugs are recommended for metastatic anal cancer that progresses after chemotherapy?",
        "answer": [
            "Nivolumab, pembrolizumab"
        ],
        "original_answer": [
            "Nivolumab and pembrolizumab are recommended."
        ],
        "evidence": "Immunotherapy (nivolumab, pembrolizumab) is recommended for metastatic anal cancer that progresses after chemotherapy",
        "context": [
            [
                "58_Anal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_920",
        "type": "factual",
        "question": "What is the preferred radiation technique for anal cancer?",
        "answer": [
            "IMRT"
        ],
        "original_answer": [
            "IMRT is the preferred radiation technique."
        ],
        "evidence": "IMRT is the preferred radiation technique for anal cancer",
        "context": [
            [
                "58_Anal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_923",
        "type": "factual",
        "question": "What is the most common site of origin for anal cancer?",
        "answer": [
            "Squamous cells"
        ],
        "original_answer": [
            "Anal cancer most often starts in squamous cells lining the anal canal."
        ],
        "evidence": "Anal cancer most often starts in squamous cells lining the anal canal",
        "context": [
            [
                "58_Anal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_926",
        "type": "factual",
        "question": "What precancerous lesions are associated with anal squamous cell carcinoma?",
        "answer": [
            "AIN, LSIL, HSIL, Stage"
        ],
        "original_answer": [
            "AIN, LSIL, HSIL, and Stage 0 are precancerous lesions."
        ],
        "evidence": "Anal squamous cell carcinoma: Precancerous Lesion: [AIN, LSIL, HSIL, Stage 0]",
        "context": [
            [
                "58_Anal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_927",
        "type": "factual",
        "question": "What are the consequences of abdominoperineal resection (APR)?",
        "answer": [
            "Permanent colostomy"
        ],
        "original_answer": [
            "APR results in a permanent colostomy."
        ],
        "evidence": "APR results in a permanent colostomy",
        "context": [
            [
                "58_Anal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_930",
        "type": "factual",
        "question": "What is the indication for groin dissection in anal cancer?",
        "answer": [
            "Lymph node recurrence"
        ],
        "original_answer": [
            "Groin dissection is indicated for lymph node recurrence."
        ],
        "evidence": "Groin dissection: Indication: Lymph node recurrence",
        "context": [
            [
                "58_Anal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_931",
        "type": "factual",
        "question": "What is the recommended treatment for persistent, recurrent, or locally progressive anal cancer?",
        "answer": [
            "Abdominoperineal resection"
        ],
        "original_answer": [
            "Abdominoperineal resection (APR) is recommended."
        ],
        "evidence": "Abdominoperineal resection (APR) is recommended for persistent, recurrent, or locally progressive anal cancer",
        "context": [
            [
                "58_Anal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_937",
        "type": "factual",
        "question": "Which populations are at increased risk of anal cancer due to immunosuppression?",
        "answer": [
            "HIV infection, immunosuppressant use"
        ],
        "original_answer": [
            "HIV infection and immunosuppressant use increase the risk of anal cancer."
        ],
        "evidence": "HIV infection increases the risk of anal cancer; Immunosuppressant use increases the risk of anal cancer",
        "context": [
            [
                "58_Anal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_938",
        "type": "factual",
        "question": "What is the standard method for diagnosing anal cancer after abnormal DRE or anoscopy?",
        "answer": [
            "Biopsy"
        ],
        "original_answer": [
            "Anal cancer is diagnosed by biopsy after abnormal findings on DRE or anoscopy."
        ],
        "evidence": "Anal cancer is diagnosed by biopsy after abnormal findings on DRE or anoscopy",
        "context": [
            [
                "58_Anal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_939",
        "type": "factual",
        "question": "Which AJCC TNM stage involves lymph node involvement and/or invasion of nearby organs in anal cancer?",
        "answer": [
            "Stage III"
        ],
        "original_answer": [
            "Stage III involves lymph node involvement and/or invasion of nearby organs."
        ],
        "evidence": "Stage III: lymph node involvement and/or invasion of nearby organs",
        "context": [
            [
                "58_Anal Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_940",
        "type": "factual",
        "question": "What is the primary cancer type described in this context?",
        "answer": [
            "Acute lymphoblastic leukemia"
        ],
        "original_answer": [
            "Acute lymphoblastic leukemia (ALL) is the primary cancer type."
        ],
        "evidence": "Acute lymphoblastic leukemia (ALL) is a fast-growing blood cancer that starts in lymphocytes",
        "context": [
            [
                "1_leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_941",
        "type": "factual",
        "question": "Which cells are the origin of ALL?",
        "answer": [
            "Lymphoid progenitor cells"
        ],
        "original_answer": [
            "ALL arises from lymphoid progenitor cells."
        ],
        "evidence": "ALL arises from lymphoid progenitor cells",
        "context": [
            [
                "1_leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_942",
        "type": "factual",
        "question": "What are the two main subtypes of acute lymphoblastic leukemia?",
        "answer": [
            "B-cell ALL, T-cell ALL"
        ],
        "original_answer": [
            "The two main subtypes are B-cell ALL (B-ALL) and T-cell ALL (T-ALL)."
        ],
        "evidence": "There are two main subtypes of ALL: B-cell ALL (B-ALL) and T-cell ALL (T-ALL)",
        "context": [
            [
                "1_leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_943",
        "type": "factual",
        "question": "Which ALL subtype is more common?",
        "answer": [
            "B-cell ALL"
        ],
        "original_answer": [
            "B-cell ALL (B-ALL) is more common than T-ALL."
        ],
        "evidence": "B-ALL starts in B-cell lymphocytes and is more common than T-ALL",
        "context": [
            [
                "1_leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_944",
        "type": "factual",
        "question": "What is the cell of origin for T-cell ALL?",
        "answer": [
            "T-cell lymphocytes"
        ],
        "original_answer": [
            "T-cell ALL starts in T-cell lymphocytes."
        ],
        "evidence": "T-ALL starts in T-cell lymphocytes and can cause an enlarged thymus",
        "context": [
            [
                "1_leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_945",
        "type": "factual",
        "question": "What diagnostic threshold defines ALL based on bone marrow lymphoblasts?",
        "answer": [
            "20 percent lymphoblasts"
        ],
        "original_answer": [
            "ALL is diagnosed when 20 percent or more lymphoblasts are present in the bone marrow."
        ],
        "evidence": "ALL is diagnosed when 20 percent or more lymphoblasts are present in the bone marrow",
        "context": [
            [
                "1_leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_947",
        "type": "factual",
        "question": "What are the common sites where ALL can be found?",
        "answer": [
            "Bone marrow, blood, testicles, CNS"
        ],
        "original_answer": [
            "ALL can be found in bone marrow, blood, testicles, and central nervous system."
        ],
        "evidence": "ALL can be found in bone marrow, blood, testicles, and central nervous system",
        "context": [
            [
                "1_leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_948",
        "type": "factual",
        "question": "Which ALL subtype can cause an enlarged thymus?",
        "answer": [
            "T-cell ALL"
        ],
        "original_answer": [
            "T-cell ALL (T-ALL) can cause an enlarged thymus."
        ],
        "evidence": "T-ALL starts in T-cell lymphocytes and can cause an enlarged thymus",
        "context": [
            [
                "1_leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_949",
        "type": "factual",
        "question": "What is mature B-cell ALL also called?",
        "answer": [
            "Burkitt leukemia"
        ],
        "original_answer": [
            "Mature B-cell ALL is also called Burkitt leukemia."
        ],
        "evidence": "Mature B-cell ALL (Burkitt leukemia) is a rare subtype and is treated differently from B-ALL",
        "context": [
            [
                "1_leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_951",
        "type": "factual",
        "question": "What is B-cell lymphoblastic lymphoma (B-LL/B-LBL)?",
        "answer": [
            "B-cell lymphoblastic lymphoma"
        ],
        "original_answer": [
            "B-cell lymphoblastic lymphoma occurs when B-cell lymphoblasts grow mostly in lymph nodes."
        ],
        "evidence": "B-cell lymphoblastic lymphoma (B-LL/B-LBL) occurs when B-cell lymphoblasts grow mostly in lymph nodes",
        "context": [
            [
                "1_leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_952",
        "type": "factual",
        "question": "Where do T-cell lymphoblastic lymphomas (T-LL/T-LBL) primarily grow?",
        "answer": [
            "Thymus"
        ],
        "original_answer": [
            "T-cell lymphoblastic lymphomas grow mostly in the thymus."
        ],
        "evidence": "T-cell lymphoblastic lymphoma (T-LL/T-LBL) occurs when T-cell lymphoblasts grow mostly in the thymus",
        "context": [
            [
                "1_leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_953",
        "type": "factual",
        "question": "What are the main treatment modalities for ALL?",
        "answer": [
            "Steroids, multiagent chemotherapy"
        ],
        "original_answer": [
            "Everyone with ALL is treated with steroids and multiagent chemotherapy."
        ],
        "evidence": "Everyone with ALL is treated with steroids and multiagent chemotherapy",
        "context": [
            [
                "1_leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_959",
        "type": "factual",
        "question": "What are some risk factors for developing ALL?",
        "answer": [
            "Genetic syndromes, family history"
        ],
        "original_answer": [
            "Risk factors for ALL include certain genetic syndromes and family history."
        ],
        "evidence": "Risk factors for ALL include certain genetic syndromes and family history",
        "context": [
            [
                "1_leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_961",
        "type": "factual",
        "question": "Which biomarker is associated with B-cell ALL?",
        "answer": [
            "BCR::ABL1"
        ],
        "original_answer": [
            "BCR::ABL1 is a biomarker associated with B-cell ALL."
        ],
        "evidence": "B-cell ALL (B-ALL): Biomarker: [BCR::ABL1, Other gene or chromosome changes]",
        "context": [
            [
                "1_leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_962",
        "type": "factual",
        "question": "What supportive care should be considered before ALL treatment?",
        "answer": [
            "Fertility preservation"
        ],
        "original_answer": [
            "Fertility preservation should be considered before treatment."
        ],
        "evidence": "Fertility preservation should be considered before treatment",
        "context": [
            [
                "1_leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_964",
        "type": "factual",
        "question": "What laboratory method is essential for immunophenotyping in ALL diagnosis?",
        "answer": [
            "Flow cytometry"
        ],
        "original_answer": [
            "Flow cytometry is essential for immunophenotyping in ALL diagnosis."
        ],
        "evidence": "Diagnosis of ALL involves flow cytometry, immunophenotyping",
        "context": [
            [
                "1_leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_965",
        "type": "factual",
        "question": "What genetic alteration is targeted in BCR::ABL1-positive B-ALL?",
        "answer": [
            "BCR::ABL1 fusion"
        ],
        "original_answer": [
            "BCR::ABL1 fusion is the genetic alteration targeted in BCR::ABL1-positive B-ALL."
        ],
        "evidence": "Genetic Alteration: [BCR::ABL1 fusion, Other gene or chromosome changes]",
        "context": [
            [
                "1_leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_966",
        "type": "factual",
        "question": "Which organs may show involvement in ALL besides bone marrow?",
        "answer": [
            "Blood, lymph nodes, thymus, testicles"
        ],
        "original_answer": [
            "ALL may involve blood, lymph nodes, thymus, testicles, and central nervous system."
        ],
        "evidence": "ALL can be found in bone marrow, blood, testicles, and central nervous system",
        "context": [
            [
                "1_leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_967",
        "type": "factual",
        "question": "What is the initial cell type affected in ALL?",
        "answer": [
            "Lymphoblasts"
        ],
        "original_answer": [
            "Lymphoblasts are the initial cell type affected in ALL."
        ],
        "evidence": "ALL is diagnosed when 20 percent or more lymphoblasts are present in the bone marrow",
        "context": [
            [
                "1_leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_968",
        "type": "factual",
        "question": "Which subtype of ALL is associated with an enlarged thymus?",
        "answer": [
            "T-cell ALL"
        ],
        "original_answer": [
            "T-cell ALL (T-ALL) is associated with an enlarged thymus."
        ],
        "evidence": "T-ALL starts in T-cell lymphocytes and can cause an enlarged thymus",
        "context": [
            [
                "1_leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_970",
        "type": "factual",
        "question": "Which diagnostic procedure is used to examine the central nervous system in ALL?",
        "answer": [
            "Lumbar puncture"
        ],
        "original_answer": [
            "Lumbar puncture is used to examine the central nervous system in ALL."
        ],
        "evidence": "Diagnosis of ALL involves lumbar puncture",
        "context": [
            [
                "1_leukemia_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_971",
        "type": "factual",
        "question": "What is the most common subtype of pancreatic cancer?",
        "answer": [
            "Pancreatic ductal adenocarcinoma"
        ],
        "original_answer": [
            "Pancreatic ductal adenocarcinoma (PDAC) is the most common subtype."
        ],
        "evidence": "Pancreatic ductal adenocarcinoma (PDAC) is the most common subtype of pancreatic cancer",
        "context": [
            [
                "33_Pancreatic Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_978",
        "type": "factual",
        "question": "What is another name for Stage IV pancreatic cancer?",
        "answer": [
            "Metastatic cancer"
        ],
        "original_answer": [
            "Stage IV pancreatic cancer is also known as metastatic cancer."
        ],
        "evidence": "Stage IV pancreatic cancer is metastatic cancer",
        "context": [
            [
                "33_Pancreatic Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_979",
        "type": "factual",
        "question": "List three risk factors for pancreatic cancer.",
        "answer": [
            "Smoking, alcohol use, unhealthy diet"
        ],
        "original_answer": [
            "Risk factors include smoking, heavy alcohol use, and unhealthy diet."
        ],
        "evidence": "Risk factors for pancreatic cancer include smoking, heavy alcohol use, unhealthy diet, exposure to pesticides, diabetes, chronic pancreatitis, and family history of certain cancers",
        "context": [
            [
                "33_Pancreatic Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_983",
        "type": "factual",
        "question": "Which test can detect inherited mutations linked to hereditary pancreatic cancer?",
        "answer": [
            "Genetic tests"
        ],
        "original_answer": [
            "Genetic tests can detect inherited mutations linked to hereditary pancreatic cancer."
        ],
        "evidence": "Genetic tests can detect inherited mutations linked to hereditary pancreatic cancer",
        "context": [
            [
                "33_Pancreatic Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_984",
        "type": "factual",
        "question": "What symptom may indicate pancreatic cancer?",
        "answer": [
            "Jaundice"
        ],
        "original_answer": [
            "Jaundice (yellowed skin or eyes) may indicate pancreatic cancer."
        ],
        "evidence": "Symptoms of pancreatic cancer may include jaundice (yellowed skin or eyes)",
        "context": [
            [
                "33_Pancreatic Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_985",
        "type": "factual",
        "question": "What treatment is an option for some patients with stage I, II, or III pancreatic cancer?",
        "answer": [
            "Surgery"
        ],
        "original_answer": [
            "Surgery is a treatment option for some patients with stage I, II, or III pancreatic cancer."
        ],
        "evidence": "Surgery is a treatment option for some patients with stage I, II, or III pancreatic cancer",
        "context": [
            [
                "33_Pancreatic Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_987",
        "type": "factual",
        "question": "Are clinical trials available for pancreatic cancer patients?",
        "answer": [
            "Clinical trials"
        ],
        "original_answer": [
            "Yes, clinical trials are available for pancreatic cancer patients."
        ],
        "evidence": "Clinical trials are available for pancreatic cancer patients",
        "context": [
            [
                "33_Pancreatic Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_990",
        "type": "factual",
        "question": "Which cancer type starts in the pancreas?",
        "answer": [
            "Pancreatic cancer"
        ],
        "original_answer": [
            "Pancreatic cancer is a type of cancer that starts in the pancreas."
        ],
        "evidence": "Pancreatic cancer is a type of cancer that starts in the pancreas",
        "context": [
            [
                "33_Pancreatic Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_991",
        "type": "factual",
        "question": "Which care team member specializes in imaging for diagnosis?",
        "answer": [
            "Diagnostic radiologist"
        ],
        "original_answer": [
            "A diagnostic radiologist specializes in imaging for diagnosis."
        ],
        "evidence": "Diagnostic radiologist is listed as a Care Team Role in the ontology",
        "context": [
            [
                "33_Pancreatic Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_992",
        "type": "factual",
        "question": "Who on the care team provides genetic counseling for pancreatic cancer?",
        "answer": [
            "Genetic counselor"
        ],
        "original_answer": [
            "A genetic counselor provides genetic counseling for pancreatic cancer."
        ],
        "evidence": "Genetic counselor is listed as a Care Team Role in the ontology",
        "context": [
            [
                "33_Pancreatic Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_993",
        "type": "factual",
        "question": "Which care team member is responsible for performing biopsies?",
        "answer": [
            "Pathologist"
        ],
        "original_answer": [
            "A pathologist is responsible for performing biopsies."
        ],
        "evidence": "Pathologist is listed as a Care Team Role in the ontology",
        "context": [
            [
                "33_Pancreatic Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_994",
        "type": "factual",
        "question": "Which care team professional manages drug treatments for pancreatic cancer?",
        "answer": [
            "Medical oncologist"
        ],
        "original_answer": [
            "A medical oncologist manages drug treatments for pancreatic cancer."
        ],
        "evidence": "Medical oncologist is listed as a Care Team Role in the ontology",
        "context": [
            [
                "33_Pancreatic Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_997",
        "type": "factual",
        "question": "Which diagnostic method is used to obtain tissue samples in pancreatic cancer?",
        "answer": [
            "Biopsy"
        ],
        "original_answer": [
            "Biopsy is used to obtain tissue samples in pancreatic cancer."
        ],
        "evidence": "Biopsy is listed as a Diagnostic Method for pancreatic cancer",
        "context": [
            [
                "33_Pancreatic Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_998",
        "type": "factual",
        "question": "Name a blood-based diagnostic method for pancreatic cancer.",
        "answer": [
            "Blood test"
        ],
        "original_answer": [
            "Blood test is a blood-based diagnostic method for pancreatic cancer."
        ],
        "evidence": "Blood test is listed as a Diagnostic Method for pancreatic cancer",
        "context": [
            [
                "33_Pancreatic Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_999",
        "type": "factual",
        "question": "Which lifestyle factor is a risk factor for pancreatic cancer?",
        "answer": [
            "Smoking"
        ],
        "original_answer": [
            "Smoking is a lifestyle risk factor for pancreatic cancer."
        ],
        "evidence": "Risk factors for pancreatic cancer include smoking",
        "context": [
            [
                "33_Pancreatic Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1001",
        "type": "factual",
        "question": "Which syndrome is characterized by increased risk of both melanoma and pancreatic cancer?",
        "answer": [
            "Familial malignant melanoma syndrome"
        ],
        "original_answer": [
            "Familial malignant melanoma syndrome (FAMMM syndrome) is associated with increased risk of both."
        ],
        "evidence": "Familial malignant melanoma syndrome, FAMMM syndrome, is listed under Genetic Syndrome increasing risk of pancreatic cancer",
        "context": [
            [
                "33_Pancreatic Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1003",
        "type": "factual",
        "question": "What is the primary cancer type discussed in this dataset?",
        "answer": [
            "Prostate cancer"
        ],
        "original_answer": [
            "Prostate cancer is the primary cancer type."
        ],
        "evidence": "Prostate cancer is a disease where cells in the prostate gland grow out of control",
        "context": [
            [
                "49_Prostate Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1004",
        "type": "factual",
        "question": "Which subtype of prostate cancer is confined to the prostate gland?",
        "answer": [
            "Localized prostate cancer"
        ],
        "original_answer": [
            "Localized prostate cancer is confined to the prostate."
        ],
        "evidence": "Localized prostate cancer is early-stage and confined to the prostate",
        "context": [
            [
                "49_Prostate Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1005",
        "type": "factual",
        "question": "What stage is regional prostate cancer classified as?",
        "answer": [
            "Regional prostate cancer"
        ],
        "original_answer": [
            "Regional prostate cancer is classified as advanced-stage."
        ],
        "evidence": "Regional prostate cancer has spread to nearby lymph nodes",
        "context": [
            [
                "49_Prostate Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1006",
        "type": "factual",
        "question": "Which organs can metastatic prostate cancer spread to?",
        "answer": [
            "Bones, liver, lungs"
        ],
        "original_answer": [
            "Metastatic prostate cancer can spread to bones, liver, or lungs."
        ],
        "evidence": "Metastatic prostate cancer has spread to distant organs such as bones, liver, or lungs",
        "context": [
            [
                "49_Prostate Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1007",
        "type": "factual",
        "question": "What blood test is commonly used for prostate cancer screening?",
        "answer": [
            "PSA test"
        ],
        "original_answer": [
            "The PSA test is commonly used for screening."
        ],
        "evidence": "PSA test and digital rectal exam are used for screening and diagnosis",
        "context": [
            [
                "49_Prostate Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1008",
        "type": "factual",
        "question": "What procedure is required to confirm a prostate cancer diagnosis?",
        "answer": [
            "Biopsy"
        ],
        "original_answer": [
            "A biopsy is required to confirm the diagnosis."
        ],
        "evidence": "Biopsy is required to confirm prostate cancer diagnosis",
        "context": [
            [
                "49_Prostate Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1009",
        "type": "factual",
        "question": "Which imaging modalities are used to assess the extent of prostate cancer?",
        "answer": [
            "MRI, CT, PET, ultrasound, bone scan"
        ],
        "original_answer": [
            "MRI, CT, PET, ultrasound, and bone scan are used to assess extent of disease."
        ],
        "evidence": "MRI, CT, PET, ultrasound, and bone scan are imaging methods used to assess extent of disease",
        "context": [
            [
                "49_Prostate Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1010",
        "type": "factual",
        "question": "Which genetic mutation increases the risk of prostate cancer?",
        "answer": [
            "BRCA2 mutation"
        ],
        "original_answer": [
            "BRCA2 mutation increases risk of prostate cancer."
        ],
        "evidence": "BRCA2 mutation increases risk of prostate cancer",
        "context": [
            [
                "49_Prostate Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1013",
        "type": "factual",
        "question": "Which grading systems are used to estimate prostate cancer aggressiveness?",
        "answer": [
            "Grade Group, Gleason score"
        ],
        "original_answer": [
            "Grade Group and Gleason score are used to estimate aggressiveness."
        ],
        "evidence": "Grade Group and Gleason score are used to estimate cancer aggressiveness",
        "context": [
            [
                "49_Prostate Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1016",
        "type": "factual",
        "question": "What is the mainstay of advanced prostate cancer treatment?",
        "answer": [
            "Androgen deprivation therapy"
        ],
        "original_answer": [
            "Androgen deprivation therapy (ADT) is a mainstay of advanced prostate cancer treatment."
        ],
        "evidence": "Androgen deprivation therapy (ADT) is a mainstay of advanced prostate cancer treatment",
        "context": [
            [
                "49_Prostate Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1017",
        "type": "factual",
        "question": "Which management strategy is recommended for low-risk, early-stage prostate cancer?",
        "answer": [
            "Active surveillance"
        ],
        "original_answer": [
            "Active surveillance is a management option for low-risk, early-stage prostate cancer."
        ],
        "evidence": "Active surveillance is a management option for low-risk, early-stage prostate cancer",
        "context": [
            [
                "49_Prostate Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1023",
        "type": "factual",
        "question": "Which genetic alterations are associated with metastatic prostate cancer?",
        "answer": [
            "BRCA1, BRCA2, ATM"
        ],
        "original_answer": [
            "BRCA1, BRCA2, ATM, CHEK2, MLH1, MSH2, MSH6, PALB2, PMS2, and FANCA are associated with metastatic prostate cancer."
        ],
        "evidence": "Metastatic prostate cancer: Genetic Alteration: BRCA1, BRCA2, ATM, CHEK2, MLH1, MSH2, MSH6, PALB2, PMS2, FANCA",
        "context": [
            [
                "49_Prostate Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1025",
        "type": "factual",
        "question": "Which blood and urine biomarker tests are used in prostate cancer diagnosis?",
        "answer": [
            "4Kscore, PHI, IsoPSA"
        ],
        "original_answer": [
            "4Kscore, PHI, IsoPSA, ExoDx, miR Sentinel, MPS, PCA3, and SelectMDx are used for biomarker testing."
        ],
        "evidence": "Blood and urine biomarker tests (4Kscore, PHI, IsoPSA, ExoDx, miR Sentinel, MPS, PCA3, SelectMDx)",
        "context": [
            [
                "49_Prostate Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1028",
        "type": "factual",
        "question": "Which imaging test is specifically used to detect bone metastases in prostate cancer?",
        "answer": [
            "Bone scan"
        ],
        "original_answer": [
            "Bone scan is used to detect bone metastases."
        ],
        "evidence": "Bone scan are imaging methods used to assess extent of disease",
        "context": [
            [
                "49_Prostate Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1029",
        "type": "factual",
        "question": "Which treatment is a surgical option for advanced prostate cancer?",
        "answer": [
            "Orchiectomy"
        ],
        "original_answer": [
            "Orchiectomy is a surgical option for advanced prostate cancer."
        ],
        "evidence": "Metastatic prostate cancer: Treatment: Orchiectomy",
        "context": [
            [
                "49_Prostate Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1030",
        "type": "factual",
        "question": "What is a common symptom of prostate cancer that affects sexual function?",
        "answer": [
            "Erectile dysfunction"
        ],
        "original_answer": [
            "Erectile dysfunction is a common symptom affecting sexual function."
        ],
        "evidence": "Symptom: Erectile dysfunction",
        "context": [
            [
                "49_Prostate Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1031",
        "type": "factual",
        "question": "Which demographic factor increases prostate cancer risk?",
        "answer": [
            "Black race"
        ],
        "original_answer": [
            "Black race increases the risk of prostate cancer."
        ],
        "evidence": "Risk Factor: Black race",
        "context": [
            [
                "49_Prostate Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1034",
        "type": "factual",
        "question": "What is the main hormonal therapy for advanced prostate cancer?",
        "answer": [
            "Androgen deprivation therapy"
        ],
        "original_answer": [
            "Androgen deprivation therapy (ADT) is the main hormonal therapy."
        ],
        "evidence": "Androgen deprivation therapy (ADT) is a mainstay of advanced prostate cancer treatment",
        "context": [
            [
                "49_Prostate Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1035",
        "type": "factual",
        "question": "What is the most common type of adrenal gland tumor?",
        "answer": [
            "Adenoma"
        ],
        "original_answer": [
            "Adenoma is the most common type of adrenal gland tumor."
        ],
        "evidence": "Adenoma is the most common type of adrenal gland tumor and can be functioning or nonfunctioning",
        "context": [
            [
                "65_Adrenal Tumors_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1036",
        "type": "factual",
        "question": "Which adrenal tumor arises from the adrenal cortex and is malignant?",
        "answer": [
            "Adrenocortical carcinoma"
        ],
        "original_answer": [
            "Adrenocortical carcinoma (ACC) is a rare malignant tumor of the adrenal cortex."
        ],
        "evidence": "Adrenocortical carcinoma (ACC) is a rare malignant tumor of the adrenal cortex",
        "context": [
            [
                "65_Adrenal Tumors_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1037",
        "type": "factual",
        "question": "What hormone is produced in excess by aldosteronoma?",
        "answer": [
            "Aldosterone"
        ],
        "original_answer": [
            "Aldosteronoma produces excess aldosterone."
        ],
        "evidence": "Aldosteronoma produces excess aldosterone",
        "context": [
            [
                "65_Adrenal Tumors_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1038",
        "type": "factual",
        "question": "Which adrenal tumor is associated with Cushing syndrome?",
        "answer": [
            "Adenoma"
        ],
        "original_answer": [
            "Adenoma producing excess cortisol causes Cushing syndrome."
        ],
        "evidence": "Adenoma producing excess cortisol causes Cushing syndrome",
        "context": [
            [
                "65_Adrenal Tumors_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1041",
        "type": "factual",
        "question": "What is the main population affected by neuroblastoma?",
        "answer": [
            "Children under 5"
        ],
        "original_answer": [
            "Neuroblastoma is a rare malignant adrenal tumor affecting mainly children under 5."
        ],
        "evidence": "Neuroblastoma is a rare malignant adrenal tumor affecting mainly children under 5",
        "context": [
            [
                "65_Adrenal Tumors_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1042",
        "type": "factual",
        "question": "Which adrenal tumor is often associated with high blood pressure and headaches?",
        "answer": [
            "Pheochromocytoma"
        ],
        "original_answer": [
            "Pheochromocytoma arises from the adrenal medulla and is often associated with high blood pressure, headache, rapid heartbeat, and sweating."
        ],
        "evidence": "Pheochromocytoma arises from the adrenal medulla and is often associated with high blood pressure, headache, rapid heartbeat, and sweating",
        "context": [
            [
                "65_Adrenal Tumors_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1048",
        "type": "factual",
        "question": "Which adrenal tumor originates from the adrenal medulla?",
        "answer": [
            "Pheochromocytoma"
        ],
        "original_answer": [
            "Pheochromocytoma originates from the adrenal medulla."
        ],
        "evidence": "Origin of Pheochromocytoma is Adrenal medulla",
        "context": [
            [
                "65_Adrenal Tumors_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1052",
        "type": "factual",
        "question": "Which adrenal tumor may metastasize to bones?",
        "answer": [
            "Neuroblastoma"
        ],
        "original_answer": [
            "Neuroblastoma may metastasize to bones."
        ],
        "evidence": "Spread of Neuroblastoma: May metastasize to bones",
        "context": [
            [
                "65_Adrenal Tumors_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1056",
        "type": "factual",
        "question": "What are the two functional categories of adenoma in the adrenal gland?",
        "answer": [
            "Functioning, nonfunctioning"
        ],
        "original_answer": [
            "Adenoma can be functioning or nonfunctioning."
        ],
        "evidence": "Adenoma is the most common type of adrenal gland tumor and can be functioning or nonfunctioning",
        "context": [
            [
                "65_Adrenal Tumors_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1057",
        "type": "factual",
        "question": "What is the biomarker for aldosteronoma?",
        "answer": [
            "Aldosterone"
        ],
        "original_answer": [
            "Aldosterone is the biomarker for aldosteronoma."
        ],
        "evidence": "Biomarker of Aldosteronoma: Aldosterone",
        "context": [
            [
                "65_Adrenal Tumors_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1058",
        "type": "factual",
        "question": "What is the biomarker for cortisol-producing adenoma?",
        "answer": [
            "Cortisol"
        ],
        "original_answer": [
            "Cortisol is the biomarker for cortisol-producing adenoma."
        ],
        "evidence": "Biomarker of Cortisol-producing Adenoma: Cortisol",
        "context": [
            [
                "65_Adrenal Tumors_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1059",
        "type": "factual",
        "question": "Which syndrome is associated with excess cortisol production by adrenal adenoma?",
        "answer": [
            "Cushing syndrome"
        ],
        "original_answer": [
            "Cushing syndrome is associated with cortisol-producing adenoma."
        ],
        "evidence": "Associated Syndrome of Cortisol-producing Adenoma: Cushing syndrome",
        "context": [
            [
                "65_Adrenal Tumors_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1060",
        "type": "factual",
        "question": "Which tests are used to identify hereditary risk factors for adrenal tumors?",
        "answer": [
            "Genetic testing"
        ],
        "original_answer": [
            "Genetic test is used to identify hereditary risk factors for adrenal tumors."
        ],
        "evidence": "Genetic testing may be performed to identify hereditary risk factors",
        "context": [
            [
                "65_Adrenal Tumors_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1065",
        "type": "factual",
        "question": "What is the most common type of invasive breast cancer?",
        "answer": [
            "Invasive ductal carcinoma"
        ],
        "original_answer": [
            "Invasive ductal carcinoma is the most common type."
        ],
        "evidence": "Invasive ductal carcinoma is the most common type of invasive breast cancer",
        "context": [
            [
                "16_Breast Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1066",
        "type": "factual",
        "question": "Which breast cancer subtype is noninvasive and found in the ducts?",
        "answer": [
            "Ductal carcinoma in situ"
        ],
        "original_answer": [
            "Ductal carcinoma in situ (DCIS) is a noninvasive breast cancer found in the ducts."
        ],
        "evidence": "Ductal carcinoma in situ (DCIS) is a noninvasive breast cancer found in the ducts",
        "context": [
            [
                "16_Breast Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1067",
        "type": "factual",
        "question": "What subtype of breast cancer is characterized by cancer cells blocking lymph vessels in the skin?",
        "answer": [
            "Inflammatory breast cancer"
        ],
        "original_answer": [
            "Inflammatory breast cancer (IBC) is characterized by cancer cells blocking lymph vessels in the skin."
        ],
        "evidence": "Inflammatory breast cancer (IBC) is a rare, aggressive subtype characterized by cancer cells blocking lymph vessels in the skin",
        "context": [
            [
                "16_Breast Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1069",
        "type": "factual",
        "question": "Which system is used for staging breast cancer?",
        "answer": [
            "TNM system"
        ],
        "original_answer": [
            "The TNM system (Tumor, Node, Metastasis) is used for breast cancer staging."
        ],
        "evidence": "Breast cancer staging uses the TNM system (Tumor, Node, Metastasis)",
        "context": [
            [
                "16_Breast Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1070",
        "type": "factual",
        "question": "What stage is assigned to noninvasive ductal carcinoma in situ (DCIS)?",
        "answer": [
            "Stage 0"
        ],
        "original_answer": [
            "Stage 0 is assigned to noninvasive DCIS."
        ],
        "evidence": "Stage 0 breast cancer is noninvasive (DCIS)",
        "context": [
            [
                "16_Breast Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1071",
        "type": "factual",
        "question": "Which stages of breast cancer are considered invasive?",
        "answer": [
            "Stages I-III"
        ],
        "original_answer": [
            "Stages I-III are invasive breast cancer."
        ],
        "evidence": "Stages I-III are invasive breast cancer",
        "context": [
            [
                "16_Breast Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1072",
        "type": "factual",
        "question": "What stage is metastatic breast cancer classified as?",
        "answer": [
            "Stage IV"
        ],
        "original_answer": [
            "Stage IV is metastatic breast cancer."
        ],
        "evidence": "Stage IV is metastatic breast cancer",
        "context": [
            [
                "16_Breast Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1074",
        "type": "factual",
        "question": "Which biomarkers are key for breast cancer?",
        "answer": [
            "Hormone receptor status, HER2 status"
        ],
        "original_answer": [
            "Hormone receptor status (ER, PR) and HER2 status are key biomarkers."
        ],
        "evidence": "Hormone receptor status (ER, PR) and HER2 status are key biomarkers for breast cancer",
        "context": [
            [
                "16_Breast Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1075",
        "type": "factual",
        "question": "What genetic mutations increase the risk of breast cancer?",
        "answer": [
            "BRCA1, BRCA2 mutations"
        ],
        "original_answer": [
            "BRCA1 and BRCA2 mutations increase the risk."
        ],
        "evidence": "BRCA1 and BRCA2 mutations increase the risk of breast cancer",
        "context": [
            [
                "16_Breast Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1076",
        "type": "factual",
        "question": "Which mutation can be targeted with specific therapies in breast cancer?",
        "answer": [
            "PIK3CA mutation"
        ],
        "original_answer": [
            "PIK3CA mutation can be targeted with specific therapies."
        ],
        "evidence": "PIK3CA mutation can be targeted with specific therapies",
        "context": [
            [
                "16_Breast Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1077",
        "type": "factual",
        "question": "Which biomarker status may influence immunotherapy options in breast cancer?",
        "answer": [
            "MSI-H/dMMR status"
        ],
        "original_answer": [
            "MSI-H/dMMR status may influence immunotherapy options."
        ],
        "evidence": "MSI-H/dMMR status may influence immunotherapy options",
        "context": [
            [
                "16_Breast Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1078",
        "type": "factual",
        "question": "Which biomarker may guide immunotherapy use in breast cancer?",
        "answer": [
            "PD-L1 expression"
        ],
        "original_answer": [
            "PD-L1 expression may guide immunotherapy use."
        ],
        "evidence": "PD-L1 expression may guide immunotherapy use",
        "context": [
            [
                "16_Breast Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1082",
        "type": "factual",
        "question": "What procedure is required for definitive diagnosis and biomarker testing in breast cancer?",
        "answer": [
            "Biopsy"
        ],
        "original_answer": [
            "Biopsy is required for definitive diagnosis and biomarker testing."
        ],
        "evidence": "Biopsy is required for definitive diagnosis and biomarker testing",
        "context": [
            [
                "16_Breast Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1083",
        "type": "factual",
        "question": "How is lymph node involvement assessed in breast cancer?",
        "answer": [
            "Sentinel lymph node biopsy"
        ],
        "original_answer": [
            "Sentinel lymph node biopsy is used to assess lymph node involvement."
        ],
        "evidence": "Sentinel lymph node biopsy is used to assess lymph node involvement",
        "context": [
            [
                "16_Breast Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1086",
        "type": "factual",
        "question": "Which therapy is used for hormone receptor-positive breast cancer?",
        "answer": [
            "Endocrine therapy"
        ],
        "original_answer": [
            "Endocrine therapy is used for hormone receptor-positive breast cancer."
        ],
        "evidence": "Endocrine therapy is used for hormone receptor-positive breast cancer",
        "context": [
            [
                "16_Breast Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1087",
        "type": "factual",
        "question": "What therapy is used for HER2-positive breast cancer?",
        "answer": [
            "HER2-targeted therapy"
        ],
        "original_answer": [
            "HER2-targeted therapy is used for HER2-positive breast cancer."
        ],
        "evidence": "HER2-targeted therapy is used for HER2-positive breast cancer",
        "context": [
            [
                "16_Breast Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1088",
        "type": "factual",
        "question": "Which therapy is used for BRCA-mutated, HER2-negative breast cancer?",
        "answer": [
            "PARP inhibitors"
        ],
        "original_answer": [
            "PARP inhibitors are used for BRCA-mutated, HER2-negative breast cancer."
        ],
        "evidence": "PARP inhibitors are used for BRCA-mutated, HER2-negative breast cancer",
        "context": [
            [
                "16_Breast Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1089",
        "type": "factual",
        "question": "Which inhibitors are used for hormone receptor-positive, HER2-negative breast cancer?",
        "answer": [
            "CDK4/6 inhibitors"
        ],
        "original_answer": [
            "CDK4/6 inhibitors are used for hormone receptor-positive, HER2-negative breast cancer."
        ],
        "evidence": "CDK4/6 inhibitors are used for hormone receptor-positive, HER2-negative breast cancer",
        "context": [
            [
                "16_Breast Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1093",
        "type": "factual",
        "question": "What should be discussed before starting breast cancer treatment regarding reproductive health?",
        "answer": [
            "Fertility preservation"
        ],
        "original_answer": [
            "Fertility preservation should be discussed before starting treatment."
        ],
        "evidence": "Fertility preservation should be discussed before starting treatment",
        "context": [
            [
                "16_Breast Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1094",
        "type": "factual",
        "question": "What patient factor is considered in treatment planning for breast cancer?",
        "answer": [
            "Performance status"
        ],
        "original_answer": [
            "Performance status is considered in treatment planning."
        ],
        "evidence": "Performance status is considered in treatment planning",
        "context": [
            [
                "16_Breast Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1096",
        "type": "factual",
        "question": "Which breast cancer subtype commonly presents with redness, swelling, and peau d’orange?",
        "answer": [
            "Inflammatory breast cancer"
        ],
        "original_answer": [
            "Inflammatory breast cancer (IBC) commonly presents with redness, swelling, and peau d’orange."
        ],
        "evidence": "Inflammatory breast cancer (IBC): Symptom: Redness, Swelling, Peau d’orange",
        "context": [
            [
                "16_Breast Cancer_processed",
                []
            ]
        ]
    },
    {
        "_id": "medical_type1_1097",
        "type": "factual",
        "question": "What is the main symptom of metastatic breast cancer involving bones?",
        "answer": [
            "Bone pain"
        ],
        "original_answer": [
            "Bone pain is a main symptom of metastatic breast cancer involving bones."
        ],
        "evidence": "Metastatic breast cancer (MBC): Symptom: Bone pain",
        "context": [
            [
                "16_Breast Cancer_processed",
                []
            ]
        ]
    }
]